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Enhancing Meniscus Repair through Biomaterial Design
Abstract
The knee meniscus is prone to damage, which leads to pain and inhibits mobility in the joint long term.
Due to the minimal vascularity, low cellularity and large mechanical forces imparted on the meniscus with
normal use, endogenous repair is limited. Resection of the damaged region of the tissue (meniscectomy)
remains the most common treatment for a torn meniscus, but this procedure results in cartilage
degradation and other adverse changes in the knee joint. Given the prevalence of meniscus damage,
there is thus a pressing need for novel approaches to meniscus repair. To address this issue, this thesis
developed in vitro techniques to analyze the time-varying properties of the aging meniscus, and to
address how the meniscus repair interface might be modulated through the use of growth factors.
Further, electrospun scaffolds were designed to replicate key architectures of the native tissue while
providing controlled release of biologic factors. Our findings demonstrated marked biological,
biochemical, and structural changes in meniscus with age. These findings pointed to key factors that
could play a role in meniscus integration (ie repair) capacity after meniscus injury; these factors were
evaluated in the context of meniscus repair using a mechanical in vitro model. To address situations
where substantial meniscus tissue would be removed, we tested the integration capacity of electrospun
scaffolds with native tissue and maturation of these scaffolds in response to growth factor regimens, as
well as how changes in scaffold characteristics (i.e. porosity and organization) and cell seeding
techniques influence integration potential. Finally, we developed novel techniques to deliver bioactive
growth factors and other molecules from components of electrospun scaffolds, including entrapped
microspheres, with distinct release profiles. These novel, bioactive scaffolds were utilized to orchestrate
complex regenerative signaling cascades from the scaffolds, with demonstration of efficacy via improved
vascular density in an in vivo model. This work provides new approaches for the treatment of meniscus
tears using novel electrospun materials, bringing us one step closer to new clinical options for meniscus
repair.
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Abstract
ENHANCING MENISCUS REPAIR THROUGH BIOMATERIAL DESIGN
Lara Ionescu Silverman
Supervisor: Dr. Robert Mauck
The knee meniscus is prone to damage, which leads to pain and inhibits mobility in the
joint long term. Due to the minimal vascularity, low cellularity and large mechanical
forces imparted on the meniscus with normal use, endogenous repair is limited.
Resection of the damaged region of the tissue (meniscectomy) remains the most
common treatment for a torn meniscus, but this procedure results in cartilage
degradation and other adverse changes in the knee joint. Given the prevalence of
meniscus damage, there is thus a pressing need for novel approaches to meniscus repair.
To address this issue, this thesis developed in vitro techniques to analyze the timevarying properties of the aging meniscus, and to address how the meniscus repair
interface might be modulated through the use of growth factors. Further, electrospun
scaffolds were designed to replicate key architectures of the native tissue while providing
controlled release of biologic factors. Our findings demonstrated marked biological,
biochemical, and structural changes in meniscus with age. These findings pointed to key
factors that could play a role in meniscus integration (ie repair) capacity after meniscus
injury; these factors were evaluated in the context of meniscus repair using a mechanical
in vitro model.

To address situations where substantial meniscus tissue would be

removed, we tested the integration capacity of electrospun scaffolds with native tissue
and maturation of these scaffolds in response to growth factor regimens, as well as how
changes in scaffold characteristics (i.e. porosity and organization) and cell seeding
techniques influence integration potential. Finally, we developed novel techniques to
deliver bioactive growth factors and other molecules from components of electrospun
scaffolds, including entrapped microspheres, with distinct release profiles. These novel,
bioactive scaffolds were utilized to orchestrate complex regenerative signaling cascades
from the scaffolds, with demonstration of efficacy via improved vascular density in an in
vivo model. This work provides new approaches for the treatment of meniscus tears
using novel electrospun materials, bringing us one step closer to new clinical options for
meniscus repair.
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1:

Introduction

1.1

Meniscus Structure and Function

The menisci are two semilunar cartilaginous structures in the knee that function to
transmit and distribute load from the femur to the tibia [1, 2], maintain knee joint
stability [3], and provide shock absorption [4]. The organization and composition of the
meniscus allows it to withstand both tensile and compressive forces [5] in order to
distribute load and protect the cartilage surfaces. The compressive equilibrium modulus
ranges from 25-350 kPa [6, 7] and the tensile modulus ranges from 100-300 MPa [4, 8],
depending on the species, sample location and testing parameters.

The tissue is composed primarily of water (72% of wet weight), as well as collagens (22%
of wet weight), proteoglycans (0.8% of wet weight), and a number of other trace
components that contribute to meniscus function [5, 9]. Meniscus is made up of sparsely
populated fibrochondrocytes that vary in shape according to region [10]. Further, it
withstands its complex loading environment with a carefully tuned architecture that
features circumferentially oriented collagen bundles opposing tensile deformation [11]
and glycosaminoglycans (GAG) concentrated in the inner region withstanding
compressive deformation [12-14]. In the adult, the meniscus has a limited vascular
supply, with vessel infiltrating only to the outer third [15].

1.2

Meniscus Injury and Repair

Tears or injury to the meniscus are very common, with 600,000 meniscus surgeries
annually in the US [16] and meniscus surgery being the most prevalent of all orthopedic
surgeries [17]. A typical procedure to address meniscus damage involves removal of the
injured portion, since tears, particularly in the inner avascular region, rarely heal [18].
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Unfortunately, resection changes load bearing and presages the long-term development
of osteoarthritis [19, 20], prompting surgical methods towards maintaining as much of
the original structure as possible [21]. Sutures [22], arrows or screws [23], and the use of
the collagen implant [24] or a cadaveric allograft [25] in extreme cases, have all been
explored with moderate clinical success.

Over and above stabilizing the damaged segment, many clinical solutions have been
predicated on expanding the vascular supply to the damaged area to promote natural
healing, since tears in the vascular region of the meniscus heal [18, 26-28]. Solutions
such as rasping [29], vascular channels [26, 27], and the application of fibrin glue [30]
all utilize this idea. The concept seems particularly promising as young patients with a
more completely vascularized meniscus [15, 18, 26, 31, 32] rarely present with meniscal
injuries [33].

Many interesting techniques have been recently explored that may some day be used in
the clinic. Rather than connecting a meniscus tear with a fabricated material such as a
suture, a biological ‘glue’ such as platelet rich plasm (PRP) [34] may support biomimetic
integration. Further, rather than adding a material to promote repair, chemicals could be
delivered locally that promote integration. For example, chemicals to suppress MMPs
and cytokines could be used in order to bolster natural healing [35-39].

1.3

Tissue Engineering Strategies for Meniscus Repair to Date

In the instance where damage is too great, a meniscus replacement would be necessary
to replace the resected tissue. This material could be permanent and impermeable to
cells; however, such materials would likely face long-term issues such as dislodging,
immune responses, wear, fatigue and failure. In contrast, a tissue engineering approach
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could be utilized, where the combination of a temporary scaffold, chemical/mechanical
cues and cells could be used to create meniscus tissue [40]. The integration of such a
material into the existing tissue is of paramount importance in order to reestablish the
mechanical and structural capabilities of the tissue. Other important factors are relevant
mechanical properties as well as favorable conditions for the proliferation and matrix
deposition by fibrochondrocytes or stem cells induced to become fibrochondrocyte-like
cells. While many envision a temporary material to replace a region of meniscus, it may
also be possible to design a full meniscus replacement that would feature bone insertions
mimicking meniscal horns; however, such a material would provide significantly more
design challenges.

Numerous materials have been tested for meniscus tissue engineering, including
collagen [24], small intestinal submucosa (SIS) [41-43], dermis [44], estane [45],
polyurethane [46], agarose gels [47] and alginate [48], to name a few [49]. While it is
evident that many strategies have been explored, none except for the collagen meniscus
implant has reached clinical availability, although its efficiency is not yet clearly
demonstrated [24].

To expand the palette of materials for meniscus tissue engineering, we have developed a
nanofibrous electrospun scaffold. This material mimics the mechanical properties of the
tissue relatively well and emulates the collagen bundle architecture of native meniscus.
The fabrication technique is relatively simple and robust, and it could be easily modified
to incorporate other features, such a sacrificial fibers, microspheres, biological factors or
cells. In these scaffolds, MFCs and mesenchymal stem cells infiltrate and deposit ordered
matrix, generating an engineered tissue with physiologically relevant mechanical
properties [50-53].
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1.4

Thesis Overview and Specific Aims

In this thesis, we will explore the physiological properties of aging meniscus as well as
potential biomaterials for its repair. Specifically, we will analyze changes in biochemical
content and matrix formation capacity in the tissue with aging, and will test the repair
potential mechanically using an in vitro integration model (Chapter 2, 3). These
chapters address Aim 1: Characterize fetal, juvenile and adult meniscus to define native
tissue and cell properties, and potential limiters of adult healing. We will also identify
fundamental differences between immature and mature meniscus cells in both ovine and
bovine tissue, and subsequently choose relevant growth factors that successfully bolster
the repair of an avascular meniscus tear in vitro (Chapter 3, 4) according to Aim 3:
Promote meniscus integration in vitro through modulation of adult extracellular
matrix (ECM) and soluble environment. Next, we will apply the in vitro integration
model to electrospun scaffolds, and analyze the role of growth factors in scaffold
integration and maturation (Chapter 4). We will also modify the characteristics of the
scaffold (porosity, alignment) and the cell seeding technique, and identify optimal
conditions for repair (Chapter 5). Chapter 4 and 5 address Aim 4: Investigate the
integration and maturation of electrospun composites adjacent to native meniscus
tissue in vitro. In order to transition to the in vivo environment, we will review current
techniques for delivering molecules from electrospun scaffolds, with a special focus on
growth factors (Chapter 6). Next, we will present a novel fabrication technique to
entrap drug-delivering microspheres between structural electrospun fibers (Chapter 7)
that addresses Aim 2: Create a microsphere/nanofiber composite scaffold with drug
delivering capacity. Finally, we will deliver growth factors from these microspheres, as
well as from the fibers themselves, and stimulate both proliferation and angiogenesis in
vivo (Chapter 8) as described in Aim 5: Evaluate biomaterial-driven meniscus repair
in an in vivo model. This work represents significant steps forward in our understanding
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of the knee meniscus and in the potential of using electrospun scaffold for meniscus
tissue engineering.
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2:

The Differential Regenerative Potential of Fetal and
Adult Meniscus Fibrochondrocytes

2.1

Abstract

The adult knee meniscus is prone to injury and has limited intrinsic healing potential,
with few successful therapeutic options for repair. In order to direct the development of
new approaches for meniscus repair, we investigated the properties of the fetal and adult
meniscus tissue and isolated meniscus fibrochondrocytes (MFCs). While little data exists
on meniscus repair potential as a function of age, other related fibrous and cartilaginous
tissues have been shown to heal regeneratively in the fetal environment. Further,
significantly fewer young patients present clinically with meniscus tears compared to
adults. We hypothesized that fetal meniscus cells would be more active than their adult
counterparts. Our results showed that while meniscus structure changed with
development, cellular characteristics such as migration and proliferation were
comparable. However, when cultured in three-dimensional pellets, adult cells responded
less robustly than fetal cells to the addition of the chondrogenic growth factor TGF-β,
with markedly lower improvements in weight, DNA, glycosaminoglycan (GAG), and
collagen content after 42 days, supporting our hypothesis. Taken together, this work
demonstrates that while the proliferative and migratory capacity of MFCs do not
diminish with age in the ovine meniscus, the ability to deposit matrix in the presence of
TGF-β decreases by adulthood. These findings may provide novel directions for adult
meniscus repair strategies through the promotion of matrix deposition as well as guide
the development of tissue engineered meniscus repair approaches.
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2.2

Introduction

The menisci are two semilunar cartilaginous structures in the knee that function to
transmit and distribute load from the femur to the tibia [1, 2], maintain knee joint
stability [3], and provide shock absorption [4]. The organization and composition of the
meniscus allows it to withstand both tensile and compressive forces [5] in order to
distribute load and protect the cartilage surfaces. The tissue is composed primarily of
water (72% of wet weight), as well as collagens (22% of wet weight), proteoglycans (0.8%
of wet weight), and a number of other trace components that contribute to meniscus
function [5, 9]. The meniscus withstands its complex loading environment with a
carefully tuned architecture that features circumferentially oriented collagen bundles
opposing tensile deformation [11] and glycosaminoglycans (GAG) concentrated in the
inner region withstanding compressive deformation [12-14]. In the adult, the meniscus
has a limited vascular supply, with vessel infiltration only to the outer third [15].

Tears or injury to the meniscus are very common and lead to degenerative changes in the
knee such as osteoarthritis [19, 20]. A typical procedure to address meniscus damage
involves removal of the injured portion, since tears, particularly in the inner avascular
region, rarely heal [18]. However, resection changes load bearing and presages the longterm development of osteoarthritis, prompting surgical methods towards maintaining
maintain as much of the original structure as possible [21]. Sutures [22], arrows or
screws [23], and the use of a collagen implant [24] or allograft [25] in extreme cases,
have all been explored with moderate clinical success.

Over and above stabilizing the damaged segment, many clinical solutions have been
predicated on expanding the vascular supply to the damaged area to promote natural
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healing. Solutions such as rasping [29], vascular channels [26, 27], and the application of
fibrin glue [30] all utilize this concept. The concept seems particularly promising as
young patients with a more completely vascularized meniscus [31] rarely present with
meniscal injuries. In addition to vascular supply, other factors, such as cell density,
extracellular matrix (ECM) properties and sensitivity to growth factors, may also
distinguish healing in the young meniscus from the failure to heal in the adult meniscus.
In fact, it has been observed that related fiber-reinforced fetal tissues with similarly
limited vascular supply heal regeneratively, including articular cartilage [54] and tendon
[55, 56]. Those findings suggest that meniscus may also heal regeneratively during fetal
development based on factors not associated with is vascular network.

In this work, we explored how fetal and adult ovine menisci and meniscus
fibrochondrocytes (MFCs) vary with development. Previous studies have shown that
cells from related tissues, such as ACL fibroblasts [57], tendon fibroblasts [58], and
chondrocytes [59, 60], lose the capacity to proliferate and/or migrate with age, while
other tissues such as dermal fibroblasts do not [61]. Additional studies have
demonstrated a marked decrease in matrix forming capacity with development [57-59,
61, 62]. Based on these findings, we hypothesized that the proliferation, migration and
matrix forming capacity of meniscus fibrochondrocytes (MFCs) would decrease with age.
To test this hypothesis, we extracted MFCs from fetal and adult ovine menisci and
performed migration and proliferation studies. Further, we cultured pellets of MFCs in a
chemically defined media with the addition of the chondrogenic growth factors TGF-β1
or -β3, known to be involved uniquely in the fetal environment and in adult healing [63,
64]. We found major changes in the ECM distribution and cell density between fetal and
adult ovine menisci. However, fetal and adult MFCs proliferated and migrated at the
same rate once extracted from the tissue. When grown in pellets, fetal MFCs responded
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more robustly to TGF-β than adult cells by proliferating and depositing more ECM,
particularly GAG. Our findings suggest that while adult MFCs do not lose the ability to
migrate or proliferate to an injury site, a diminished capacity to deposit matrix may be a
limiting factor in meniscus healing in adult tissue. Such findings may direct novel clinical
solutions for meniscus injury repair in adults.

2.3

Materials and Methods

2.3.1

Tissue Source

Hinds limbs from mid gestation (~75 days) ovine fetuses and skeletally mature adults
were isolated from waste tissue from an unrelated study. Approval from the Institutional
Animal Care and Use Committee (IACUC) at the University of Pennsylvania was
obtained for the transfer and use of all tissue.

2.3.2

Histological Analysis of Meniscus as a Function of Age

To establish baseline histological features of the meniscus as a function of age, hind
limbs were isolated from ovine fetuses and disarticulated. The tibial plateau with
adjoining menisci were fixed for 2-3 days in 4% paraformaldahyde and paraffin
embedded. Similarly, maternal hind limbs were disarticulated and the medial menisci
were carefully removed by cutting the horns and exterior rim of the synovium, fixed, and
prepared for histology as above. Tissue was sectioned to 7 µm thickness in the axial and
coronal directions and affixed to glass slides. Sections were stained with either Alcian
Blue to identify proteoglycans (PG), Picrosirius Red to identify collagens, or hematoxylin
and eosin (H&E) to identify cell nuclei and matrix structure.
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2.3.3

Analysis of Migratory and Replicative Capacity of Fetal and Adult Meniscus
Fibrochondrocytes

For cell culture studies, medial menisci from twin ~75 day old sheep fetuses and the
corresponding maternal sheep were aseptically dissected. Care was taken to remove any
remaining synovium from the outer rim of the menisci, and the entire meniscus tissue
was plated due to the small size of the fetal tissue and resulting inability to separate
inner and outer regions. The menisci were diced into 1 mm3 pieces and plated onto tissue
culture plates in a basal medium (BM) consisting of high glucose DMEM supplemented
with 10% fetal bovine serum (FBS) and 1% penicillin/streptomyosin/fungizone (PSF). To
determine the rate of emergence of MFCs from the tissue, ~20 mg of diced menisci was
cultured for 7 days (ensuring sub-confluency) and the cells were trypsinized and
counted. MFCs from each twin fetus and from the maternal source were maintained
separately. Cell number was normalized by the initial tissue mass. For further studies,
MFCs were expanded to passage 2 in BM.

To determine whether proliferation rate was age dependent, 20,000 passage 2 cells from
each fetal and the maternal menisci were plated in BM in individual wells of a 6-well
tissue-culture treated plate. Every day, in triplicate, MFCs were lysed with distilled
water, dislodged with a cell scraper, and analyzed for DNA content using the PicoGreen
dsDNA assay (Invitrogen, Carlsbad, CA). To assess migration capacity, confluent layers
of cells on tissue-culture treated plastic were scratched using the tip of a 0.1-10 µl sterile
plastic pipette. The wells were washed twice with PBS to remove cell debris and filled
with BM. Light microscope images were captured at the onset and after 15 hours to
observe cell migration into the gap. All studies were performed in triplicate, with one
representative study shown.
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2.3.4

Analysis of Matrix Accumulation in 3D Pellet Culture

After expansion through passage 2, 250,000 cells from each fetal meniscus and the
maternal adult meniscus (fetus 1, fetus 2, adult) were formed into pellets in 96-well
conical plates (Nunc, Thermo Scientific, Waltham MA). Pellet culture has been used
previously as a three-dimensional chondrogenic environment that fosters meniscus-like
tissue deposition [65]. Pellets were maintained in four media conditions: BM
supplemented with 50 mg/ml ascorbate 2-phosphate; a chemically defined media (CDM; high glucose DMEM with 1X PSF, 0.1 mM dexamethasone, 50 mg/ml ascorbate 2phosphate, 40 mg/ml L-proline, 100 mg/ml sodium pyruvate, 6.25 mg/ml insulin, 6.25
mg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum albumin, and
5.35 mg/ml linoleic acid); CDM supplemented with 10 ng/ml TGF-β1 (CDM+β1); CDM
supplemented with TGF-β3 (CDM+β3).

At 2 week intervals, pellets were removed from culture, situated in agarose, paraffin
embedded, sectioned and stained as described above. On additional sections,
immunohistochemical analysis was carried out to visualize the location of Collagen I and
Collagen II [66]. Briefly, samples underwent antigen retrieval with 300 mg/mL
hyaluronidase (Type IV, Sigma, St. Louis, MO), 3% H2O2, and blocking reagent (DAB150
IHC Select, Millipore, Billerica, MA). Samples were then treated with antibodies (5
µg/mL) to Col I (MAB3391, Millipore) or Col II (11e-116B3, Developmental Studies
Hybridoma Bank, Iowa City, IA) in 3% BSA (control sections treated with 3% BSA only).
Finally, biotinylated goat anti-rabbit IgG secondary antibody conjugated with
streptavidin horseradish peroxidase was localized to primary antibodies, and color
developed with 3,30-diaminobenzidine (DAB) chromagen reagent (DAB150 IHC Select,
Millipore).
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Biochemical content of pellets from each condition was determined after papain
digestion. The digestate was analyzed for DNA content (Picogreen Assay, Invitrogen,
Carlsbad, CA), sulfated glycosaminoglycan (s-GAG) content (DMMB Assay [67]) and
collagen content (OHP assay [68] using a conversion factor 7.14 to convert to collagen
content. This work was performed in triplicate with n=3 (2 to 3 pellets per n), with the
results of one representative study shown.

2.3.5

Statistical Analysis

Two-way analysis of variance (ANOVA) was carried out using SYSTAT software
(Chicago, IL) with Bonferonni’s post-hoc tests (n=3), with significance set at p < 0.05.

2.4

Results

2.4.1

Histological Analysis of Meniscus as a Function of Age

Histological analysis revealed considerable changes from the fetal meniscus to the
mature, adult meniscus. Developmentally, the meniscus is distinct in composition from
the underlying cartilaginous tibial plateau (Fig 2-1A). The fetal meniscus stained
strongly for collagen (red) while the cartilage below stained strongly for proteoglycans
(PG, blue). Further, only a faint quantity of PG was observed in the inner tip of the fetal
meniscus (Fig 2-1A). Similarly, the adult meniscus stained strongly for collagen, but in
contrast, PG was present throughout the meniscus, although less dense in the central
region of the tissue (Fig 2-1B). Closer inspection revealed that the fetal meniscus was
densely populated with cells located between thin and undulating collagen bundles (Fig
2-1C). In the adult meniscus, the cell density was considerably lower and the collagen
bundles appeared linear and were larger and more robust (Fig 2-1D). Indeed, sectioning
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for histology was more difficult when cutting perpendicular to the collagen bundles in
the adult compared to the fetal meniscus.

Figure 2-1 Histological sections of fetal (A) and adult (B) ovine meniscus, stained with Picrosirius
Red for collagens and Alcian Blue for proteoglycans (PG). The meniscus increases in size as the
animal matures and an increase in PG content and distribution is evident. (Adult: 13mm, Fetal:
1.5mm). Hematoxylin and eosin (H&E) staining of fetal (C) and mature adult (D) meniscus
demonstrates a decrease in cell density and increase in collagen bundle thickness as the animal
matures (Scale = 50 µm). After plating minced fetal (E) and adult (F) meniscus, light micrographs
reveal significantly more cells emerging from the fetal tissue which were larger in size and more
spindly. Quantification of the outgrowth indicated that over the first 7 days, 200 times the
number of cells emerged from fetal compared to adult tissue, per gram of tissue. (Scale = 100
µm).

2.4.2

Migration and Proliferation Capacity of Adult and Fetal MFCs

When fetal and adult meniscus tissue was plated on tissue-culture treated plastic in basal
media, MFCs emerged over the first few days of culture. Cells that emerged from the fetal
meniscus were more spindle-like in appearance. When normalized to tissue weight, 200
times more MFCs emerged from the fetal tissue compared to the adult tissue (Fig 2-1E,
F). Once removed from the tissue, however, proliferation rates of extracted fetal and
adult MFCs did not differ over 12 days (Fig 2-2A). When a gap was introduced to a
confluent monolayer, cells filled the new space completely within 24 hours (data not
shown). Images acquired at 15 hours (prior to closure) showed equivalent migration by
cells of both ages (Fig 2-2B).
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Figure 2-2: (A) Proliferation of fetal and adult MFCs in monolayer culture are comparable over 12
days (N=3, performed in triplicate). (B) Migration of fetal and adult MFCs into an artificial
‘wound’ occurred over a similar time course. (Scale = 200 µm).

2.4.3

Matrix Elaboration by Fetal and Adult MFCs in Pellet Culture

MFCs were formed into pellets and cultured in 4 different media types for 6 weeks.
When cultured in basal media, fetal pellets did not remain viable, disintegrating by day
42. Adult pellets, on the other hand, remained viable though very little matrix deposition
occurred (Fig 2-4). When cultured in the presence of CDM-, both fetal and adult cell
pellets remained small, with comparable collagen (red) and PG (blue) deposition (Fig 23, 2-4).

Upon the addition of TGF-β, adult cell pellets increased in size by day 42 (Fig 2-3).
Adult cells had a moderate response to TGF-β with 2 to 4-fold increases in pellet weight
compared to CDM- conditions (Fig 2-4A). DNA content decreased, although not
significantly, with the addition of TGF-β compared to CDM- conditions (Fig 2-4B). GAG
and collagen content (normalized to DNA content) in adult pellets increased, although
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not significantly, compared to CDM- condition (Fig 2-4C, D). TGF-β1 promoted the
deposition of both collagen I and II, while TGF-β3 resulted in the deposition of collagen I
with no deposition of collagen II (Fig 2-3). Overall, the addition of TGF-β bolstered
deposition of a meniscus-like fibrocartilaginous extracellular matrix in adult MFC
pellets.

Figure 2-3: Histological sections of fetal and adult MFC cell pellets in CDM-, TGF-β1, and TGF-β3
media after 42 days in culture. Fetal MFCs produce larger pellets with more PG compared to adult
MFCs (Scale = 500 µm). Inlays: Immunohistochemical staining for Collagen I and Collagen II.
Collagen I and II are deposited in fetal tissue with exposure to both TGF-β isoforms, while adult
MFCs produce only collagen I in with exposure to TGF-β1. Work was performed in triplicate, with
one representative set shown. (Scale = 1000 µm)

Fetal pellets responded more robustly to the addition of TGF-β than adult pellets by day
42. Histological analysis showed a significant increase in deposition of PG and a 3 to 4fold increase in pellet diameter with TGF-β compared to CDM- conditions (Fig 2-3).
Pellet weights from Fetus 1 and 2 were 10- and 30-fold higher than CDM- conditions by
day 42, respectively (Fig 2-4A). Further, the weight of fetal pellets was significantly
higher than the adult pellets for both TGF-β isoforms. In contrast to adult MFC pellets,
DNA content increased significantly in the presence of TGF-β1 and -β3 (Fig 2-4B). The
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quantity of GAG and collagen produced per fetal cell was significantly higher in the
presence of TGF-β compared to the CDM- condition. Further, this growth factor caused
fetal MFCs to deposit significantly more matrix than adult MFCs (Fig 2-4 C,D), with the
exception of fetus 2 pellets that had comparable collagen deposition. While the quantity
of GAG deposited varied considerably between media conditions and tissue age,
biochemical analysis and histological staining for picrosirius red alone (data not shown)
showed that changes in collagen levels were less pronounced. Both collagen I and II were
produced by fetal pellets in the presence of either TGF-β isoform (Fig 2-3). Overall,
TGF-β had a stronger influence on fetal MFC pellets than adult MFC pellets, with
significant increases in proliferation and meniscus-like fibrocartilaginous matrix
deposition. However, even between twin fetuses, biological variability was observed in
the magnitude of the response to these exogenous growth factors.
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Figure 2-4 Biochemical analysis of fetal and adult MFC pellets. Serum-containing media did not
support fetal pellet growth. With the addition of TGF-β, fetal pellets increased with size and
matrix deposition compared to adult pellets. (A) Weight of all fetal pellets and TGF-β1-treated
adult pellets increased compared to CDM-. (B) DNA content by day 42 increased with the
addition of TGF-β for fetal cells compared to the CDM- condition and compared to adult MFCs.
(C) GAG content (normalized to DNA) increased in all cases compared to CDM-, with fetal MFCs
producing significantly more GAG/DNA compared to adult MFCs. (D) Collagen content
(normalized to DNA) increased for fetus 1 MFCs and for adult MFCs. Fetus 1 also increased in
collagen content with TGF-β compared to adult MFCs. * indicates significant difference via 2-way
ANOVA compared to day 42 CDM- with p < 0.05. # indicates significant difference via 2-way
ANOVA compared to adult with same TGF-β isoforms with p < 0.05.
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2.5

Discussion

In this work, we explored tissue-, matrix- and cell-level differences between the fetal and
adult ovine meniscus and the response of ovine MFCs to exogenous growth factors TGFβ1 and -β3 in three-dimensional culture. Because young patients rarely present with
meniscus tears, understanding differences in cell behavior and ECM structure and
production by age may better guide the development of meniscus healing algorithms
through recapitulation of successful repair mechanisms in the younger meniscus. The
work is further motivated by the observation that complete regenerative healing occurs
for a number of tissues in the fetus including cartilage [54], tendon [55, 56], skin [69, 70]
and bone [71]. Even in juvenile tissue, work has shown improved (although not scarless)
healing compared to adult tissue in anterior cruciate ligaments [72]. While direct
exploration of in vivo fetal meniscus healing has proved challenging, extraction of the
meniscus to a controlled in vitro environment allows one to probe various aspects of cell
and tissue behavior as a function of developmental stage.

Our results demonstrate that in situ, cell density and ECM distribution changed
significantly with meniscus tissue maturation, from a cell-dense structure with thin
collagen bundles and limited PG content (Fig 2-1C), to a cell-sparse structure filled with
thick collagen bundles and significant PG distributed throughout the tissue (Fig 2-1D).
Melrose and coworkers reported similar changes in PG deposition and collagen structure
throughout development in sheep meniscus, although that work did not extend to the
analysis of fetal meniscus specimens [73]. Clark and Ogden investigated human fetuses
and young cadavers and described the progressive development of collagen bundles and
decrease in cell density [31]. These findings are consistent with our observations and
suggest that the sheep is a good model for the study of meniscus development.
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When cells were extracted from the tissue, fetal and adult MFCs proliferated and
migrated at the same rate (Fig 2-2). Previous work by Webber showed that juvenile and
adult rabbit MFCs proliferate at the same rate [74], although they did not explore fetal
cells. Interestingly, cells emerged from fetal tissue at a much faster rate compared to
adult tissue. Because proliferation and migration did not vary between fetal and adult
MFCs in monolayer, the high cellular density of the fetal tissue may explain the markedly
higher cell emergence rate from fetal tissue. Further, limited GAG and smaller collagen
bundles may create in a more porous ECM that is permissive for cell migration within
and out of the tissue and onto the tissue culture plastic compared to dense adult tissue.
Clinically, the apparent healing of meniscus in children may relate to the ability of cells
to migrate, repopulate and ultimately heal injured regions in less dense immature
meniscus. In contrast, cells in the adult meniscus tissue might be effectively trapped
inside the dense matrix of their own creation. Work is ongoing to further explore this
hypothesis, and preliminary findings suggest enhanced injury repair in immature bovine
tissue using an in vitro meniscus defect model [75, 76].

When in pellet format, fetal and adult MFCs responded very differently to the chemical
environment in which they were cultured. Barry and coworkers found that mesenchymal
stem cells successfully differentiated in chondrocytes given the following three
conditions: three-dimensional culture environment, serum-free medium, and exposure
to a member of the TGF-β superfamily [77]. To maintain phenotype, meniscus
fibrochondrocytes are often cultured under the same conditions [65]. In this work, when
MFCs were cultured in a three-dimensional format in the presence of serum, fetal pellets
were not viable. Histology of the fetal meniscus tissue revealed minimal PG deposition
(Fig 2-1A), a hallmark of meniscus ECM, suggesting that fetal cells were not yet fully
differentiated. Absent a committed fibrochondrogenic-like phenotype, the cells were
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unable to withstand three-dimensional culture conditions without a chemically defined
and pro-chondrogenic supplement such as TGF-β. In contrast, adult pellets remained
viable but proliferated poorly and deposited little PG (Fig 4). Previous work by Mauck
also demonstrated juvenile bovine meniscus fibrochondrocytes in pellet culture with
serum were viable for 21 days, but exhibited little matrix accumulation [65]. Adult MFC
pellets remained viable in serum-containing media, but serum alone could not support
or maintain fetal MFCs in pellet form.

Pellets were also grown in a pro-chondrogenic chemically defined media without the
addition of the essential growth factor TGF-β (CDM-). Both fetal and adult pellets
showed little growth over time under these conditions. In fact, fetal pellets decreased in
weight with culture time, perhaps showing a similar sensitivity to the lack of TGF-β as
seen in the serum-containing media culture conditions. When TGF-β was added, growth
and matrix production was significantly improved, particularly for fetal pellets (Fig 2-3,
2-4). Interestingly, Vavkin and coworkers found a decrease in TGF-β receptor density
with increased donor age in ACL tissue, although fetal tissue was not assessed [78].
Numerous studies have demonstrated that the addition of TGF-β increases the quantity
of DNA [79] and GAG [80-82] over time in meniscus cells. While distinctions between
TGF-β isoforms 1 and 3 have been identified, no major differences in growth or matrix
deposition were found in this cell type under the given conditions, with only a slight (but
not significant) improvement with isoform 1 in adult pellets. TGF-β1 has been associated
with an increase in matrix synthesis and a decrease in the production of matrixdegrading proteases in adults in fibroblasts [83, 84] as well as fibrotic scar healing of
tendon [56, 85]. TGF-β3 has been shown to be more effective at inducing
chondrogenesis than TGF-β1 in mesenchymal stem cells [86] and has been associated
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with scarless fetal healing in skin [87]. Our work showed that MFCs responded similarly
to both isoforms of TGF-β.

While this work presents compelling similarities and differences in meniscus tissue and
cells through development, some limitations do exist. First, it is known that multiple cell
types can be identified in the meniscus based on region [10, 79]. However, we did not
account for these variations, and instead observed the cell populations in bulk. Further,
we used cells at passage 2, where inherent differences may have already been erased due
to dedifferentiation with culture expansion. Earlier passage cells may have revealed more
about the in situ behavior of the cells. In this work, we did not analyze gene expression,
which may provide mechanistic insight into the response of the MFCs by age and in
response to TGF-β. Also, even when studying twins, the sensitivity to TGF-β was
variable, suggesting that even wider variations would be observed between unrelated
animals. Lastly, our work only studied the effects of TGF-β. A number of other growth
factors might be relevant to explore and could provide additional insight into the
differential response of fetal and adult MFCs. For example, Webber found that FGF [10],
PDGF and IGF [88] all upregulate MFC proliferation. Despite these limitations, the
present work advances our knowledge of meniscus architecture and sensitivity of
meniscus cells to soluble factors through development.

2.6

Conclusions

Overall, this study highlights the changing regenerative potential of the meniscus and
MFCs from fetal to adult stages. The tissue undergoes significant structural changes,
with increases in collagen fiber thickness and decreases in cell density, along with
changes in PG distribution. Further, the sensitivity to exogenous growth factors
decreases significantly with maturity. Fetal MFC pellets were larger and contained
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higher levels of GAG and collagen that increased progressively over 42 days. Taken
together, this work suggests that TGF-β induced stimulation of MFC matrix production
capacity decreases in adult tissue, and that clinical strategies to bolster matrix
production may create a more regenerative state to promote adult meniscus healing.
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3:

Maturation State Dependent Alternations in Meniscus
Integration: Implications for Scaffold Design and
Tissue Engineering

3.1

Abstract

The knee meniscus is a crucial component of the knee that functions to stabilize the
joint, distribute load, and maintain congruency. Meniscus tears and degeneration are
common, and natural healing is limited. Notably, few children present with meniscus
injuries, and other related fibrocartilaginous tissues heal regeneratively in immature
animals and in the fetus. In this work, we evaluated fetal, juvenile, and adult bovine
meniscus properties and repair capacity in vitro, and hypothesized that the properties
and repair capacity would be modulated with age. While no changes in cell behavior
(migration, proliferation) were noted with age, drastic alterations in the density and
distribution of the major components of meniscus tissue (proteoglycan, collagen, and
DNA) occurred with development. Coincident with these marked tissue changes, the in
vitro healing capacity of the tissue decreased with age. Fetal and juvenile meniscus
formed a robust repair over 8 weeks on both a histological and mechanical basis, despite
a lack of vascular supply. In contrast, adult meniscus did not integrate over this period.
However, integration was improved significantly with the addition of growth factor TGFβ3. Finally, to evaluate engineered scaffold integration in the context of aging, we
monitored cellular infiltration from native tissue into engineered nanofibrous constructs.
Our findings suggest that maturation processes that enable load bearing in the adult
limit endogenous healing potential and identify new metrics for the development of
tissue engineered meniscus implants.
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3.2

Introduction

The meniscus is a fibrocartilage found in the knee whose primary function is mechanical,
withstanding both compressive and tensile forces that arise with locomotion [5]. The
extracellular matrix (ECM) is complex in architecture and composition, and is comprised
of circumferentially-oriented collagen bundles interspersed with a dense proteoglycan
(PG) network [4]. When acute injury or degenerative changes occur, meniscus loadbearing capacity is compromised [9]. Clinically, patients with meniscal tears are treated
surgically, with the torn or frayed portion resected or, when possible, reattached [22, 23,
89]. When significant damage occurs, meniscus allografts can be utilized as a total
replacement [90]. However, despite restoration of pain free motion with these
interventions, the joint compartment remains predisposed to the development of
osteoarthritis, as joint mechanics remain altered and non-ideal motion and mechanical
forces are imparted to the surrounding tissues [19, 20, 91].

The adult meniscus has limited vascularity and healing capacity [18], and so simple
repairs often fail over time. To better study meniscus healing, in vitro models have been
developed. Early work by Webber and coworkers [92] demonstrated that meniscus
sections remain viable in culture media supplemented with bovine serum or in a
chemically defined media. Kobayashi and coworkers showed that outer meniscus defects
heal better than inner meniscus, at least on a histological basis [93]. More recently,
Hennerbichler and coworkers adopted a method commonly employed to assess
cartilage-to-cartilage integration [94] to mechanically evaluate meniscus repair in vitro.
This method involves the formulation of a cylindrical full thickness concentric defect
within a meniscus explant [95]. Integration strength is determined by measuring the
force required to extrude the inner core from the outer ring. Using this approach, no
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measurable differences in mechanical integration were noted comparing the inner and
outer regions. This technique has also been used to study the influence and interplay of
inflammatory cytokines and matrix metalloproteinases in meniscus healing [35-39]. The
organ culture model allows for the careful analysis of healing by region, the influence of
soluble factors, and how repair changes over time—factors that are difficult to observe or
control in the joint space.

While adult meniscus healing is limited, a number of observations in immature meniscus
and related tissues suggest that young fibrocartilage may possess a greater healing
potential. First, younger patients rarely present with acute meniscal tears [33]. The
repair capacity may be due to the more complete vascular infiltration of immature
meniscus compared to adult meniscus, which is only vascularized in the outer third of
the tissue [31, 32]. Indeed, repairs to the more vascular outer region of the adult
meniscus can have long-term success [26]. Further, in vitro studies have shown that
juvenile cartilage heals better than adult cartilage even in the absence of a blood supply
[96, 97]. Similarly, immature rat lateral collateral ligament heals better than mature
ligament in vivo [98]. In the fetus, complete regenerative healing of tendon and cartilage
has been observed [54-56]. Taken together, these findings motivated us to evaluate
differences in healing potential between fetal, juvenile, and adult meniscus, as well as to
characterize the properties of the meniscus and associated meniscus fibrochondrocytes
(MFCs) as a function of age.

Beyond evaluation of natural tissue healing, this in vitro meniscus culture system can be
used as a test bed for meniscus tissue engineering, similar to approaches used in
cartilage tissue engineering [99-101]. Numerous materials have been tested for meniscus
tissue engineering, including collagen [24], small intestinal submucosa (SIS) [42, 43],
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estane [45], polyurethane [46], hyaluronic acid [102], agarose gels [47] and alginate
[48]. However, due to the complex loading environment many of these approaches have
shown limited success in vivo. The only material translated to the clinic in the U.S. is the
Collagen Meniscus Implant (Menaflex), although its efficiency is not yet clearly
demonstrated [24]. A polyurethane foam product (Orteq) is also available in Europe,
although its use has not been approved by the US FDA. To expand the palette of
materials for meniscus tissue engineering, we have developed a nanofibrous electrospun
scaffold, with aligned fibers that mimic the native collagen architecture of meniscus. In
these scaffolds, MFCs and mesenchymal stem cells infiltrate and deposit ordered matrix,
generating an engineered tissue with physiologically relevant mechanical properties [5053].

In this work, we evaluated cellular and architectural changes in the meniscus as a
function of age. Further, we used an in vitro integration model to assess the healing
capacity of fetal, juvenile and adult bovine meniscal defects. To expedite integration, we
evaluated the effect of the exogenous addition of the chondrogenic growth factor TGF-β
[35, 80-82] in explants of different ages. Finally, we established a test bed for the in vitro
optimization of a tissue engineered meniscus construct by modifying the meniscus
integration model to include an electrospun scaffold.

3.3

Materials and Methods

3.3.1

Age-Dependent Characteristics of Bovine Meniscus Fibrochondrocytes

Menisci from fetal (mid-gestation), juvenile (0-3 months) and adult (skeletally mature)
cows were sterilely dissected with care taken to remove adherent synovium from the
meniscal rim. A 5 mm radial slice was cut, minced into 3 mm3 pieces and plated onto
tissue culture plastic (Corning, Sigma-Aldrich, St. Louis MO) in basal media (DMEM
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with 10% fetal bovine serum and 1% penicillin/streptomyosin/fungizone). MFCs
emerged onto the plate and divided.

After one passage, cells from each age were used to assess proliferation and migration
capacity [103]. Briefly, for proliferation, 20,000 cells were expanded in basal media in
individual tissue-culture treated 6-well plates. Each day, in triplicate, the cells were
dislodged using a cell scraper and DNA content analyzed using the PicoGreen assay
(Invitrogen, Carlsbad, CA). The experiment was performed with three different donors,
with one donor data set shown. To assess migration capacity, a defined ‘wound’ was
created in a confluent monolayer with a 0.1-10 µl pipette. The wells were washed to
remove cell debris and filled with basal media. Initial light microscope images were
captured of the regions and the locations were marked on the plate. Over 15 hours, the
same regions were photographed. Extent of infiltration was determined in duplicate
using ImageJ (Wayne Rasband, NIH, USA) by measuring the change in area of the gap in
a given sample over time.

3.3.2

Histological and Mechanical Alterations in Bovine Meniscus as a Function of
Age

Axial and radial samples of meniscus (thickness = 5 mm) from each age were fixed in
paraformaldahyde, embedded with paraffin and sectioned. Radial sections were stained
with a mixture of Alcian Blue for proteoglycans (PG) and Picrosirius Red for collagens.
Axial sections were stained with hematoxylin and eosin (H&E) to identify nuclei.

Unconfined compression testing was performed on native tissue as in [104]. A 4 mm
circular explant was taken from the central region of the meniscus in the vertical axis
using a dermal punch. The top and bottom of the explant was removed on a freezing
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stage sledge microtome to produce cylindrical samples with parallel surfaces (3 mm
height, n=6/age). Height was measured using a digital caliper before mechanical testing.
Next, a creep test was performed in a PBS bath with a 0.05 N load applied for 5 minutes,
with displacement noted at equilibrium. Finally, a stress relaxation test was performed
by applying three step-wise compressive deformations of 3% of the post-creep thickness
(at 0.05%/s) followed by 800 seconds of relaxation to equilibrium. The compressive
equilibrium modulus was calculated from the equilibrium stress and strain values.

3.3.3

Biochemical Analysis of Bovine Meniscus as a Function of Age

To assess biochemical content of meniscus by age, radial sections from different menisci
(n=6/age) were divided into three regions (inner, middle and outer) and weighed (Fig 3,
top). After lyophilization, samples were reweighed to determine water content and
digested in a buffer containing 2% papain at 60°C. The resulting digestate was used to
assess DNA content (PicoGreen Assay, Invitrogen, Carlsbad, CA), glycosaminoglycan
(GAG) content using the DMMB Assay [105] and collagen content using the OHP assay
with a conversion factor of 7.14 [68]. Results are reported normalized to sample dry
weight.

3.3.4

Integration Potential of Bovine Meniscus as a Function of Age

Fetal, juvenile and adult menisci were isolated as above. Using a sterile 8 mm diameter
dermal punch, circular explants were excised from the tissue in the vertical axis. The top
and bottom portions of the explant were removed with a scalpel to create parallel
surfaces, creating a 3 mm tall cylinder. A 4 mm diameter dermal punch was used to
create an inner core, with care taken to ensure that the cut was complete and that
minimal rotation occurred (Fig 3-4A). Explants were cultured for 8 weeks in basal
media supplemented with 50 µg/ml ascorbate-2-phosphate. At bi-weekly intervals, 2
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constructs were processed for histology as above. Picrosirius Red stained sections were
viewed under polarized light to assess collagen bundle organization at the injury site. At
bi-weekly intervals, 7-12 samples were tested for mechanical integration using a custom
testing device (Fig 4B) [75, 76, 106]. Briefly, an Instron 5848 was outfitted with a 3.5
mm diameter indenter in series with a 50 N load cell. This indenter was placed above a
plate with a 5 mm diameter hole. The meniscus sample was placed onto the plate, and
the indenter progressed through the defect site at a rate of 0.0833 mm/sec [95].
Integration strength was determined by normalizing the maximum force by the contact
area between the core and annulus. This study was conducted in duplicate, with one
representative data set presented.

3.3.5

Integration Potential in the Presence of TGF-β

To assess the influence of the proliferative and pro-chondrogenic growth factor TGF-β3
on the long-term culture and integration potential of meniscus, juvenile and adult
meniscus explants were constructed as described above and cultured in either basal
media

supplemented

with

50

µg/ml

ascorbate-2-phosphate

or

basal

media

supplemented with 50 µg/ml ascorbate-2-phosphate and 10 ng/mL TGF-β3 for 8 weeks.
Every 4 weeks, 2 samples were fixed for histology and 7-18 samples were tested for
integration strength as above. After testing, both portions of the explant were digested
for biochemical analysis. Likewise, histological analysis was conducted on fresh samples
from each condition and time point.

3.3.6

Integration Potential of a Fibrous Scaffold

To assess the migratory potential of meniscus cells out of native tissue and through a 3dimensional engineered structure, 8 mm diameter explants of juvenile and adult menisci
were generated. As before, a 4 mm diameter internal core was created, but this time the
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core was removed and replaced with an electrospun aligned poly(ε-caprolactone) multilamellar column (Fig 3-8A). The column was created by spot-welding multiple 4 mm
discs of 1 mm thick scaffold at the center point and press-fitting the column into the
meniscus annulus. At 4 and 8 weeks, samples were fixed in paraformaldehyde and frozen
in OCT sectioning medium. Sections from the top, middle and bottom of each explant
were stained with DAPI (Prolong Gold, Invitrogen, Carlsbad CA) to identify cell nuclei. A
custom MATLAB program based on [107] was used to quantify cell infiltration by
dividing the scaffold into 4 concentric zones with radii equating 25%, 50%, 75%, or 100%
of the total scaffold radius. Images were converted to a binary image (Fig 3-8B), and for
each zone, the cell density (cells/pixel) was normalized by the native tissue density in
three 100x100 pixel squares of native tissue, and multiplied by the average native tissue
cell count to allow for comparisons across sections and between juvenile and adult
tissue.

3.3.7

Statistical Analysis

All statistical analysis was performed using SYSTAT (Chicago, IL) with Bonferonni’s
post-hoc tests and p < 0.05. One-way ANOVA was used to compare the compressive
modulus of meniscus by age. For biochemical analysis, one-way ANOVA for age-related
differences and two-way ANOVA for age and region differences were employed.
Integration strength was compared with a two-way ANOVA with age and culture
duration as independent variables. For the TGF-β integration studies, 3-way ANOVA was
utilized. Finally, significant differences in cellular distribution in the scaffolds were
evaluated via 2-way ANOVA.
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3.4

Results

3.4.1

Age-Dependent Characteristics of Bovine Meniscus Fibrochondrocytes

The proliferation and migration capacity of MFCs isolated from fetal, juvenile and adult
bovine menisci were compared. Across all ages, proliferation rates were consistent over
14 days (Fig 3-1A). Further, no difference in migration into an artificial ‘wound’ was
observed (Fig 3-1B, 3-1C).

Figure 3-1: Proliferation and migration of fetal, juvenile and adult bovine MFCs are comparable.
(A) MFCs proliferate over 14 days at similar rates (n=3/age). (B) Cell migration into a gap was
tracked over 15 hours. Example images of the initial gap and appearance after 6 hours for MFCs
from each age (Scale = 200 µm). (C) Image analysis of (B) demonstrates similar cell migration
rates between MFC ages (n=3/age).

3.4.2

Histological and Mechanical Alterations in Bovine Meniscus as a Function of
Age

Histological analysis revealed dramatic structural changes in meniscus through
development. The meniscus increased in size with age, particularly in the medial-lateral
direction (Fig 3-2A). In fetal and juvenile menisci, proteoglycan (PG) was concentrated
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in the inner-most tip of the tissue (Fig 3-2, arrows) with little staining throughout the
rest of the tissue. Adult menisci stained darkly for PG throughout the tissue. H&E
staining showed a progressive decline of cell density with advancing age (Fig 3-2B).
Morphologically, the thickness of collagen bundles increased through development (Fig
3-2B). The age-dependent changes observed histologically were concurrent with
mechanical changes, with ~5-fold improvements in the equilibrium compressive
modulus between each age tested.

Figure 3-2 Histological and mechanical properties of bovine meniscus are modulated by age. (A)
Radial sections from the central region of the meniscus stained with Picrosirius Red (top), Alcian
Blue (middle), and a combination of the two (bottom) reveals changes in tissue size and PG
distribution (blue) with age (Scale: 10 mm). Arrows indicate concentration of Alcian Blue staining
at the inner tip. (B) Transverse sections of meniscus stained with H&E reveal decreasing cell
density with age (Scale: 100 µm). (C) Compressive equilibrium modulus increases significantly
with each increase in age (n=6). * indicates difference from fetal with p<0.0001. # indicates
difference from juvenile with p<0.0001.

3.4.3

Biochemical Analysis of Bovine Meniscus as a Function of Age

Samples from the inner, middle and outer region of the meniscus were digested to
elucidate biochemical changes with development. Overall, water content did not change
with age (Fig 3-3A). In contrast, fetal and juvenile meniscus contained significantly
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lower GAG content than adult meniscus (Fig 3-3B). Fetal meniscus had significantly
more GAG in the inner region than the outer region, although by the juvenile stage,
difference by region was less pronounced. Adult meniscus also had significantly more
GAG in the inner region compared to outer region. Further, the relative proportion of
GAG in the middle region of the meniscus increased in adult specimens. The overall
collagen content increased significantly from fetal to juvenile meniscus, but remained
the same between juvenile and adult meniscus (Fig 3-3C). The outer region of the fetal
meniscus had significantly less collagen than the other regions, perhaps due a blending
of the synovial rim with the tissue early in development. By juvenile and adult stages,
there were no differences in collagen content between regions. Finally, adult meniscus
had significantly less DNA content than fetal or juvenile meniscus (Fig 3-3D). Cell
density in the fetal meniscus showed the largest distribution with location, with
significantly more DNA found in the inner region compared to the outer region. With
maturation, the distribution of DNA equilibrated.
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Figure 3-3 Biochemical content and distribution of the bovine meniscus is modulated by age. (A)
Water content as a function of tissue wet weight. (B) GAG, (C) collagen content as a percent of dry
weight. (D) DNA content per dry weight. N = 6/region/age. – indicates significant differences
between groups with p<0.05.

3.4.4

Integration Potential of Bovine Meniscus as a Function of Age

For each age, circular meniscus explants with concentric full-thickness defects were
formed and cultured for up to 8 weeks. Histology revealed continual improvements in
matrix connectivity at the injury site in fetal and juvenile tissue. In contrast, no
integration was seen in adult samples through 8 weeks (Fig 3-5A). Viewing the ‘best’
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integrated samples (juvenile, week 8) under polarized light microscopy showed that
while new collagen was deposited at the injury site, this new matrix was not aligned or
contiguous with the surrounding collagen bundles (Fig 3-5A, green arrows).

Figure 3-4 Experimental design for meniscus integration studies. (A) Cylindrical explants (8 mm)
were removed sterilely from fetal, juvenile and adult meniscus. After flattening surfaces, central
cores were punched with a 4mm dermal punch, removed, and replaced into the original position
to simulate a full-thickness meniscus injury. (B) A custom mechanical testing device was used to
measure the force required to extrude the inner core from the meniscus explant.

The mechanical testing results mirrored these histological observations. Fetal explants
improved in integration strength over 8 weeks, with significant improvements at 6 and 8
weeks compared to week 0 (p < 0.05). Integration strength of juvenile defects increased
at a slower pace, with significant improvements by week 8. The integration strength of
adult samples did not change (Fig 3-5B).
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Figure 3-5 Age-dependent integration of bovine meniscus. (A) H&E staining of the injury site at
week 8 shows signs of repair in fetal and juvenile tissue, but not in adult tissue (Scale = 200 µm).
Lower right: Picrosirius Red staining of 8 week juvenile sample viewed under polarized light
reveals lack of collagen continuity at the injury site. (B) Integration strength as a function of
meniscus age with time in culture. Integration strength increases significantly for fetal and
juvenile samples, but not for adult samples. (C) Mechanical testing results demonstrating
variability in response between specimens. N = 7-12. * indicates significant difference (p < 0.05)
from week 0. # indicates significant difference (p < 0.05) compared to adult week 8.

3.4.5

Integration Potential in the Presence of TGF-β

To further improve repair, juvenile and adult meniscus explants were cultured with and
without 10 ng/mL TGF-β3, a concentration previously shown to promote matrix
deposition in meniscus fibrochondrocytes [50, 51, 65]. Addition of TGF-β3 increased
matrix deposition at the injury site in both juvenile and adult samples (Fig 3-6A, B).
Picrosirius Red staining revealed no major changes in collagen levels (Fig 3-6C, D).
However, Alcian Blue staining of PG was significantly greater in explants cultured in the
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presence of TGF-β (Fig 3-6C, D). Even in the presence of TGF-β, some sections of the
injuries appeared to be disconnected. It is unclear if this is an artifact from histology, or
if these regions contribute to the variability seen in the mechanical testing results.

Figure 3-6 Histological analysis of integration in the presence or absence of TGF-β after 8 weeks
of in vitro culture. (A) H&E staining reveals that while the juvenile sample appears to have healed
across the injury site, no obvious integration is visible in the adult sample. (B) The addition of
TGF-β improved cell and matrix formation at the injury site for both juvenile and adult samples.
Scale = 100 µm. (C and D) Picrosirius Red staining (left) is consistent across samples at 8 weeks.
However, Alcian Blue staining (right) of PG reveals significant depletion in the presence BM
compared to TGF-β in both juvenile and adult specimens. Scale = 500 µm.

The integration strength of both juvenile and adult meniscus explants improved 7-fold
by 8 weeks with the addition of TGF-β, reaching 97 kPa and 57 kPa, respectively (Fig 37A). Continued exposure to TGF-β for 8 weeks resulted in significant improvements
from week 4 and compared to basal media alone. Further, juvenile meniscus integration
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strength was significantly higher than adult meniscus integration strength by 8 weeks.
Biochemical analysis of the tissue after mechanical testing showed that GAG content
decreased over time when cultured in basal media; GAG content was far below native
tissue, particularly for adult tissue (Fig 3-7B, dotted line). Conversely, addition of TGFβ maintained native levels of GAG in the explants. Due to the lower initial concentration
of GAG in juvenile tissue, the quantity of GAG in the explants cultured in TGF-β did not
increase significantly. However, adult explants had almost 2-fold more GAG by 8 weeks
than explants cultured in basal media alone. Further, adult explants contained
significantly more GAG than juvenile explants cultured in the same conditions, similar to
the trend in native tissue. These quantitative measures of GAG content correlate well
with histological staining (Fig 3-6C and 3-6D). Even in the presence of TGF-β, DNA
content in explants fell below native levels (Fig 3-7C). Similar to native tissue, adult
explants had significantly less DNA than juvenile explants. As shown via histology (Fig
3-6C, 3-6D) and by quantification (Fig 3-7D), collagen content did not change between
groups or over time.
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Figure 3-7 TGF-β improves integration strength and preserves explant GAG content after 8 weeks
of in vitro culture. (A) Integration strength of juvenile and adult defects improved in the presence
of TGF-β (n = 7-18) compared to basal media (BM). (B) GAG content was depleted in the absence
and maintained in the presence of TGF-β (n = 6) compared to native tissue (dashed line). (C)
DNA content decreased in all conditions. (D) Collagen content remained consistent across all
conditions. (E) Appearance of explants after 8 weeks in culture. Scale = 5 mm. * indicates
significant difference (p < 0.05) between ages within a given media condition and time point. #
indicates significant difference (p < 0.05) between media conditions at a given time point. –
indicates significant difference (p < 0.05) between time points within a given media condition and
age.
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3.4.6

Integration Potential of a Fibrous Scaffold

To evaluate integration between engineered materials and native meniscus, PCL was
electrospun in 1mm thick aligned sheets and cut into 4mm diameter discs. These discs
were subsequently spot-welded to one another to form columns (Fig 3-8A) that were
situated inside juvenile and adult meniscus explants and cultured for 1, 3 and 6 weeks.
Despite the significantly higher native tissue density of juvenile tissue, similar numbers
of cells populated the scaffolds by 6 weeks (Fig 3-8D). The infiltration was progressive
and occurred more quickly for juvenile compared to adult explants, with significantly
fewer cells in the adult scaffold than in the juvenile scaffold at 3 weeks. No differences
were detected in cell density between the bottom, middle and top of the column,
suggesting uniform infiltration from the exterior circular wall of the native tissue. In
terms of location (Fig 3-8E), most cells were located in the outer-most zone (1) adjacent
to the native tissue and the fewest cells reached the center region (4). Although juvenile
tissue had almost 5-fold higher average cell density, the zonal cell density was similar
between juvenile and adult tissue.
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Figure 3-8 Comparable cellular infiltration in juvenile and adult meniscus defects repaired with
nanofibrous scaffolds. (A) Cylindrical meniscus explants were formed, and a central core was
removed and replaced with a column of electrospun poly(ε-caprolactone) nanofibrous scaffold
disks welded together at the central point. (B) Cell infiltration into the cylindrical constructs was
quantified using a custom MATLAB program. Left: Excerpt of image of the DAPI-stained
composite with the electrospun scaffold (ES) region divided to quantify cell infiltration from the
surrounding native tissue (NT). Right: Cells were counted in binary images by zone. Native tissue
density was determined using 3 regions from each image (boxes) and averaged across all samples.
(C) Left: DAPI staining of integration zone between native tissue (NT) and scaffold (Sc). Scale bar
= 100 µm. Right: H&E staining of integration zone. Scale bar = 500 µm. (D) Significant cell
infiltration was seen after 3 and 6 weeks for juvenile and adult meniscus defects, respectively. By
week 6, scaffold infiltration was comparable between ages (n=9/age/timepoint). (E) Juvenile cells
populated the scaffold more rapidly than adult scaffolds, although the overall densities were
comparable despite a significantly higher starting density in juvenile native tissue. * indicates
significant difference (p < 0.05) from week 1. # indicates significant difference (p < 0.05) between
ages. α indicates significant difference (p < 0.05) from zone 1.
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3.5

Discussion

While injury to the meniscus is the leading cause for orthopedic surgery [17], therapeutic
options are limited and still often lead to the development of osteoarthritis [19, 20, 108,
109]. In this work, we characterized cell behavior, tissue architecture, and integration
potential of the meniscus as a function of age given prior evidence of healing in
immature meniscus [33] and in related juvenile [72, 96, 98] and fetal [54-56]
fibrocartilaginous tissues. Further, we established a test bed for the optimization of a
tissue engineered scaffold.

When bovine MFCs were extracted from fetal, juvenile and adult menisci, age did not
alter their behavior in monolayer culture. Consistent with these findings, we have
previously shown that in the ovine model, fetal and adult MFCs proliferate and migrate
at the same rate [103]. In contrast, related cell types, such as ACL fibroblasts and dermal
fibroblasts, lose proliferation and migration capacity with age [57, 58].

At the tissue level, meniscus size and architecture changed with development. In fetal
and juvenile meniscus, cell density was higher, collagen bundles were smaller, and PG
was concentrated in the inner tip of the tissue. In adult tissue, PG filled the majority of
the tissue, DNA content decreased and became more uniform, and collagen fiber bundles
increased in thickness. The majority of these changes occurred upon skeletal maturity
(i.e. from juvenile to adult), rather than progressively through early development. Our
findings are corroborated by other work in the field; similar changes in PG deposition
and collagen development were noted by Melrose and coworkers in an ovine model [73].
Chen and coworkers found that PG content increased with age, DNA content decreased,
and collagen content increased in the inner region of the meniscus from the fetus to

42

adult in bovine meniscus tissue [110]. Further, Clark and Ogden observed progressive
changes in collagen bundle thickness and cell density in human fetal and juvenile
meniscus [31].

These architectural changes corresponded to functional improvements in the
compressive moduli concomitant with the increasing weight-bearing demands in the
joint. The equilibrium compressive modulus (163 kPa) for adult bovine tissue was higher
than that found in human tissue (25-37 kPa) [6] and is similar to that reported for
porcine meniscus (170-350 kPa) [7]. Chen and coworkers found similar compressive
properties for fetal tissue, but a significantly lower compressive modulus (30 kPa) in the
adult [110]. The differences in adult compressive modulus may be attributed the location
from which the samples were obtained; Chen and coworkers tested explants from the
inner region perpendicular to the femoral surface of the meniscus, while we tested
explants taken from the middle region of the meniscus perpendicular to the tibial
surface.

The similarities between fetal and juvenile meniscus were also apparent in the explant
integration studies (Fig 3-5). Both fetal and juvenile defects increased in integration
strength by 8 weeks, although fetal explants improved at a faster rate. In contrast, and as
is seen clinically in the avascular region, adult meniscus showed very little healing [26].
Interestingly, DiMicco and coworkers demonstrated that fetal cartilage does not heal as
well as juvenile cartilage in vitro [96], suggesting that although the meniscus and
cartilage are related, the healing mechanisms at young ages may be different between
these tissues.
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TGF-β is known to promote the deposition of a fibrocartilaginous matrix and the
maintenance of phenotype in MFCs [65, 79, 80, 82]. Exposure of meniscus explants to
10 ng/mL of TGF-β3 for 8 weeks improved integration strength significantly, to 7 times
the level of basal media alone (~100 kPa) (Fig 3-7A). Adult meniscus healed
significantly better with the addition of TGF-β, though juvenile meniscus improved more
than adult meniscus. Previously, McNulty and coworkers utilized a similar in vitro
model to evaluate the dose responsivity (0.1-10 ng/mL) to TGF-β1 and found a small but
significant improvement at the 1 ng/mL dose (12 kPa) after 14 days. TGF-β played a
number of roles that may contribute to the observed improvement in healing. First, it
maintained the PG content of explants over 8 weeks (Fig 3-6D) compared to basal
media alone. Imler and coworkers previously showed that the addition of TGF-β to
meniscus explants increases sulfate incorporation [111]. Interestingly, GAG content in
the explants cultured in basal media were comparable between ages at 8 weeks, despite
significantly higher initial GAG content in adult explants. Further, the loss was
progressive, with adult meniscus segments failing to maintain native levels of GAG at 8
weeks, even in the presence of TGF-β. While leaching or degradation of PG may an
artifact of in vitro culture, the power of TGF-β to promote PG deposition to native levels
may contribute to the regeneration of meniscus-like ECM at the site of injury. In keeping
with these findings, Wilson and coworkers recently showed that PG levels in meniscus
explants decreased over time in culture, and that the addition of TGF-β increased PG
levels in the tissue [112]. Further, exposure to a broad-spectrum metalloproteinase
inhibitor significantly reduced PG loss over time [113].

While no quantitative improvements in collagen content were found, histology of the
injury site suggested that more collagen was deposited with exposure to TGF-β3.
Further, we have previously found that immature ovine MFCs deposit more collagen

44

than adult MFCs in the presence of TGF-β when cultured in pellets [103]. DNA levels
decreased in all explants to 50-75% of native levels. Cell death may occur early in culture
due to the lack of physiologically relevant stimuli, impaired nutrition, or from the
process of defect formation itself. These observations are another artifact of in vitro
culture, but must be considered when endeavoring to develop in vitro protocols for
meniscus repair.

Translating this work to tissue engineering approaches, we incorporated electrospun
scaffolds into this in vitro defect model. These scaffolds support MFC proliferation and
matrix deposition over time, and increase in mechanical properties in vitro using both
bovine and human cells [50, 51]. Despite marked differences in tissue structure and
composition, implanting these scaffolds into juvenile and adult meniscus defects yielded
surprisingly similar results. While the infiltration of the scaffold was somewhat faster in
younger tissue, after 8 weeks the average cell number within was comparable, despite
significantly more cells adjacent to the scaffold in the juvenile tissue (Fig 3-8C). Similar
to the behavior in monolayer culture (Fig 3-1), migration into and subsequent
proliferation in the scaffold were comparable by age, although perhaps slightly better
distributed in the scaffold containing adult MFCs. The finding suggests that while
heightened cell density at the injury site may promote integration, it may not improve
colonization and maturation of a tissue engineered scaffold.

Identifying distinguishing features of immature, healing meniscus may provide new
directions for advancing repair in the adult and tailoring engineered scaffolds to advance
regeneration. Specifically, we noted a simultaneous loss of healing capacity with
increased GAG concentration, decreased DNA content, and thickening of collagen
bundles. Modifying the structure of mature meniscus to more closely resemble immature
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meniscus might promote healing. While depletion of GAG appears to be an interesting
therapeutic option, GAG levels depleted quickly and significantly during in vitro culture
(Fig 3-7B). The addition of TGF-β maintained near-native levels of GAG content and
improved integration, suggesting that GAG depletion may in fact hinder meniscus repair
rather than promote it. Similarly, the quantity of DNA dropped in all meniscus samples
with in vitro culture. While the addition of TGF-β did not change the overall DNA
content of the explants, it is possible that small local increases in cell density occurred at
the injury sites and bolstered healing. Drug delivery of TGF-β directly to the site of injury
at high doses through a system such as the one described in [114] may support local
proliferation at the injury site. While bulk collagen content did not change progressively
with tissue maturation, the bundle size increased. No major changes in collagen content
were observed during in vitro culture, even in the presence of TGF-β. However, it is
possible that small increases in collagen content occurred at the injury site. It may be
speculated, but remains to be seen, that decreasing collagen bundle size through partial
degradation might enhance tissue healing.

Although this work contributes to our knowledge of the meniscus and develops an in
vitro test bed for the integration of tissue engineered materials with native tissue, some
limitations do exist. First, we only analyzed overall collagen and GAG content, rather
than considering individual components that may vary with development. While
culturing explants for 8 weeks allowed us to evaluate the reparative capacity of the
tissue, this in vitro environment is artificial, with no mechanical loading and loss of PG
and cellularity. Also, we have only explored one concentration of TGF-β, whereas other
concentrations may have yielded different or improved integration levels. Given that
matrix formation, integration, and healing will depend on both anabolism and
catabolism, it will be important to explore expression and activity of matrix
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metalloproteinases (MMPs) and other matrix modulating enzymes in future studies.
Further, although cells infiltrated the electrospun scaffold, minimal matrix was
deposited (data not shown) due to a lack of additional matrix stimulating factors in the
media that might also influence migration, proliferation, and tissue formation. Finally,
while this in vitro test bed provides a facile system for understanding meniscus healing
and optimizing scaffold design, it may not translate directly to the in vivo articular
environment. Future work will include extending these experiments to clinically relevant
large animal models, as well as models involving human meniscus tissue to ensure that
our in vitro findings translate to clinical applicability.

3.6

Conclusions

Overall, this study explored developmental changes in bovine meniscus in terms of tissue
architecture, extracellular matrix distribution and content, and cell behavior. These
changes corresponded to differential integration capacity of the meniscus with aging.
Integration was significantly enhanced by the addition of the exogenous growth factor
TGF-β, which also served to better maintain overall explant properties. Moreover, we
showed that in vitro models such as this can be test beds for optimizing engineered
meniscus scaffolds before in vivo implantation. To glean instructive information
regarding healing with age, we noted that while cell behavior did not change with age,
the overall balance between cells, GAG and collagen content in the meniscus changed
markedly. While loss of GAG content to immature meniscus levels (a natural
consequence of the in vitro culture system) did not promote adult meniscus healing,
increasing local DNA content or decreasing collagen fiber diameter remain viable targets
for enhancing repair. As such, this work identifies new targets for meniscus tissue
engineering as well as a method for testing and optimizing potential clinical solutions for
meniscus repair.

47

3.7

Acknowledgements

This work was done in collaboration with Gregory C. Lee, Grant H. Garcia, Tiffany L.
Zachry, Roshan P. Shah, Brian J. Sennett, and Robert L. Mauck, and was published
Tissue Engineering Part A (2011 Jan;17(1-2):193-204). Funding was provided in part by
the National Institutes of Health (R01 AR056624 and T32 AR007132) and the Penn
Center for Musculoskeletal Disorders.

48

4:

Growth Factor Supplementation Improves Native and
Engineered Meniscus Repair in Vitro

4.1

Abstract

Few therapeutic options exist for meniscus repair after injury. Local delivery of growth
factors may stimulate repair and create a favorable environment for engineered
replacement materials. In this study, we hypothesized that basic fibroblast growth factor
(bFGF) (a pro-mitotic agent) and transforming growth factor beta 3 (TGF-β3) (a promatrix formation agent) would modulate meniscus repair and the integration/
maturation of electrospun poly(ε-caprolactone) (PCL) scaffolds for meniscus tissue
engineering. Circular meniscus defects were formed and refilled with either native tissue
or scaffolds. Constructs were cultured in serum-containing media for 4 and 8 weeks with
various growth factor formulations, and assessed for mechanical strength, biochemical
content and histological appearance. Our results showed that either short-term delivery
of bFGF or sustained delivery of TGF-β3 increased integration strength for both juvenile
and adult bovine tissue, with similar findings for engineered materials. While TGF-β3
increased proteoglycan content in the explants, bFGF did not increase DNA content after
8 weeks. This work suggests that in vivo delivery of bFGF or TGF-β3 may stimulate
meniscus repair, but that the timecourse of delivery will strongly influence success.
Further, electrospun scaffolds are a promising material for meniscus tissue engineering
with comparable or superior integration properties compared to native tissue.
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4.2

Introduction

The meniscus is a C-shaped fibrocartilage in the knee that distributes load from the
femur to the tibia [1, 2]. Its unique architecture, composed of aligned collagen bundles
and centrally-located proteoglycan, allow it to withstand both tensile and compressive
forces in order to maintain joint stability during movement [3]. Due to the strong forces
imparted on the tissue [5], both acute and degenerative tears are common, and natural
repair capacity is limited, especially in the inner avascular regions [15]. Of the 850,000
meniscus surgeries performed annually in the US [115], resection is the most common
technique to alleviate symptoms associated with meniscal tears. However, the procedure
can result in joint incongruency and significantly increased loads on the surrounding
cartilage, which can lead to osteoarthritis [19, 20]. Few procedures exist to repair the
meniscus and none have gained widespread acceptance. Thus, there is a need for novel
repair strategies for meniscus repair.

Delivery of biological factors may stimulate tissue repair either alone or in combination
with mechanical stabilization. Early work delivered vascular endothelial growth factor
(VEGF) from sutures to stimulate blood vessel formation in the damaged region [116].
However, delivery of VEGF from sutures failed to improve healing in vivo in a number of
studies, perhaps due to suboptimal timecourse of delivery [117, 118]. Rather than
modulating the vascular supply, another approach is to alter the biochemical properties
of the tissue using different growth factors. During repair, new matrix must be formed by
nearby cells to bridge the wound edges, creating a mechanically stable interface across
the damaged region. Increasing the amount of matrix deposited by each cell or
increasing the overall number of cells (or a combination of the two) would improve
repair. One of the most potent stimulators of matrix deposition by meniscal cells is
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transforming growth factor beta 3 (TGF-β3) [65, 77, 80, 104, 111], although other growth
factors such as bFGF, PDGF-AB, IGF-1 and EGF all increase matrix production to a
lesser extent [119]. Basic fibroblast growth factor (bFGF) strongly stimulates
proliferation of meniscus cells in monolayer culture as well as in tissue engineered
constructs [10, 119-121]. Both TGF-β3 and bFGF were identified as potential repair
factors for meniscus by Kasemkijwattana et al [122], and Imler et al showed that TGF-β3
stimulated protein and proteoglycan deposition more than bFGF in meniscus explants
[111]. Due to the ability of these growth factors to stimulate matrix deposition and
improve cell density, they are promising candidates for repairing avascular meniscus
tears as well as promoting the maturation and integration of engineered materials in
vivo.

Another important parameter is the timecourse for delivery of these factors. Many
growth factors function during a very specific window and at precise doses, and may
work in concert with other cues [123]. Clinically, growth factors could be delivered with a
bolus injection or via sustained release from a biomaterial over a given period of time;
continual delivery of growth factors over a long period of time is not a clinically relevant
dosing regimen. Fortunately, recent work suggests that short-term exposure to growth
factors may actually have superior efficacy compared to continual delivery, perhaps due
to reduced receptor desensitization [124]. For example, agarose hydrogels containing
bovine chondrocytes were exposed to 2 weeks of TGF-β3, and had more matrix
deposition than continual delivery of TGF-β3 for 2 months [125]. Similar results were
found when dynamic loading was applied [126] and with mesenchymal stem cells [127].

Chemical cues alone may not be sufficient to restore meniscus function in situations
where repair is not possible. To address this issue, tissue engineering generates
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structures that, with time in situ, recapitulate native tissue architecture and behavior
[14]. Recently, biodegradable scaffolds composed of porous collagen (Menaflex) or
porous polyurethane (ActiFit) were developed to replace regions of resected meniscus,
but their use is limited due to questions surrounding their efficacy. Another promising
approach to meniscus repair utilizes electrospun scaffolds, which are fabricated by
collecting nano-sized synthetic and biological polymeric fibers on electrically charged
surfaces [53]. These scaffolds are amenable to cell attachment, proliferation and
infiltration [107, 128, 129]. Further, they can be functionalized to release chemicals such
growth factors [130-132]. More work is needed to understand how electrospun scaffolds
become colonized by native cells, what is the strength of the scaffold/meniscus interface,
and what are the key modulators in this integration process.

Because large animal studies of meniscus repair are quite costly, smaller in vitro
experiments are beneficial for assessing the potential of novel therapies [94]. Early work
demonstrated that meniscus tissue remains viable when cultured in proper media
conditions [92]. Later, concentric explants were used to test the influence of
inflammatory cytokines and matrix metalloproteinases on meniscus integration [35].
More recently, we have used this model to demonstrate that, in accordance to
observations made clinically [33], immature meniscus heals better than mature
meniscus in vitro [128] and that TGF-β3 bolsters that integration [35, 128]. Also, we
filled meniscus rings with electrospun scaffolds and demonstrated increased colonization
of scaffolds with time in culture [128]. While juvenile tissue is significantly more cellular
than adult tissue, both were colonized at the same rate, suggesting at innate speed for
colonization despite starting cell density [128]. In order to further functionalize these
scaffolds, we also developed a technique to deliver drugs from PLGA microspheres
entrapped between electrospun fibers using a sacrificial fiber population, with limited
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impact on mechanical properties and independent release profiles [114]. These
microspheres could eventually release growth factors to promote repair in meniscus.

To further these lines of inquiry, we treated juvenile and adult bovine meniscus defects
with TGF-β3 and bFGF for both short-term (1 week) and sustained (8 weeks)
timecourses, alone and in combination, and assessed the mechanical integration
strength of the repair as well as the biochemical content of the repair material. Further,
we ‘repaired’ meniscus defects with electrospun scaffold and tested the mechanical
integration of the two materials under various growth factor delivery schemes and
timecourses. If successful, growth factors found to improve repair could be released from
fibers or entrapped microspheres in vivo. We hypothesized that bFGF would improve
integration properties by increasing the cell density in the tissue, and that short-term
delivery of the growth factors would result in comparable integration to continual
delivery. Further, mechanical integration of electrospun scaffolds would be comparable
to tissue integration.

4.3

Materials and Methods

4.3.1

Evaluation of Meniscus-to-Meniscus Repair with Growth Factor Addition

Menisci were dissected from the knee joints of juvenile (0-3 months old) and adult
(skeletally mature) bovine limbs in a sterile manner. Cylinders (8 mm diameter x 3 mm
thick) were excised centrally in the axial direction using a dermal punch (Miltex,
Plainsboro, NJ), as shown in Figure 4-1A. To simulate a meniscus tear, a full-thickness
inner columnar defect (4 mm diameter) was made and the core reinserted with care to
maintain fiber alignment, as shown in Figure 4-1B-C.
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Figure 4-1 Experimental set-up and design. (A) 8 mm cylinders were excised from bovine
meniscus. (B) The cylinders were flattened and a smaller biopsy punch was used to remove a 4
mm core. (C) The core was either reinserted back into the tissue (left), or replaced with a 1 mm
thick disc of electrospun PCL (right, inlay scale = 20 µm). (D) Temporal schematic of media
formulations over 8 weeks and testing timepoints.

Meniscus repair constructs were cultured in control media (Dulbecco’s modified Eagle’s
medium (DMEM) with 10% fetal bovine serum (FBS), 1% penicillin/streptomysin/
fungizone (PSF), 50 µg/mL ascorbate-2-phosphate) supplemented with 5 different
growth factor regimens: continual 50 ng/mL bFGF, 1 week of bFGF, continual 10 ng/mL
TGF-β3, combined continual bFGF and TGF-β3, combined 1 week bFGF and continual
TGF-β3, or 1 week of TGF-β3 (Figure 4-1D). After 4 and 8 weeks of culture, the
mechanical integration strength was evaluated using a custom testing device [128].
Briefly, an Instron 5848 was outfitted with a 3.5 mm diameter indenter in series with a
50 N load cell. This indenter was placed above a plate with a 5 mm diameter throughhole. The meniscus sample was placed onto the plate, and the indenter progressed
through the defect site at a rate of 0.0833 mm/sec. Integration strength was calculated
as:

Integration Strength =

Maximum force ( N ) ⋅ 1000
2π r ⋅ h
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where r was the core radius (2 mm). Height (h) of the interface was determined by
averaging four caliper measurements of the construct prior to testing (n=5-8/condition,
work performed in triplicate for control, TGF-β3 and bFGF conditions, duplicate for all
other conditions, all data shown).

4.3.2

Biochemical and Histological Analysis of Meniscus-to-Meniscus Repair

After testing, the meniscus-to-meniscus construct was reassembled and prepared for
biochemical analysis by lyophilizing and digesting the tissue in a buffer containing 2%
papain at 60°C. The resulting digestate was used to assess DNA content (PicoGreen
Assay, Invitrogen, Carlsbad, CA), glycosaminoglycan (GAG) content (DMMB Assay [67])
and collagen content (OHP assay with a conversion factor of 7.14 [68]). Results were
normalized to sample dry weight. Histological analysis was conducted on fresh, untested
samples at each condition and time point. Constructs were fixed in phosphate-buffered
4% paraformaldahyde (PFA), embedded in paraffin and cut into 8 µm sections that were
placed onto glass slides. Samples were stained with Alcian blue for proteoglycans (PG),
Picrosirius red for collagen, and DAPI (Prolong Gold, Invitrogen, Carlsbad, CA) or a
mixture of hematoxylin and eosin (H&E) to identify cell nuclei. Immunohistochemical
staining for anti-phospho-histone H3 (Sigma-Aldrich, Saint Louis, MO), a proliferation
marker, was performed after antigen retrieval (2% hyaluronidase), followed by exposure
to hydrogen peroxide and background blocking (Background Buster, American Master
Tech, Lodi, CA) for 10 minutes each, using 8 µm sections of rat spleen as a positive
control (data not shown). The primary antibody was incubated for 90 minutes at room
temperature, with subsequent secondary antibody incubation and color development
using the SuperPicture DAB kit (Invitrogen, Carlsbad, CA). Images were acquired at 20X
using a Nikon Eclipse 50i microscope with NIS Elements F3.0 software
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4.3.3

Formation of Electrospun Scaffolds

To generate electrospun scaffolds for meniscus repair, 14.3% w/v poly(ε-caprolactone)
(PCL, 80 kDa, Sigma-Aldrich, St. Louis MO) in a 1:1 mixture of tetrahydrofuran (THF,
Fisher Chemical, Fairlawn NJ) and N,N-dimethylformamide (DMF, Fisher Chemical)
was mixed overnight. A 20 mL syringe was filled with PCL electrospinning solution and
fitted with a stainless steel 18G blunt-ended needle that served as a charged spinneret. A
flow rate of 2.5 mL/h was maintained with a syringe pump (KDS100, KD Scientific,
Holliston, MA). A power supply (ES30N-5W, Gamma High Voltage Research, Inc.,
Ormond Beach, FL) applied a +13 kV potential difference between the spinneret and the
grounded mandrel located at a distance of 12 cm from the spinneret. Additionally, two
aluminum shields charged to +10 kV were placed perpendicular to and on either side of
the mandrel to better direct the fibers towards the grounded mandrel. The mandrel was
rotated via a belt mechanism conjoined to an AC motor (Pacesetter 34R, Bodine Electric,
Chicago, IL) at a speed of 10 m/sec to form 800 µm thick mats.

4.3.4

Evaluation of Meniscus-to-Scaffold Repair

After scaffold fabrication, 4 mm scaffold discs were excised using a dermal punch and
sterilized under UV light for 10 minutes. Meniscus constructs were created as previously
described, but instead of reinserting the central core of the construct, a disc of scaffold
was press fit into the defect (Figure 4-1C). The scaffold repair constructs were cultured
in 5 different growth factor regimens: control, continual 50 ng/mL bFGF, 1 week of
bFGF, continual 10 ng/mL TGF-β3, or combined 1 week bFGF and continual TGF-β3
(n=8-10/condition, performed in duplicate for control and TGF-β3 conditions). After 4
weeks, mechanical integration was assessed as described above, with h of the scaffold
disc measured using an OptoNCDT laser measuring device (Micro-Epsilon, Raleigh, NC)
after testing. Scaffolds were digested and analyzed for biochemical content as previously
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described. Similarly, histology was performed by fixing samples in 4% PFA, embedding
in Cryo-OCT Compound (Tissue Tek, Fisher, Fairlawn, NJ) with an axial orientation,
sectioning and staining as previously described.

4.3.5

Statistical Analysis

For this work, 2-way ANOVAs were performed using SYSTAT software (Chicago, IL) to
compare timepoints and conditions using Tukey’s post-hoc test. In some conditions,
non-TGF-β3 groups were considered separately from TGF-β3 groups, as indicated.
Significance was set at p ≤ 0.05.

4.4

Results

4.4.1

Evaluation of Meniscus-to-Meniscus Repair with Growth Factor Addition

Meniscus-to-meniscus repair constructs were formed and cultured in vitro. Overall, and
similar to previous findings [128], juvenile tissue integrated to a greater extent than
adult tissue, with 2- to 4-fold differences in integration strength after 8 weeks (Figure
4-2A,B). After 8 weeks, short-term (1 week) delivery of 50 ng/mL bFGF resulted in
better integration compared to control conditions or continual addition of bFGF for both
juvenile and adult tissue. Exposure to TGF-β3 resulted in more extensive improvements
in integration strength compared to all non-TGF-β3 groups after 4 weeks in juvenile and
after 8 weeks in adult meniscus-to-meniscus samples. In this context, transient bFGF did
not further improve repair. Interestingly, continual delivery of bFGF in the context of
continual TGF-β3 resulted in integration properties comparable to those found in the
absence of TGF-β3. Transient delivery of TGF-β3 resulted in comparable integration
strength to continual TGF-β3 exposure after 4 weeks but not after 8 weeks.
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Figure 4-2 Integration properties of meniscus-to-meniscus repair constructs. (A) Juvenile
integration strength. (B) Adult integration strength. Growth factors and timecourse of delivery
strongly influenced integration properties, with TGF-b3 increasing integration strength the most,
followed by transient bFGF. Continual bFGF or a mixture of bFGF and TGF-β3 did not improve
integration. ‡ indicates difference from control and continual bFGF, comparisons made only
between non-TGF-β3 groups. θ indicates difference from all non-TGF-β3 groups and bFGF+TGFβ3. Line indicates difference between timepoints. # indicates difference from TGF-β3 and
transient bFGF+TGF-β3. For all comparisons, p < 0.05; n = 10-24/condition.

Biochemical analysis revealed minor fluctuations in DNA content across all groups, with
increases after 4 weeks in the continual presence of bFGF and in conditions of transient
bFGF. However, these effects were no longer apparent at 8 weeks (Figure 4-3B). GAG
content was higher and closer to native levels in all samples exposed to TGF-β3, with
some variations in the group containing TGF-β3 and bFGF (Figure 4-3C). Juvenile and
adult tissue responded in similar patterns to the different media formulations in terms of
biochemical content.
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Figure 4-3 Biochemical content of meniscus-to-meniscus repair constructs. (A) Short term and
continual bFGF increased DNA content at 4 weeks, but the effect mostly subsided by 8 weeks. (B)
Continual delivery of TGF-β3 stimulated GAG deposition in the constructs. Data normalized to
dry weight. * indicates difference from control. For all comparisons, p < 0.05.

Histologically, cells populated the injury rim in all conditions, with more tissue bridging
the injury region in constructs cultured with continual TGF-β3 alone. No connections
formed when TGF-β3 and bFGF where delivered simultaneously (Figure 4-4Ai). The
injury region did not stain strongly for proliferating cells, despite the presence of bFGF
(Figure 4-4Aii). While few significant differences were noted between groups at the
injury region, there were major differences at the exterior edge of the tissue, where a
thick cell sheath formed in the presence of TGF-β3 (Figure 4-4Bi) that stained strongly
for proliferating cells only when bFGF was added (Figure 4-4Bii). Because continual
combined delivery TGF-β3 and bFGF also resulted in sheath development and exhibited
low integration strength, the sheath alone does not account for the large forces required
to separate the tissue explants. In contrast, only a very thin layer of cells stained
positively for proliferation in the presence of bFGF alone. Overall, the groups exposed to
TGF-β3 had the greatest PG staining in the bulk of the tissue (Figure 4-4Biii)
compared to non-TGF-β3 groups.
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Figure 4-4 Histology of meniscus-to-meniscus repair constructs. (A) The injury region and (B) the
outer edge after 8 weeks in either control media or media supplemented with bFGF, both bFGF
and TGF-β3, or TGF-β3. H&E (i) identifies cell nuclei, PHH3 (ii) identifies cells in mitosis, and
Alcian Blue (iii) stains for glycosaminoglycans. Scale = 200 µm.

4.4.2

Evaluation of Meniscus-to-Scaffold Repair with Growth Factor Addition

Aligned PCL electrospun scaffolds (Figure 4-5A) were used to fill meniscus defects in
order to form meniscus-to-scaffold repair constructs. Generally, the integration
properties of meniscus-to-scaffold constructs in various media conditions followed the
same pattern as meniscus-to-meniscus repair constructs (Figure 4-5A). In control
conditions, meniscus-to-scaffold integration strength was 2- to 3-fold greater than
meniscus-to-meniscus integration. Unlike meniscus-to-meniscus repair constructs,
transient application of bFGF did not further improve integration strength. Similar to
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meniscus-to-meniscus repair, the continual addition of bFGF significantly decreased
integration strength. The addition of TGF-β3 resulted in 2-fold improvements in
integration strength that were comparable to meniscus-meniscus construct integration.
Similar to previous findings, transient bFGF did not improve integration in the presence
of TGF-β3. Unlike the native tissue, biochemical content of the scaffolds did not vary
significantly, with inclusion of bFGF only slightly improving cellularity and TGF-β3
producing small increases in GAG and collagen content compared to controls (Figure
4-5B).

Figure 4-5 Integration properties of meniscus-to-scaffold repair constructs. (A) Scaffold-tomeniscus integration is better than meniscus-to-meniscus integration in the absence of TGF-β3
after 4 weeks. Integration strengths are comparable in the presence of TGF-β3. (B) Cell density
and collagen content does not change in different media conditions; TGF-β3 increases GAG
content slightly. Line indicates difference between groups and * indicates difference from control
and transient bFGF, considering only non-TGF-β3 groups. ‡ indicates difference from non-TGFβ3 groups. For all comparisons, p < 0.05; n = 8-20/condition.
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Histologically, we observed that meniscus cells from the tissue colonized the scaffold,
populating the outer regions most densely after 4 weeks (Figure 4-6C). Both collagen
(red) and proteoglycan (blue) were found throughout the scaffold (Figure 4-6D),
particularly when constructs were cultured in the presence of TGF-β3 (Figure 4-6E). In
the absence of TGF-β3, little tissue was found bridging the scaffold and the native tissue
compared to constructs exposed to TGF-β3 (Figure 4-6F).

Figure 4-6 Histology of meniscus-to-scaffold repair constructs. (A) SEM of electrospun scaffolds
(scale = 10 µm). (B) Schematic of sectioning plane for histology. (C) DAPI staining reveals cells in
the scaffold (‘S ’) and in the meniscus (‘M ’) after 4 weeks (scale = 500 µm, TGF-β3 treated). (D)
Collagen (red) and GAGs (blue) are found in the scaffold, although are not as dense as the native
meniscus tissue (M) (scale = 500 µm, TGF-β3 treated). (E) Matrix deposition in the scaffold in
various media conditions (scale = 200 µm). (F) Neo-tissue (white arrows) bridges the scaffold and
meniscus in TGF-β3 conditions, but not in control or bFGF conditions (scale = 200 µm).
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4.5

Discussion

Clinical techniques to repair or replace the knee meniscus remain limited. Here, we
explored how delivery of various growth factors, their combination and the duration of
delivery might modulate the repair response. First, we studied growth factors in the
context of acute, avascular meniscal tears, which represents 2/3 of the tissue [26].
Hypercellular juvenile and hypocellular adult meniscus tissue were studied, and patterns
of repair were similar across both groups, with juvenile tissue healing twice as strongly
as adult tissue [128]. These findings suggest that there are no innate differences to
growth factor response by age. Growth factors were provided to the tissue through the
aqueous environment; however, in vivo delivery will require a finite delivery time course,
and so short-term, 1-week delivery schemes were also explored. Short-term delivery of
bFGF was superior to continual bFGF and control conditions, although neither bFGF
conditions resulted in a sustained increase in cell density beyond 4 weeks, contrary to
our hypothesis. This finding suggests that cells in meniscus explants are not as sensitive
to the mitogenic effects of bFGF as cell in monolayer [10, 119-121]. Perhaps the
differences in response can be associated with modification of cell phenotype when in
monolayer expansion; Kato et al found that chondrocytes, a related cell population, only
had elevated matrix synthesis with exposure to bFGF during the logarithmic cell
expansion phase and not after becoming confluent [133]. Supporting this theory, cells in
bFGF-containing media did not stain more for the proliferation marker PHH3 within the
bulk of the tissue or at the injury site, but only at the very exterior of the tissue.

In contrast to the 2- to 4-fold increases in integration strength resulting from short-term
bFGF exposure, the addition of TGF-β3 resulted in greater than 10-fold improvements in
integration strength in meniscus-to-meniscus repair constructs. Unfortunately,
combining these two successful regimens did not result in further, synergistic
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improvements. While long-term delivery of TGF-β3 improves integration the most,
short-term delivery of bFGF offers some important benefits over that delivery scheme.
bFGF is significantly less expensive than TGF-β3 and requires a shorter time of
exposure, resulting in less volume of growth factor overall. Further, while the primary
effect of bFGF may be mitosis, it also stimulates matrix deposition, although not as
robustly as TGF-β3 [111, 121, 134]. Interestingly, combined continual delivery of TGF-β3
and bFGF decreased the integration properties compared to continual TGF-β3 alone,
demonstrating that together, the growth factors would not support repair in vivo. Also,
short-term TGF-β3 did not improve integration strength past 4 weeks, contrary to our
hypothesis. Previous work that examined fibrochondrocytes in agarose gels from the
temporomandibular joint, a related structure, found continuous TGF-β3 exposure
improved properties better than intermittent exposure in agarose gels [135], consistent
with the findings of the present study. Taken together, these findings illustrate the
importance of delivery duration and growth factor combination when repairing meniscus
tears.

In addition to meniscus-to-meniscus integration, we evaluated the integration and
maturation of electrospun PCL scaffolds as a meniscus repair material. Such a therapy is
useful for instances where meniscus damage is too severe for repair to be attempted. In
these cases, it would be beneficial for the damaged portion to be replaced with a
synthetic material capable of mimicking the ECM of native tissue and sustaining cell
viability. Further, this electrospun scaffold could be used to deliver growth factors to the
repair site through the use of heparin binding, emulsion electrospinning, coaxial
electrospinning or other novel techniques [130-132]. Cells from the native tissue densely
colonized the exterior of the scaffold and then uniformly infiltrated the scaffold, without
favoring the region closest to the tissue itself (Figure 4-6C). However, a practical
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limitation of implanting an acellular scaffold is that patient mobility would be limited to
minimize scaffold compression prior to cell infiltration and matrix deposition. Scaffold
preseeding techniques are currently being explored.

The meniscus-to-scaffold repair constructs integrated equivalently or better than the
meniscus-to-meniscus repair constructs, as hypothesized. Similar to native tissue,
integration strength increased with short-term exposure to bFGF, and increased further
with continual TGF-β3 delivery, where new tissue bridged the scaffold with the native
meniscus (Figure 4-6F, arrows). While growth factors influenced the integration
properties of meniscus-to-scaffold repair constructs, they did not result in significant
changes in the bulk characteristics of the scaffold after 4 weeks. In contrast, Pangborn et
al demonstrated that exposure to TGF-β1, an isoform of TGF-β3, stimulated significantly
more collagen and proteoglycan deposition than exposure to bFGF in scaffold-based
approaches to meniscus engineering [136]. Also, bFGF was found to increase cell density
in PLLA scaffolds compared to control conditions [134]. However, these studies and
other work from our group that demonstrated more significant matrix deposition [50]
utilized serum-free media, suggesting that serum may have mitigated the effect of growth
factors in our experiment.

Although this work represents novel approaches to identifying targets for meniscus
repair and replacement, some drawbacks can be identified. The work was performed on
bovine rather than human tissue, so some differences may develop when this work is
translated to humans. Further, the synovial environment of the knee was not captured in
the culture system. Finally, while growth factors are extremely potent, their half-life
tends to be short, so they will need to be stabilized in some way. Previous work tried to
overcome the problem through gene therapy approaches [122].
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4.6

Conclusions

Identifying novel approaches to meniscus repair and replacement require the screening
of many candidate molecules and materials. This work clearly shows that growth factor
regimen and timecourse of delivery play a key role in repair success. Future work will
translate this research into large animal studies, as we continue to develop our
understanding for how to bolster repair mechanisms in tissue and promote successful
formation and maturation of synthetic meniscus. With this work, we hope to develop
novel approaches to meniscus repair and replacement.
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5.1

Abstract

Electrospinning generates fibrous scaffolds ideal for engineering soft orthopedic tissues,
such as the knee meniscus. By modifying the electrospinning apparatus, scaffolds with
many different structures can be created. For example, fibers can be aligned in one
direction, or the porosity of the scaffold can be modified through the use of multi-jet
electrospinning and the removal of sacrificial fibers. In this work, we investigated the
role of fiber alignment and scaffold porosity on construct maturation and integration
within in vitro meniscus defects. Further, we explored the effect of preseeding expanded
meniscus fibrochondrocytes (MFCs) onto the scaffold at a high density prior to in vitro
repair. Our results showed that high porosity electropun scaffolds integrated better to
native tissue and matured to a greater extent than low porosity scaffolds, while scaffold
alignment did not influence integration or maturation. Further, the addition of expanded
MFCs to scaffolds prior to in vitro repair improved integration with native tissue, but did
not influence maturation. In contrast, preculture of these same scaffolds for 1 month
prior to repair decreased integration with native tissue, but resulted in a more mature
scaffold compared to cellular scaffolds or acellular scaffolds. This work informs scaffold
selection in future in vivo studies, bringing us closer to identifying an ideal scaffold for
meniscus tissue engineering.
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5.2

Introduction

Interest in electrospun scaffolds for fibrous tissue engineering has grown dramatically in
recent years. In this technique, electrostatic forces are used to generate nano- to micronsized fibers that resemble the collagen fibers found in orthopedic soft tissues, including
the knee meniscus. Electrospun scaffolds can mimic both the anisotropy of fibrous
tissues as well as withstand the high loads that are imposed on the tissues during
physiologic deformation [52]. Depending on the choice of material, cells will attach,
proliferate and deposit matrix in these structures, improving the mechanical properties
of the scaffolds over time [53]. Further, electrospun scaffolds have been used in a wide
range of applications, including cardiovascular, orthopedic, skin and neurological tissue
engineering [137-140]. The ability to electrospun a wide range of materials, including
synthetic and natural polymers, the potential to include drug delivery components, and
the ease of tuning fiber properties provide a wide array of scaffolds to explore [53].

Previously, we assessed the role of fiber alignment on electrospun scaffold maturation in
vitro. By collecting fibers onto a rotating mandrel rather than on a flat surface, one can
form aligned architectures that resemble native tissue structures. When cells were
seeded onto these scaffolds and cultured for 10 weeks in vitro, total matrix production
was comparable between disorganized and aligned scaffolds, increasing with time in
both conditions. However, the tensile modulus in the fiber direction of aligned scaffolds
was 7-fold higher than disorganized scaffolds, approaching that of native meniscus [50].
These findings indicate that scaffold architecture can dictate long term maturation
properties. Beyond internal organization, sheets of electrospun fibers can be organized
into tissue-like structures. For example, bilayers of electrospun scaffold were assembled
into rings and filled with a hydrogel to form an engineered intervertebral disc, a fibrous
tissue related to the meniscus, with histological and mechanical properties similar to the
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native tissue [129]. Also, sheets of electropun scaffold can be folded into a wedge-shaped
structure resembling native meniscus [141].

For meniscus tissue engineering, different cell types can be isolated, expanded and
manually seeded onto the surface of electrospun scaffolds prior to implantation in order
to expedite the regenerative process. Over time, these cells (along with host cells) will
migrate into the scaffold, depositing both proteoglycan and collagen [50]. There are a
number of potential cell sources for meniscus tissue engineering. One option is to use
autologous meniscus fibrohcnodrocytes (MFCs). This would require a surgery prior to
implantation to isolate the cells, followed by a period of expansion prior to seeding,
maturing and implanting the scaffold. While MFCs are already conditioned for the
specific mechanical environment and nutrient levels in the knee, and will produce
appropriate extracellular matrix, this approach has a number of drawbacks, including
the costs associated with a second knee surgery and cell handling, and potential MFC
dedifferentiation during expansion. Another cell source is mesenchymal stem cells
(MSCs). These cells can be differentiated into numerous musculoskeletal phenotypes
[142]. When bovine MSCs were seeded onto electrospun scaffolds in a pro-chondrogenic
media, higher amounts of matrix were deposited compared to expanded MFCs [50].
Notably, the behavior of MSCs on electrospun scaffolds appears to differ by species;
while bovine MSCs performed better than their associated MFCs, human MSCs
performed significantly worse than their associated MFCs, with limited cell infiltration
and matrix deposition over 9 weeks [143]. Finally, cells from related tissues, such as
synovial cells, chondrocytes or fibroblasts, could also be a viable cell source with
potentially beneficial properties [144, 145].
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Regardless of the starting cell source, one drawback of electrospun materials is that the
structure is quite dense, which can limit cell infiltration into the center of the scaffold.
Uneven distribution of cells prevents the development of a homogeneous matrix, and so
limits the improvement of tensile strength over time. To promote cell infiltration and
matrix production, we have explored a number of different techniques. One approach is
to modify the culture conditions; culturing these materials on a rocking bioreactor after
seeding resulted in better cell infiltration, although the technique limited matrix
accumulation over time [146]. Alternatively, multi-jet electrospinning can be used to
create scaffolds with distinct fibers populations that degrade at different rates. Slowdegrading poly(ε-caprolactone) (PCL) fibers can be intermixed with water-soluble
poly(ethylene oxide) (PEO) fibers. Upon hydration, these ‘sacrificial’ PEO fibers dissolve,
leaving a more porous architecture of PCL fibers. Scaffolds of varying porosities can be
fabricated by changing the relative percentage of sacrificial PEO fibers. Previously, we
found that increased porosity resulted in better cell infiltration and matrix distribution,
although there was an associated decrease in mechanical strength and architectural
stability at very high sacrificial levels [107]. This finding might be remedied with the
inclusion of a third fiber population (e.g. PLGA) that has an intermediate degradation
rate, helping to maintain higher mechanical properties within a dynamic scaffold that
changes in porosity over a longer period of time [147].

While cell-seeded electropun scaffolds will mature in vitro, another equally important
consideration is how such materials integrate with native meniscus tissue. If electrospun
scaffolds are to replace regions of resected tissue (as is commonly done during
meniscectomy, the most prevalent orthopedic surgery in the US [115]), their initial and
long term integration with native structures is of paramount importance. Previously, we
utilized an explant defect model to assess the integration potential of native tissue as a
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function of age [128]. In this system, the force required to separate apposing pieces of
tissue formed into concentric circles (i.e. the integration strength) was determined. This
approach has been used in both meniscus and cartilage tissue engineering to assess
tissue-tissue and tissue-biomaterial integration [35-37, 94]. In our prior study, we also
replaced the inner core of the meniscus defect with a disc of electrospun scaffold, and
found that native meniscus cells infiltrated the material well after 6 weeks of in vitro
culture. In this work, we expanded upon this model to test the mechanical integration
strength between electrospun scaffold and native tissue. We hypothesized that increasing
scaffold porosity would improve both the maturation and integration strength of the
scaffolds in vitro.

Clinically, the implantation of an acellular material into a meniscal defect would be the
simplest and most cost effective approach for repair. As previously noted, prior studies
have demonstrated that nanofibrous materials are readily populated by native meniscus
cells in vitro. Indeed, other acellular scaffolds, such as the collagen meniscus implant
(CMI) [24], have been implanted adjacent to the meniscus and became colonized by
endogenous cells. However, acellular electrospun scaffolds are delicate materials, and
are particularly susceptible to compaction upon exposure to compressive forces. Thus,
post-operative rehabilitation will require a significant period of non-weight bearing,
similar to the post-operative procedure for the CMI. As the scaffold becomes colonized
by local cells and matrix is deposited, the new extracellular matrix will reinforce the
nanofibrous architecture. As previously discussed, one approach to reduce the nonweight bearing period would be to implant mature scaffolds that are already colonized
with cells. Pre-seeded or pre-matured scaffolds might also integrate more rapidly with
native tissue given the increase in early cell number at the construct border. To address
this issue, we evaluated the effect of the direct addition of expanded MFCs to the scaffold
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immediately prior to in vitro defect repair, as well as placement after a 1-month
preculture period. With this work, we hope to better understand the optimal properties
for electrospun scaffolds with respect to both maturation and integration with native
tissue. These findings will guide our selection for material implantation in future large
animal studies.

5.3

Materials and Methods

Figure 5-1 Schematics of experiments. (A) Multiple scaffold architectures were tested after 4 and
8 weeks of in vitro culture in the presence of FBS and TGF-β3 to determine the scaffold with the
best maturation and integration properties (scale = 20 µm). (B) Different seeding techniques were
utilized, including a 1-month preculture prior to construct assembly, to determine the most
appropriate cellular context for implantation.

5.3.1

Fabrication of Electrospun Scaffolds with Varying Alignment and Porosity

To create electrospun scaffolds, two separate solutions (14.3% w/v poly(ε-caprolactone)
(PCL, 80 kDa, Sigma-Aldrich, St. Louis MO) in a 1:1 mixture of tetrahydrofuran (THF,
Fisher Chemical, Fairlawn NJ) and N,N-dimethylformamide (DMF, Fisher Chemical)
and 10% polyethylene oxide (PEO, 200 kDa, Polysciences, Warrington PA) in 90%
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EtOH) [107] were mixed overnight prior to electrospinning. Four scaffolds with distinct
fiber architectures were created (Figure 5-1A) with two alignment schemes
(disorganized, aligned) and 3 levels of PEO fiber fraction (0, 30%, 60%) to change the
porosity. To create disorganized PCL scaffolds, a 20 mL syringe was filled with PCL
electrospinning solution and fitted with a stainless steel 18G blunt-ended needle that
served as a charged spinneret. A flow rate of 2.5 mL/h was maintained with a syringe
pump (KDS100, KD Scientific, Holliston, MA). A power supply (ES30N-5W, Gamma
High Voltage Research, Inc., Ormond Beach, FL) applied a +13 kV potential difference
between the spinneret and the grounded mandrel located at a distance of 12 cm from the
spinneret. Additionally, two aluminum shields charged to +10 kV were placed
perpendicular to and on either side of the mandrel to better direct the electrospun fibers
towards the grounded mandrel. The mandrel was rotated via a belt mechanism
conjoined to an AC motor (Pacesetter 34R, Bodine Electric, Chicago, IL) at a speed of
0.34 m/sec, slow enough to limit any pronounced alignment.

To fabricate the remaining three aligned scaffolds, a custom trijet electrospinning device
[147] was utilized to generate an intermingled composite of PCL and PEO fibers. Three
syringes were fitted with needles, as described previously, and were directed at a single
central rotating mandrel (10 m/s) equidistant from each other and separated by shields
(+5 kV charge). The speed of the mandrel was sufficiently fast to align the collecting
fibers into a single direction. A flow rate of 2 mL/h and a +15 potential difference
between the needles and mandrel was utilized. The distance between the mandrel and
the needle was 12 cm. The needles followed a reciprocating path using a custom fanner in
order to better disperse the fibers along the length of the mandrel. As depicted in Figure
5-1A, the following configurations were used to create each of the three aligned
scaffolds: 3 jets of PCL to create ‘Low Porosity’, 1 jet of PCL/1 jet of PEO to create
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‘Medium Porosity’, and 1 jet of PCL/2 jets of PEO to create ‘High Porosity’ scaffolds. The
resulting PCL content was 100%, 70%, and 30%, respectively. The grading (low,
medium, high) indicates the relative porosity of the material after PEO removal. A total
volume of 20 mL of spinning solution was used to generate each mat with a final
thickness of ~1 mm prior to PEO removal. After fabrication, 4 mm discs were excised
using a dermal punch and stored in a desiccator until use. The percent of PEO
incorporation was verified by measurement of mass loss following exposure to aqueous
solution.

5.3.2

Formation of Meniscus/Scaffold Constructs

Menisci were dissected from the knee joints of juvenile (3 months old) bovine limbs in a
sterile manner. Cylinders (8 mm diameter x 3 mm thick) were excised centrally in the
axial direction using a dermal punch (Miltex, Plainsboro, NJ). A smaller dermal punch
(4 mm diameter) was used to remove a central core from the cylinder to form a ring, and
an electrospun disc was press-fit into the meniscus ring as depicted in Figure 5-1A
[128]. Prior to insertion, scaffolds were sterilized with UV light for 10 minutes.

5.3.3

Optimization of Scaffold Alignment and Porosity

Electrospinning was carried out as described above to generate disorganized low
porosity, aligned low porosity, aligned medium porosity and aligned high porosity
scaffolds (n=7-9/condition, all work performed in duplicate, one representative data set
shown). In order to assess if the presence of tissue influenced scaffold maturation,
tissue-free control scaffolds were cultured by seeding meniscus fibrochondrocytes
(MFCs) directly onto both sides of the four types of scaffold discs at a density of 3333
MFCs/mm2 scaffold per side (n=6-7/condition, work performed in duplicate, one
representative data set shown). MFCs were extracted from a 5 mm radial slice of sterile
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juvenile meniscus by mincing the tissue into 2 mm3 pieces and allowing the cells to
migrate out onto the tissue culture plastic (Corning, Sigma-Aldrich, St. Louis MO) to
establish primary cultures over the course of a few weeks. For expansion, cells were
cultured in basal media (Dulbecco’s modified Eagles medium (DMEM) with 10% fetal
bovine serum (FBS) and 1% penicillin/streptomycin/fungizone (PSF)). After formation,
the tissue-free control scaffolds and scaffold/meniscus repair constructs were cultured in
DMEM with 10% FBS, 1% PSF, 50 µg/mL ascorbate-2-phosphate (vitamin C) and 10
ng/mL TGF-β3. After 4 and 8 weeks, samples were removed from culture and prepared
for histology (control scaffolds and repair constructs) or tested mechanically (repair
constructs only). The mechanical integration strength between the scaffold and native
meniscus tissue was measured using a custom push-through testing device [128]. Briefly,
an Instron 5848 was outfitted with a 3.5 mm diameter indenter in series with a 50 N
load cell. This indenter was placed above a plate with a 5 mm diameter hole. The
construct was placed onto the plate, and the indenter progressed through the defect site
at a rate of 0.0833 mm/sec. Integration strength was calculated using the following
formula:

Integration Strength =

Maximum force( N )
2πr ⋅ h

The height (h) of the scaffold disc was measured using an OptoNCDT laser measuring
device (Micro-Epsilon, Raleigh, NC) after pushout.

After testing, the native tissue was discarded and the scaffold was lyophilized and
digested in a buffer containing 2% papain at 60°C. The resulting digest was used to
assess DNA content (PicoGreen Assay, Invitrogen, Carlsbad, CA), glycosaminoglycan
(GAG) content (DMMB assay [67]) and collagen content (OHP assay with a conversion
factor of 7.14 [68]). Results were normalized to sample dry weight. To assess cell and
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matrix distribution, 1-2 fresh constructs per condition were prepared for histology by
fixing the samples in 4% paraformaldahyde overnight, embedding in OCT freezing media
(Tissue-Tek, Fisher, Fairlawn, NJ) and cryosectioning onto glass slides (12 µm thick)
perpendicular to the plane of the electrospun disc. Slides were stained with Alcian blue
for proteoglycan, Picrosirius red for collagen and DAPI (Prolong Gold, Invitrogen,
Carlsbad, CA) to identify cell nuclei.

5.3.4

Optimization of Scaffold Seeding Method

In order to assess the role of cell seeding (Figure 5-1B) on maturation and integration,
juvenile bovine MFCs were seeded onto aligned Low and High porosity scaffolds as
previously described. Scaffold discs were seeded and immediately implanted (‘Cellular’),
or seeded and cultured for 4 weeks prior to implantation (‘Preculture’). Acellular
scaffolds were also inserted as a control (‘Acellular’) (n=7-8/group, performed in
duplicate, one representative data set shown). After 4 and 8 weeks, constructs were
processed for histology and mechanical integration as previously described.

5.3.5

Statistical Analysis

For all work, 1 and 2-way ANOVAs were performed using SYSTAT software (Chicago, IL)
to compare timepoints and conditions using Tukey’s post-hoc test. Significance was set
at p ≤ 0.05.

5.4

Results

5.4.1

Optimization of Scaffold Architecture: Alignment and Porosity

Four types of electrospun scaffolds were created with various alignments and porosities.
The disorganized scaffold had no prevailing fiber direction, whereas the aligned scaffolds
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had a single predominant fiber direction (Figure 5-2A). When scaffolds were seeded
with expanded MFCs and cultured for 8 weeks, histology revealed the formation of celland matrix-dense capsules around the scaffolds. While no differences were seen
histologically between disorganized and aligned scaffolds, higher porosity scaffolds had
better cell infiltration (Figure 5-2B) and more uniform matrix deposition (Figure 52C). Further, increasing porosity resulted in incrementally higher quantities of cells and
matrix in the scaffold (p < 0.05) (Figure 5-2D).

Figure 5-2 Tissue-free control scaffolds seeded with MFCs. (A) SEM images of scaffold fiber
morphology (scale = 20 µm). Cross section of scaffolds with (B) DAPI staining for cell nuclei and
(C) Picrosirius red / Alcian blue staining for matrix deposition indicates superior properties in
high porosity scaffolds, with no difference based on alignment (scale = 200 µm). A thick capsule
was observed around all scaffolds. (D) DNA (top) and GAG (bottom) content increased relative to
scaffold weight with alignment and in higher porosity scaffolds. Line indicates significant
difference, with p< 0.05; n=6-7/condition.
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To test the impact of scaffold architecture and porosity on cell colonization directly from
native tissue, we inserted discs of acellular scaffold into circular meniscus defects and
evaluated infiltration into the scaffold and mechanical integration with the native tissue.
This approach mimics the implantation of an acellular scaffold in vivo. We measured the
force required to displace the inner scaffold disc from the outer meniscus ring, and
calculated the integration strength based on the construct geometry at 4 and 8 weeks.
High porosity scaffolds integrated with native tissue to a much greater degree than low
porosity scaffolds, with a 3-fold improvements in integration strength at 8 weeks (p <
0.05) (Figure 5-3A). Fiber alignment did not modulate the integration capacity for the
low porosity scaffolds. Scaffolds pushed out of meniscus rings were digested and the
biochemical content measured after 8 weeks in vitro. Quantification confirmed that
twice as many cells per weight of scaffold populated high porosity scaffolds compared to
low porosity scaffolds (p < 0.05) (Figure 5-3B). Further, scaffold porosity strongly
affected matrix deposition, with low, medium and high porosity scaffolds containing
incrementally more matrix (Figure 5-3C).
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Figure 5-3 Optimization of scaffold architecture: Mechanical properties and biochemistry. (A)
Integration with native tissue was greater for high porosity scaffolds than for disorganized or
aligned low porosity scaffolds. (B) DNA content was higher in high porosity scaffolds compared to
disorganized and aligned low porosity scaffolds after 8 weeks. (C) Scaffold porosity (but not
alignment) influenced GAG deposition, with differences found between low, medium and high
porosity scaffolds after 8 weeks. Line indicates significant difference, with p < 0.05; n = 78/condition.

Thin capsules of cells and matrix formed around the scaffold in this in vitro defect, but it
was less pronounced than in tissue-free control scaffolds (Figure 5-4A, B). New
ancillary tissue was deposited between the scaffold and native tissue, creating a bridge of
matrix that influenced integration properties (Figure 5-4A). The ancillary tissue was
more pronounced in high porosity scaffolds (data not shown). Furthermore, high
porosity scaffolds showed the best cell distribution, with similar cell density to native
meniscus tissue after 8 weeks in culture and almost uniform cell distribution throughout
the material (Figure 5-4B, lower-right image).
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Figure 5-4 Optimization of scaffold architecture: Histology. (A) Alcian blue and Picrosirius red
staining of high porosity scaffold discs cultured in meniscus defects for 8 weeks in vitro revealed
significant matrix deposition in the scaffold and the formation of surrounding ancillary tissue
(scale = 500 µm). (B) High porosity scaffolds had better cell distribution through the depth
compared to low porosity scaffolds, and alignment did not affect cell infiltration (scale = 500 µm).
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5.4.2

Optimization of Scaffold Seeding Method

Aligned low and high porosity scaffolds were next used to determine whether the seeding
method influenced scaffold maturation and integration. While low porosity scaffolds are
the easiest to fabricate and are most extensively tested, high porosity scaffolds
demonstrate

superior

integration

and

maturation

properties.

Three

different

scaffold/meniscus repair constructs were formulated: acellular implantation, the
addition of expanded MFCs immediately prior to insertion (‘cellular’), and 4 weeks of
preculture of seeded scaffolds prior to insertion (‘preculture’).
Mechanical testing revealed that, as previously shown, high porosity acellular scaffolds
integrated to a greater extent than low porosity scaffolds after 8 weeks in vitro (p < 0.05)
(Figure 5-5A). Seeding the scaffold immediately prior to implantation with a high
density of expanded MFCs resulted in significantly better integration in low porosity
scaffolds, but did not further improve high porosity scaffold integration capacity.
Preculturing scaffolds for 4 weeks prior to implantation resulted in significantly lower
integration strengths for both scaffold types compared to cellular conditions (p < 0.05).
Biochemical analysis of scaffolds revealed variable maturation based upon seeding
technique. Seeding expanded MFCs onto the scaffold (‘cellular’ and ‘preculture’
conditions) resulted in lower cell densities in the scaffolds after 8 weeks compared to
acellular controls, where MFCs populated the scaffold directly from the tissue (Figure
5-5B). One extra month of preculture did not bolster DNA content; however, it greatly
increased GAG content in the scaffold, suggesting that the cells were steadily forming
matrix that accumulated in the scaffold, with little proliferation, during the preculture
period (Figure 5-5C).

81

Figure 5-5 Optimization of seeding method: Mechanical properties and biochemistry. (A) For low
porosity scaffolds, cellular scaffolds integrated significantly better than acellular or preculture
scaffolds after 8 weeks. For high porosity scaffolds, acellular and cellular scaffolds had
comparable integration strength. Both low and high porosity precultured scaffolds exhibited
significantly lower integration strength with native tissue compared to cellular scaffolds. (B)
Scaffolds seeded with expanded MFCs (cellular and preculture conditions) contained less DNA
per dry weight than acellular scaffolds, which were populated by MFCs that migrated directly
from the surrounding meniscus ring. (C) Precultured scaffolds contained more GAG overall than
acellular or cellular scaffolds after 8 weeks. (D) High porosity scaffolds weighed less than low
porosity scaffolds; preculture scaffolds were heavier than acellular and cellular scaffolds (dry
weight). Line indicates difference, with p > 0.05.

Histologically, cellular and preculture constructs had incrementally thicker cell capsules
surrounding the scaffold compared to acellular controls (Figure 5-6B). Examination of
the scaffold/meniscus interface showed that the cellular capsule in precultured samples
appeared to prevent integration with native tissue in preculture constructs. In contrast,
cellular scaffolds had a tight connection with the native tissue (Figure 5-6C, arrows).
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Figure 5-6 Optimization of seeding method: Histology. (A) Schematic of histology sectioning
planes. (B) DAPI staining reveals better cell infiltration in high porosity scaffolds and thicker cell
capsules in precultured samples (scale = 500 µm). (C) Alcian blue and Picrosirius red staining
shows robust integration (arrows) between cellular scaffolds and native tissue. In contrast,
limited integration was observed between the preculture scaffolds and native tissue, likely due to
the formation of a cell capsule (arrows) during preculture (high porosity scaffold shown, scale =
250 µm).

5.5

Discussion

Electrospinning is an extremely versatile fabrication method that can produce scaffolds
with a wide array of properties. By changing the collection surface, the type of polymer,
and the number of spinnerets in the electrospinning apparatus, many different scaffold
architectures can be created and evaluated. Over the years, our lab and others have
explored a number of different types of electrospun scaffolds for use in fibrous tissue
engineering. These tissues, such as the knee meniscus, suffer from low intrinsic repair
capacity, low cell metabolic activity and density, and experience extremely high
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mechanical stresses in vivo, so advanced materials must be used to engineer
replacement tissues that can successfully promote repair and reestablish joint
mechanics.

In this work, we employed a concentric explant model wherein a disc of electrospun
scaffold was cultured inside a ring of bovine meniscus. We used this approach to assess
both maturation (histology, biochemical content of the scaffold after 8 weeks) and
integration of the scaffold to native tissue (mechanical integration strength after 4 and 8
weeks). Specifically, we explored the role of scaffold alignment, porosity and seeding
technique on these outcomes. In this context, we found that scaffold alignment did not
influence maturation or integration capacity. Also, the alignment of the fibers in the
scaffold with respect to the alignment of the collagen fibers in the tissue did not influence
integration (data not shown), although we hypothesize that it could influence the tensile
load transmission under more physiologic loading scenarios. We also found that higher
porosity scaffolds mature faster and integrated better with native tissue than their less
porous counterparts. When considering different cell seeding techniques, the addition of
cells immediately prior to implantation enhanced integration strength, particularly with
low porosity scaffolds. While precultured scaffolds had the highest matrix content,
integration with native tissue was markedly reduced. In future work, the outer rim of the
precultured scaffolds might be removed to improve the integration properties of these
more mature construct.

While the concentric explant model has been used by us and other groups to assess
integration, it does not represent the most physiologically relevant damage force in the
knee. A tissue engineering meniscus patch would primarily experience compressive
forces and tensile forces, rather than shear extrusion. However, the technique does
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provide us with comparative information on the relative integration potential between
scaffold types, which can motivate other studies. While bioreactors and subcutaneous
studies can mimic the in situ environment of the knee, direct implantation of the
material into a meniscus defect will give us the best information on its repair potential.
Indeed, preliminary data from an ovine implantation suggest that high porosity
constructs integrate better than low porosity constructs in situ [148].

During in vitro testing, the composition of the culture media will influence the results of
the experiment profoundly. All of the constructs in this study were cultured in the
presence of fetal bovine serum, rather than in a chemically defined media, in order to
more closely mimic the complexity of the in vivo environment. Notably, a thicker capsule
was seen around the scaffolds and less pronounced matrix deposition was seen
throughout the scaffolds compared to prior work that employed a pro-chondrogenic,
chemically defined media [50, 129]. This capsule confounds the biochemical analysis, as
we were unable to remove it prior to digestion. Also, we included TGF-β3 to the media in
order to stimulate matrix production and a chondrogenic phenotype; without this
growth factor, limited matrix would be deposited (data not shown). In vivo, local
delivery of TGF-β3 could be accomplished through entrapped drug-delivering
microspheres [114] or other delivery techniques from electropun fibers [53], in order to
ensure that sufficient matrix is deposited to support the scaffold during compression and
reinforce the fibers during tension.

Further, in this work, we employed two distinct cell populations. MFCs were either
extracted from the tissue, expanded in monolayer and than added back to the scaffold at
a high density, or acellular scaffolds were colonized by MFCs directly from the adjacent
tissue. The expanded MFCs are likely phenotypically different from the native MFCs due
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to dedifferentiation during monolayer expansion [149]. Thus, it is unclear if the
maturation differences seen between tissue-free control scaffolds and scaffold-meniscus
constructs are due to changes in cells themselves with passaging, or to the presence of
the native tissue in the culture well. The tissue extracellular matrix is known to store a
number of growth factors and those molecules could be released and alter cell behavior
[150]. Alternatively, living MFCs within the meniscus ring may produce factors and
signal to the adjacent scaffold [151].

While this work represents an important step towards identifying the optimal
electrospun scaffold for meniscus tissue engineering, a few drawbacks exist. First, bovine
meniscus rather than human meniscus was used. While bovine tissue has been used
previously for in vitro meniscus work [107, 128, 152], differences in bovine MFC
behavior compared to human MFCs has been identified [51]. Further, while the
mechanical properties of meniscus from humans and domesticated animals like the cow
are similar, the exact composition and the distribution of matrix elements are not
identical [153]. Also, in this work, only one form of mechanical testing was explored. Lap
testing or uni-axial tensile testing could all be explored by using different construct
geometries, and could be related more closely to the specific mechanical challenges
experienced by an implanted scaffold during normal knee motion; however, these
constructs have proven challenging to test consistently in previous studies. Finally,
young (0-3 month) tissue was used for this study. We have previously shown that this
tissue is hypercellular and has a distinct matrix composition compared to mature bovine
meniscus tissue, which is more clinically relevant to the aged human population that
typically presents with meniscus tears. However, despite these differences, we can still
learn a significant amount about how the different scaffolds mature and integrate with
meniscus tissue.
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5.6

Conclusions

In this work, we considered the effect of scaffold alignment, porosity and seeding
technique on scaffold maturation and integration with native tissue. While in vitro
techniques are valuable in assessing the relative potential of various scaffold
architectures and implantation schemes, other key factors will need to be considered
when

implanting

such

materials

in

vivo,

including

the

immune

response,

vascularization, and the response to the synovial environment. With this work, we
identified several optimal material attributes that may further our efforts to replace
resected meniscus in a manner that promote regeneration and reestablishes joint
mechanics. These scaffolds may one day limit the development of cartilage erosion after
meniscectomy, forestalling the onset of osteoarthritis and the need for total knee
arthroplasty.
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6:

The Delivery of Molecules from Electrospun Scaffolds:
A Review of Techniques and Biological Findings

6.1

Abstract

As previously shown, electrospun scaffolds are a versatile and promising material for
fibrous tissue engineering. Multi-jet electrospinning and different seeding techniques, as
well as exposure to various growth factors, can modulate the maturation of the scaffold
and its integration with native tissue. However, these scaffolds would be more powerful
if they could also harbor chemical cues that recruit cells, drive behavior or maintain
appropriate cell phenotypes over time. Due to the large interest in electrospinning
polymers, a wide range of drug delivery techniques have been developed. Many different
kinds of molecules can be delivered, including antibiotics, analgesics, cancer
therapeutics, and proteins. Recently, significant advances have been made in the
encapsulation and release of growth factors, particularly useful in guiding cell behavior in
tissue engineered materials. This review will assess the current landscape for drug
delivery from electrospun scaffolds.

6.2

Delivery of Antibiotics

One of the first classes of molecules to be delivered from electrospun fibers are
antibiotics, since scaffolds could be easily applied as wound dressings or formed into
sutures and designed to release antibiotics slowly to prevent infection at the site of
injury. Kenawy 2002 demonstrated for the first time the release of tetracycline
hydrochloride (tet), a broad-spectrum antibiotic, from poly(lactic acid) (PLA),
poly(ethylene-co-vinyl acetate) (PEVA) or a 50:50 blend of the two by adding tet to the
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electrospinning solution and stabilizing the mixture with methanol. Drug release was
seen over 5 days, with a significant burst release at day 1 [154].

The significant burst release has been observed by a number of groups mixing
antibiotics directly into the electrospinning solution to form a blended fiber. Zong 2002
released Mefoxin from poly(L-lactic acid) (PLLA) fibers and demonstrated that the
concentration and ionic salt addition had the largest influences on fiber morphology.
However, they were unable to remove the large burst effect [155]. Similarly, Kim 2004
showed that Mefoxin released from poly(lactide-co-glycolide) (PLGA) fibers with a burst
effect. However, this effect could be minimized by the addition of the amphiphilic block
copolymer (PEG-b-PLA). Staphylococcus aureus cultures exposed to fibers demonstrated
that the antibiotic remained bioactive upon release, with significant bacterial
suppression at early timepoints [156].

However, it has been shown that the addition of molecules to the fibers can change the
mechanical properties of the fibers. To combat this problem, Hong 2008 created
nanofibrous sheets composed of two fiber populations. Biodegradable poly(ester
urethane) urea (PEUU) fibers and PLGA fibers loaded with tet were co-electrospun into
a single mat. Mechanical properties, such as breaking strengths, tensile strength and
suture retention capacity, were greatly improved by the dual-scaffold over PLGA-tet fiber
system alone. An in vivo study demonstrated that implantation of the tet-releasing
scaffold could prevent abscess formation in a contaminated rat abdominal wall [157].

While significant effort has been made to incorporate tet, other antibiotics with variable
properties have also been blended into electrospun scaffolds. Zeng 2003 found that
adding surfactants or proteinase K decreased the burst release of the antibiotic rifampin
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from PLLA fibers [158]. Also, Katti 2003 explored how fabrication parameters, such as
needle gauge size, concentration, density and voltage influences loading of the antibiotic
cefazolin [159].

Although adding the antibiotic directly to the electrospinning solution is a simple
process, it would be desirable to decrease the burst release seen from most system. So,
an alternate system of electrospinning a co-axial fiber, with an inner core containing the
antibiotic and a protective outer shell modulating release properties. This method can
decrease exposure of drugs to harsh fabrication conditions, as well as create a coating to
decrease burst release and extend release times. He 2006 created nanofibers with a
PLLA outer shell and tet encapsulated in the interior fiber. The resulting fibers showed a
sustained release profile of tet, with almost no burst effect [160]. Huang 2006 compared
the release of resveratrol (antioxidant) and gentamycin sulfate (antibiotic) from the
inner core surrounded by a poly(capro-lactone) (PCL) shell. The degradation rate was
found to be closely related to the hydrophilicity of the drug in the core, and the
miscibility of the solvents used influenced mechanical properties of the fibers [161].

Some contest that a sustained release is ideal, but He 2009 argues that different release
profiles have uses in unique applications. By fabricating fibers using either a blending or
coaxial technique in order to create sutures, he found that the blended fibers with an
initial burst could be applicable to antibacterial release, where the drug is needed more
early on, whereas coaxial fabrication results in more sustained release appropriate for
growth factor delivery or therapeutic agents [162].
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6.3

Delivery of Analgesics

Analgesics have also been incorporated into electrospun fibers as well. Jiang 2004
demonstrated that by covalently conjugating ibuprofen with poly(ethylene glycol)-gchitosan (PEG-g-CHN) and electrospinning with PLGA, sustained release of the drug
could be attained over 16 days [163]. Also, Qi 2008 created acid-labile electrospun fibers
that released an analgesic (paracetanol) more completely and at a faster rate when
placed in acidic environments. Natural decreases in local pH often accompany
inflammation, tumor growth, and myocardial ischemia, suggesting that such a system
may provide sophisticated drug delivery capability [164]. The incorporation of
paracetanol was also more closely explored [165], and it was determined that thicker
fibers resulted in longer zero-order release profiles.

6.4

Delivery of Cancer Therapeutics

Another important class of molecules that have been incorporated and released from
electrospun fibers treats cancer. Systemic administration of anti-cancer medications
often leads to debilitating side-effects, suggesting that local delivery through a
biodegradable patch may be less damaging to the patient. In a series of experiments,
Zeng explored the incorporation of anticancer drugs into PLLA fibers. It was found that
paclitaxel incorporated uniformly into the scaffolds, whereas doxorubicin hydrochloride,
a hydrophilic drug, appeared to phase-separate onto the surface of the fibers, leading the
scientists to propose that the solubility of the drug in the polymer/solvent liquid was
essential for uniform fiber fabrication [166, 167]. Another interesting application by Xie
2006 incorporated paclitaxel into electrospun PLGA nanofibers and demonstrated
cytotoxicity against C6 glioma cell lines for local applications in brain tumor destruction
[168]. Also, Xu 2006 released BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea from PEG–
PLLA ultrafine fibers and demonstrated sustained release and decreased cell viability of
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Glioma C6 cells over time [169]. Xu 2005 also demonstrated that doxorubicin
hydrochloride could be loaded into amphiphilic poly (ethylene glycol)-poly (l-lactic acid)
(PEG-PLLA) diblock copolymer at 1-5 wt% of the fibers, with release controlled by a
combined diffusion mechanism and enzymatic degradation mechanism, that proved
cytotoxic to Glioma C6 cells [170].

6.5

Delivery of Growth Factors

Recently, there have been significant advances in the ability to deliver growth factors
from electropun scaffolds. This type of molecule is particularly challenging to deliver
because it is prone to denaturation during the electrospinning process; growth factors
are large and delicate molecules. To that end, a number of different techniques have
been developed to release growth factors from electrospun materials, including the use of
annealed fibers, blended fibers, coaxial fibers and multi-component scaffolds.

6.5.1

Annealed Fibers

One approach to functionalizing nanofibers is to modify the fibers after electrospinning
in order to promote growth factor attachment. Growth factors can be immobilized on the
fiber, reversibly attached via heparin bound to the fiber, or temporarily adsorbed to the
fiber itself. Reversible attachment through heparin molecules seems to provide the
highest loading and most sustained release over time.

The most extreme attachment of growth factors is via amine-conjugation of the proteins
directly to the fibers. While this approach appears to maintain bioactivity of the growth
factors, it limits exposure to cells directly attached to the fibers. One of the first
approaches by Choi et al used a PEG-PCL amine-terminated block copolymer to improve
wound healing in diabetic mice by binding EGF to the fibers using EDC/HOBt coupling
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technique [171]. Later work by Cho et al released NGF bound to PEG-PCL fibers through
EDC/NHS chemistry to promote a neuronal phenotype in mesenchymal stem cells, with
clearly no release of growth factor over 1 week [172]. Also, simply soaking the fibers in
NGF resulted in complete release after 1 day, suggesting that some chemical coupling is
necessary to delivery growth factors in a sustained manner [172]. Futher, Tigli et al and
Gumusderelioglu et al immobilized EGF via NHS on PCL and PCL/collagen electrospun
scaffolds, and demonstrated improved cell spreading, proliferation and wound healing,
with no proof of release over time [173, 174]. Interestingly, Lee et al first coated PLGA
fibers with polypyrrole, a conductive material, and then attached NGF using EDC/NGF
chemistry. A combination of NGF and electrical stimulated resulted optimal neutrite
outgrowth, compared to NGF alone [175]. In another unique approach, Casper et al
demonstrated that low molecular-weight heparin (LMWH) functionalized with PEG
prior to electrospinning with PEO or PLGA improved bFGF retention over time
compared to non-PEG LMWH [176].

While these approaches influence cell behavior, they only act upon cells in immediately
contact with the fibers, thus limiting their influence. In order to release growth factors
rather than immobilize them, similar chemistry can be used to immobilize heparin and
heparin sulfate to fibers. Heparin is a glycosaminoglycan that reversibly binds a
multitude of different growth factors [177]. By using EDC/NHS chemistry to attach
heparin to electrospun fibers, growth factors can be reversibly attached, with sustained
release over time. For example Kim et al found that heparin-conjugated PCL/gelatin
fibers released more bFGF in a sustained manner than soaking the unmodified fibers in
the growth factors, where release was low and abrupt. Further, heparin-fixed bFGF
fibers stimulated proliferation in a number of different cell types for a longer amount of
time than bFGF soaked fibers [130]. Similarly, Lam et al demonstrated that while PLLA
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fiber/heparin-bound bFGF and EGF resulted in neural differentiation and axon growth,
growth factor adsorption alone did not [178]. Rather than conjugating the PCL fibers
after electrospinning, Ye et al conjugated prior to electrospinning and loaded bFGF,
stimulating cell proliferation and cell adhesion in vitro better than growth-factor free
controls [179]. Interestingly, molecules related to heparin can also be used to reversibly
bind growth factors. For example, Casper et al demonstrated that attachment of perlecan
was 10-fold better than heparin at attaching high concentrations of bFGF to
collagen/gelatin fibers [180]. Further, one novel approach by Almodovar et al uses
polyelectrolyte multilayer coating of heparin and chitosan to attach bFGF to fibers,
rather than EDC/NHS chemistry. While the technique successfully attached the growth
factor, it is unclear how it compares to the traditional method [181].

6.5.2

Blended Fibers

While surface modifications and coatings are a promising approach to protein delivery
from electrospun fibers, another technique is to blend the proteins directly in the fibers.
A major drawback to this technique is that many electrospinning solutions contain harsh
organic solvents, so extra steps must be taken to prevent denaturing of growth factors.
One of the first techniques was to include bovine serum albumin in the electrospinning
solution. Chew et al was able to maintain bioactivity and sustained release for 3 months
by electrospinning a mixture of BSA, NGF and copolymer of ε-caprolactone/ethyl
ethylene phosphate (PCLEEP) [182]. Further, they improved bridging of a critical gap in
rat neurons via glial cell-derived neurotrophic factor (GDNF) delivery compared to
growth-factor free controls in vivo [183]. In contrast, Koh et al was unable to
demonstrate clear benefit from delivery of NGF from BSA-containing PLGA electrospun
fibrous bilayers in vivo. Specifically, encapsulated levels of NGF were low, perhaps due
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to denaturing of the protein while interacting with the organic solvent or being exposed
to high electric potentials during electrospinning [184, 185].

Another technique that has produced more consistent results is to create an oil/water
emulsion prior to electrospinning that creates pockets of aqueous media for growth
factors to reside. This technique is used to fabricate growth-factor laden polymeric
microspheres with clear success [186]. Sahoo et al delivered bFGF from PLGA fibers by
first emulsifying a mixture of an aqueous mixture of buffered bFGF and BSA with PLGA
in HFIP. The resulting emulsion was then electrospun and the growth-factor laden
scaffold stimulated BMSC proliferation over 2 weeks [187] and also demonstrated
favorable properties for tendon/ligament tissue engineering applications [131]. Similarly,
Valmikinathan et al electrospun an emulsion of aqueous NGF with PCL in HFIP.
Inclusion of BSA in the emulsion improved release profiles over 1 month and helped
maintained bioactivity as measured by a PC12 neurite outgrowth assay [188]. Li et al
showed related results using poly(l-lactide-co-caprolactone) chloroform/Span80, and
also found that the emulsion technique influence growth factor release properties from
the fibers [189].

Certain polymers that can be electrospun in aqueous solutions can also be electrospun
into growth factor delivery systems. Li et el electrospun mixtures of silk, poly(ethylene
oxide) (PEO) and BMP-2 that resulted in higher calcium deposition and enhanced
transcript levels of bone-specific markers than in the controls [190]. Madduri et al
delivered NGF and GNDF from electrospun silk/PEO conduits over 28 days [191].
Because PEO fibers are instantly soluble, they can be used to enhance porosity in
electrospun scaffolds [107] or to provide a quick release of drugs such as antibiotics
[157]. Early work suggests that such fibers may be a valuable tool for other forms of drug
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delivery. For example, Kluge et al released FGF from PEO/silk scaffolds stimulated cell
infiltration in a subcutaneous rat model [192] and Qu et al delivered the enzyme trypsin
from PEO fibers to degrade GAGs in cartilage in vitro [193].

6.5.3

Coaxial Fibers

Rather than creating a uniform fiber, coaxial electrospinning may offer additional
protection to growth factors and prevent burst release by entrapping drugs in a central
vein, although the technique is more technically challenging than regular fiber
electrospinning. Early work by Liao et al encapsulated an aqueous mixture of PDGF and
BSA in a PCL/PEG outer shell with zero-order release kinetics [132]. Both Liu et al and
Sahoo et al elicited biological responses from a core-shell nanofiber scaffold with an
aqueous core of NGF/solid shell of poly(lactic acid-caprolactone) (P(LLA-CL)) [194] and
aqueous core of bFGF-BSA/solid shell of PLGA [187].

Recently, many investigators have utilized solid/solid coaxial structures rather than
liquid/solid described above to extend the delivery period of the growth factor. For
vascular tissue engineering, 28 days of bioactive release were demonstrated by Jia et al
from the dextran-VEGF core/PLGA shell fibers [195] and by Li et al from dextran-PDGF
core/PLCL shell fibers [196]. Yang et al promoted wound healing in diabetic rats by
treating with cyclodextrin-bFGF core/PELA shell electrospin fibers [197]. Wang et al
delivered NGF from an inner PEG core and an outer PLGA shell, and similar to Liu et al
[194] found that nerve regeneration was comparable to autograph but better than
control in a rat scientic nerve model [198].

In a different approach, Lu et al combined a number of different techniques to create an
optimized fiber system. Specifically, they created a central core of PCL, to enhance
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morphological stability and mechanical strength, with an outer shell of cationized gelatin
which was amenable to heparin adsorption. Sustained release of VEGF was observed in
the presence of adsorbed heparin, and release profiles were controllable through changes
in cross-linking duration and pH [199].

6.5.4

Multi-Component Scaffolds

Another approach for growth factor delivery is to incorporate distinct delivery
components into or between electrospun fibers. Early work by Dong demonstrated the
feasibility of incorporating multiple microsphere populations into fibers [200]. A similar
system by DeVolder et al was used to promote vascularity in chick embryos by releasing
VEGF from PLGA microparticles contained inside PLA fibers [201]. Qi et al developed a
modified form of emulsion electrospinning where large Ca-alginate bubbles in PLLA
fibers released BSA, but most of the protein was released in the first day [202]. Rather
than incorporating microspheres inside of fibers, Ionescu et al entrapped PLGA
microspheres between PCL fibers to create a composite scaffold and demonstrated
sustained release over 30 days of BSA and chondroitin sulfate [114], therefore decoupling
the drug-deliver component from the fibers themselves.

Finally, nanofibers have been used to improve the behavior of drug-delivering hydrogels
for tissue engineering. Specifically, nanofibers can promote tissue-like cell alignment and
elongation, and promote the deposition of organized, anisotropic matrix [XXX].
Kolambkar et al delivered BMP from an alginate hydrogel embedded around an
electrospun PCL nanofibrous tube and demonstrated synergistic effects of both drug
delivery from the hydrogel and contact guidance by the fibers [203].
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6.6

Delivery of Other Molecules

Moving beyond antibiotics, anticancer drugs and proteins, other unique molecules have
been incorporated. Luu released plasmid DNA from a mixture of predominantly PLGA
random copolymer and a PLA–PEG block copolymer. Release of plasmid DNA from the
scaffolds was sustained over a 20-day study period with a significant burst release [204].
Also, Nie 2007 encapsulated DNA into chitosan nanoparticles that were electrospun into
PLGA/hydroxylapetite fibers and optimized the system for cell attachment, viability and
transfection efficiency [205]. Liang 2005 created a variation where the nanoparticles had
a core-shell structure in order to better protect the contained DNA from the harsh
electrospinning process [206]. Luong-Van 2005 created blended PCL-heparin fibers
with applications in preventing vascular smooth muscle cell (VSMC) proliferation and
graft occlusion. It was found that releasant from fibers prevented proliferation of VSMC
in a bioassay in a concentration dependent manner over 6 days [207]. Also, Gandhi 2009
demonstrated that anti-integrin antibodies could be incorporated into PCL fibers and
successfully transfect human umbilicial endothelial cells [208].

While most systems utilize biodegradable polymers, it may not be possible to incorporate
some molecules into such systems. Verreck 2003 demonstrated that poorly watersoluble molecules such as the antifungal Itraconazole and the serotonin antagonist
ketanserin could be released in a sustained manner from nonbiodegradable segmented
polyurethane fibers [209].

Rather than incorporating the molecule into the fiber, some groups have looked at
coating the fibers with the desired molecule. Casper functionalized PEG with low
molecular weight heparin and demonstrated improved binding of b-FGF [176]. Casper
when on to show that natural polymers, such as collagen or gelatin, could be
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functionalized with the perlican domain I were 10 times as effective at binding b-FGF
[180].

Finally, some groups have tried to better understand the physics drug release from
electrospun fibers. Srikar 2008 proposed that the conventional belief that release occurs
via solid-state diffusion of the encapsulated compound from the fibers into the
surrounding aqueous bath may not be true, due to often seen incomplete release of
molecules over time. Instead, they demonstrate that delivery of fluorescent dye
rhodamine 610 chloride occurs via the desorption of the embedded compound from
nanopores in the fibers or from the outer surface of the fibers in contact with the water
bath [210]. Also, Gandhi 2009 extended this hypothesis to incorporate BSA as well
[208].

6.7

Conclusions

Many different approaches have been developed to deliver a broad range of molecules
from electrospun fibers. Each approach seeks to maintain the biological activity of the
molecule during the electrospinning process or finds a way to integrate the molecule
with the fibers without exposing it to electrostatic forces. Growth factors are an
especially important class of molecules that can be used to drive cell behavior for tissue
engineering applications. Recent work identifies a number of potential ways to
incorporate these molecules; however, many of these approaches have significant
drawbacks, including changing fiber morphology, suboptimal release profiles and
complex manufacturing processes. In the next two chapters, we will present novel
approaches to deliver growth factors from electrospun scaffolds for meniscus tissue
engineering.
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7:

An Anisotropic Nanofiber/Microsphere Composite
with Controlled Release of Biomolecules for Fibrous
Tissue Engineering

7.1

Abstract

Aligned nanofibrous scaffolds can recapitulate the structural hierarchy of fiberreinforced tissues of the musculoskeletal system. While these electrospun fibrous
scaffolds provide physical cues that can direct tissue formation when seeded with cells,
the ability to chemically guide a population of cells, without disrupting scaffold
mechanical properties, would improve the maturation of such constructs and add
additional functionality to the system both in vitro and in vivo. In this study, we
developed a fabrication technique to entrap drug-delivering microspheres within
nanofibrous scaffolds. We hypothesized that entrapping microspheres between fibers
would have a less adverse impact on mechanical properties than placing microspheres
within the fibers themselves, and that the composite would exhibit sustained release of
multiple model compounds. Our results show that microspheres ranging from 10~20
microns in diameter could be electrospun in a dose-dependent manner to form
nanofibrous composites. When delivered in a sacrificial PEO fiber population,
microspheres remained securely entrapped between slow-degrading PCL fibers after
removal of the sacrificial delivery component. Stiffness and modulus of the composite
decreased with increasing microsphere density for composites in which microspheres
were entrapped within each fiber, while stiffness did not change when microspheres
were entrapped between fibers. The release profiles of the composite structures were
similar to free microspheres, with an initial burst release followed by a sustained release
of the model molecules over 4 weeks. Further, multiple model molecules were released
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from a single scaffold composite, demonstrating the capacity for multi-factor controlled
release ideal for complex growth factor delivery from these structures.

7.2

Introduction

Fibrous tissues of the musculoskeletal system are characterized by aligned collagen
bundles that impart non-linear and anisotropic mechanical properties, which enable
load bearing functionality in demanding mechanical environments over a lifetime of use.
Recapitulation of these fundamental structural and mechanical anisotropies is a key
determinant in the development of successful engineered analogues for repair or
replacement of these tissues. One scaffold fabrication technique, electrospinning, can
produce nano- to micron-sized fibers, similar in length scale to native collagen, from a
host of natural and synthetic polymers [52, 53, 211, 212]. Collection of these nanofibers
onto a rotating mandrel [213-215] or implementation of specialized collection surfaces
[216, 217] can further refine scaffolds by aligning fibers to create structural and
mechanical anisotropy within the forming network. By modifying fiber elements such as
composition, diameter, and organization, a wide range of mechanical properties can be
achieved, which in turn can be tuned to tissue-specific applications. Indeed, such fibrous
scaffolds have been used in a wide range of fibrous tissue engineering applications,
including constructs for replacement of the knee meniscus [50], the annulus fibrosus
[129, 218], tendons and ligaments [219], blood vessels [220] and articular cartilage [221,
222]. When seeded with cells, nanofibrous scaffolds have demonstrated excellent
potential for directing ordered ECM deposition, resulting in improved mechanical
properties of the engineered construct with time during in vitro culture [50, 51, 223].
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Despite the potential of these aligned micropatterns to guide new tissue formation,
further functionalization might be necessary to expand their general utility, both in vitro
and with in vivo implantation. One key area for expansion is the ability of nanofibrous
scaffolds to release select molecules in a controlled fashion. Previous work in other
scaffold formats demonstrates the potential of such an approach, for example by
promoting neo-vascularization of porous scaffolds through the dual release of proangiogenic factors (VEGF and PDGF) [123].

Recent work by several groups has

demonstrated that nanofibrous scaffolds can be modified to achieve a degree of
controlled release (as reviewed in [53, 224]). In most cases, molecules or biologic agents
(i.e., antibiotic, growth factors) are delivered from the fibers themselves. This is a
sensible approach, given the high surface area of fibers relative to the volume of the
construct, and the close proximity of the fibers to seeded or infiltrating cells. Specific
examples of delivery from nanofibrous scaffolds to date include antibiotics [155-158, 160,
225, 226], anticancer therapeutics [166-168, 170], proteins [227-231], DNA [204-206],
and growth factors [232, 233]. These successes have been achieved either through direct
blending of the molecule of interest into the polymer solution before electrospinning
[226], or via the utilization of coaxial electrospinning, wherein a customized spinneret is
employed to trap a secondary fluid layer (containing labile biofactors) within the core of
the forming nanofiber [227]. For example, Li and coworkers electrospun silk fibroin
fiber scaffolds containing a core of bone morphogenetic protein 2 (BMP-2) and
demonstrated increased osteogenic differentiation after one month by seeded human
mesenchymal stem cells [234].

Despite this progress, the incorporation of molecules into the electrospun fibers may
have adverse consequences. For example, retinoic acid added at low levels increased the
mechanical properties of single poly(caprolactone-co-ethyl ethylene phosphate) fibers,

103

while bovine serum albumin incorporated at higher concentrations decreased fiber
properties [233]. In another study, Huang and co-workers co-axially electrospun two
drugs into PCL fibers and demonstrated that, based on the limited miscibility of the two
solvents, mechanical properties were significantly altered [235]. Still other issues may
arise when release rates and mechanics are incompatible. For example, Hong and
colleagues co-electrospun two populations of fibers, biodegradable poly(ester urethane)
urea (PEUU) and poly(lactide-co-glycolide) (PLGA), where the PLGA fibers were loaded
directly with the antibiotic tetracycline hydrochloride (PLGA-tet). The PLGA fibers alone
had a modulus that was too high and a breaking strain that was too low for the intended
application (wound closure in the abdomen). However, addition of a PEUU fiber family
decreased the modulus and improved the breaking strain, resulting in more ideal
mechanical properties. While promising, this work shows that the remnant fibers
contribute to the overall scaffold mechanics, and that drug elution rates are dependent
on the fiber properties.

If a fibrous scaffold is to serve the dual roles of load bearing and drug delivery
simultaneously, then this issue is paramount and must be considered in the fabrication
of scaffolds with defined mechanical characteristics.

We report herein a new

modification of the electrospinning system to allow for the decoupling of scaffold
mechanics from biofactor delivery. This fabrication method is based on the wellestablished ability of microspheres to carry and deliver molecules of therapeutic interest
[236]. In this system, drug releasing microspheres are delivered and entrapped within
the fibrous network of the scaffold using sacrificial fibers that are removed upon
hydration. We have previously demonstrated that removal of these sacrificial fibers, at
the proper percentage [107], can act to increase cellular infiltration into these dense
fibrous networks. We hypothesize that entrapping microspheres amongst these
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sacrificial fibers, rather than releasing the drug from the fiber or placing the
microspheres inside the fibers, will mitigate any major changes to scaffold properties.
Further, this method will decouple the degradation rate of the fibers from microspheres,
thus allowing for additional flexibility when designing optimal release profiles. The
system is developed so that compatible solvent systems enable polymeric fiber formation
from organic solvents, while the solvent for sacrificial fibers (water) can maintain PLGA
microsphere in their native form. Finally, by including two populations of microspheres,
we show that multiple factors can be released independently from one another,
providing further design parameters for tissue-specific applications.

7.3

Materials and Methods

7.3.1

Materials

Polystyrene (PS) microspheres (MS) were from either Bangs Laboratories (diameters:
1.94 µm (fluorescent dragon green) and 8.31 µm, Fishers, IN) or MicrosphereNanosphere (diameter: 15.7 µm, Cold Springs, NY). For nanofiber formation,
polyethylene oxide (PEO, 200 kDa) was from Polysciences (Warrington, PA) and poly(εcaprolactone) (PCL, 80 kDa) was from Sigma-Aldrich (St. Louis MO). Tetrahydrofuran
(THF) and N,N-dimethylformamide (DMF), used to dissolve PCL, were from Fisher
Chemical (Fairlawn, NJ). Poly lactide co-glycolide 50:50 (PLGA, inherent viscosity: 0.61
dL/g in HFIP) for microsphere fabrication was from DURECT Corp (Pelham, AL).
Dichloromethane for microsphere fabrication, bovine serum albumin (BSA, Cohen V
fraction), chondroitin 6-sulfate sodium salt (CS), poly vinyl alcohol (PVA, 87-89%
hydrolyzed), and fluorescein (free acid) were all from Sigma-Aldrich (Allentown, PA).
The bicinchoninic acid (BCA) assay kit was purchased from Pierce Protein Research
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Products (Thermo Scientific, Rockford, IL). Dulbecco’s phosphate-buffered saline (PBS)
was purchased from Gibco (Invitrogen, Grand Island, NY).

7.3.2

Electrospinning Nanofibrous Scaffolds using Pre-Fabricated Microspheres

To electrospin fibers containing pre-fabricated microspheres, a high concentration of PS
microspheres (19-109 MS/mL) was dispersed in 10% PEO in 90% ethanol or in 35.7% w/v
PCL in a 1:1 mixture of THF and DMF. The suspension was sonicated for 3 minutes to
disperse the MS and electrospun as in [50]. Briefly, a 10 mL syringe was filled with the
electrospinning solution and fitted with a stainless steel 18G blunt-ended needle that
served as a charged spinneret. A flow rate of 2.5 mL/h was maintained with a syringe
pump (KDS100, KD Scientific, Holliston, MA). A power supply (ES30N-5W, Gamma
High Voltage Research, Inc., Ormond Beach, FL) applied a +15 kV potential difference
between the spinneret and the grounded mandrel located at a distance of 12 cm from the
spinneret. The mandrel was rotated via a belt mechanism conjoined to an AC motor
(Pacesetter 34R, Bodine Electric, Chicago, IL). Additionally, two aluminum shields
charged to +10 kV were placed perpendicular to and on either side of the mandrel to
better direct the electrospun fibers towards the grounded mandrel.

7.3.3

Fabrication and Electrospinning of PLGA Microsphere-Laden Nanofibrous
Scaffolds

Degradable

PLGA

microspheres

were

fabricated

using

a

double-emulsion

water/oil/water technique based on [236]. Briefly, 0.5 grams of 75:25 PLGA was
dissolved in 1 to 4 ml of DCM. The solution was further supplemented with 0.5 ml of 10%
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BSA and homogenized at Speed 5 for 30 seconds using a Homogenizer 2000 (Omni
International, Kennesaw GA). One to 2 mL of 1% PVA was then added and the entire
mixture re-emulsified by homogenization for 1 minute at Speed 1. Hardened
microspheres were collected after gentle stirring for 3 hours in 100 ml of 0.1% PVA. The
collected microsphere solution was then passed through a 70 µm nylon filter (BD
Biosciences, Bedford, MA), centrifuged, and washed 3 times in water. Fabricated
microspheres were lyophilized and stored at -20oC until use. Light microscope images
were taken after fabrication, after filtration, and before lyophilization, and diameters
determined using a custom MATLAB program.

Microsphere density in formed

nanofibers was determined after electrospinning from solutions containing 0.01, 0.03,
0.05, 0.07 and 0.09 g MS/mL PEO solution onto a glass slide for 5 seconds (n=3). For
each condition, three light microscope images were obtained with similar fiber density
per slide, and microspheres were counted in each image.

7.3.4

Fabrication of PCL/MS Composite Nanofibrous Scaffolds

Composite nanofibrous scaffolds (PCL/PCL and PCL/PEO) containing PS microspheres
(15.7 micron diameter) were formed by dual-electrospinning from two opposing
spinnerets onto a common rotating mandrel as in [107]. In one configuration, a PCL jet
(2.5 mL, +15 kV, 12 cm) and a PCL jet with microspheres (2.5 mL/hr, +11 to +16 kV, 6
cm) were electrospun together. In the second configuration, a PCL jet and a PEO jet with
microspheres (2 mL/hr, +16 kV, 6 cm) were electrospun together. Microsphere densities
in the spinning solutions were 0, 0.05, 0.1 and 0.2 g PS microspheres/mL
electrospinning solution. After fabrication, scaffold samples containing PEO were taken
along the length of the scaffold, weighed, hydrated in 50% ethanol for 10 minutes to
remove PEO, lyophilized and reweighed to determine PEO content as a function of
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position. Scaffolds were imaged via SEM (Philips XL20 by FEI, Hillsboro, Oregon)
before and after PEO elution to visualize MS inclusions.

7.3.5

Mechanical Properties of PCL/MS Composite Nanofibrous Scaffolds

For mechanical testing, 30 x 5 mm strips of scaffold were excised with their long axes
oriented in the fiber direction (along the circumference of the collecting mandrel). For
PCL/PEO-MS scaffolds, strips containing ~15% PEO were utilized. Prior to mechanical
testing, all samples were soaked in 50% ethanol for 10 minutes, and then stored in PBS
until testing. The cross-sectional area of each sample was measured using an OptoNCDT
laser measuring device (Micro-Epsilon, Raleigh, NC) combined with a custom Matlab
program [237]. Samples were loaded into an Instron 5848 Microtester equipped with
serrated vise grips and a 50 N load cell (Instron, Canton, MA). Strips were pre-loaded for
2 minutes to 0.5N, after which the gauge length was noted. Samples were then
preconditioned with extension to 0.5% of the gauge length at a frequency of 0.1 Hz for 10
cycles. Finally, samples were extended to failure at a rate of 0.1% of the gauge length per
second. Stiffness was determined from the linear portion of the force-elongation curve,
and modulus calculated by considering sample cross-sectional area and gauge length.

7.3.6

Dual Release from Composite Nanofibrous Scaffolds

PLGA microspheres were formed containing two representative molecules, bovine serum
albumin (BSA) and chondroitin sulfate (CS). BSA-containing microspheres were
prepared as above with a 10% mass/volume BSA solution encapsulated in 50:50 PLGA.
CS-containing microspheres were prepared from a 20% mass/volume CS solution that
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was mixed with 100 µl of 1% PVA with encapsulation in 50:50 PLGA.

The initial

encapsulation efficiency of BSA was determined by dissolving 50 mg of fresh MS in 0.1N
NaOH containing 5% SDS with vigorous agitation for 16 hours. The supernatant was
assessed via the BCA assay, with standards containing 0.1N NaOH with 5% SDS. To
determine CS encapsulation efficiency, 50 mg of MS were dissolved in 8 mL of a 1:1
solution of DCM and H20 with vigorous agitation for 4 hours. After overnight phase
separation, the aqueous phase was removed and CS content determined using the
DMMB assay [67].

Long term release of CS or BSA from PLGA microspheres was evaluated via incubation
in PBS (30 mg MS per 1 mL PBS) at 37°C on a 3-D mini-rocker (Denville Scientific,
South Plainfield, NJ). At defined intervals over 5 weeks, microspheres were pelleted by
centrifugation and the supernatant tested for CS content (via the DMMB assay) or BSA
content (via the BCA assay) as above. At each sampling, fresh PBS was added and MS redispersed by gentle vortexing. Next, composites were formed to evaluate release from
MS when entrapped in a PCL network. In preliminary studies, to image the composite,
PCL was doped with fluorescein and PLGA microspheres were fabricated with
rhodamine B.

Fluorescent and light micrographs were overlaid to identify each

component within the composite system. Subsequently, three microsphere-laden
nanofibrous composites were constructed: one with CS-containing microspheres, one
with BSA-containing microspheres, and one with a 1:1 mixture of CS- and BSAcontaining microspheres. For these studies, rectangles of scaffold (80 mg) were cut
across the length of the mandrel to ensure sample uniformity. Scaffolds were soaked in 5
ml of 50% ethanol for 10 minutes and washed in PBS to remove PEO. Scaffolds were
then transferred to PBS (1 mL) and incubated as above for the MS release study. At set
intervals, the supernatant was removed and CS and BSA quantified as above.
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7.3.7

Statistical Analyses

One-way analysis of variance (ANOVA) was carried out using GraphPad Prism software
(Graphpad Software, La Jolla, CA) with Bonferonni’s post-hoc tests (n=3 for
characterization of MS density, n=5 for mechanical testing, n=5 for evalution of release
kinetics), with significance set at p < 0.05.

7.4

Results

7.4.1

Formation of Nanofibers with Microspheres

Electrospinning from a solution of PEO and pre-fabricated fluorescent polystyrene
microspheres resulted in the formation of fibers with embedded microspheres (Figure
7-1A). Similar findings were noted when PS microspheres were electrospun from a PCL
solution, with thickened regions of PCL visible around the microsphere via SEM (Figure
7-1B).
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Figure 7-1 Fabrication of microsphere-laden nanofibrous scaffolds. (A) Composite light and
fluorescent micrograph showing electrospun PEO fibers with embedded PS microspheres
(diameter 2 microns) distributed along the fiber length (Scale bar = 50 µm). (B) SEM micrograph
demonstating alterations in PCL fiber morphology local to the inclusion of an 15.7 micron
diameter PS microsphere (Scale bar = 25 µm).

PLGA microspheres were fabricated via the water/oil/water double emulsion process
(Figure 7-2A). Microsphere diameters were on the order of 10-20 microns (Figure 72B), with little change through the washing process (data not shown). Increasing the
density of PLGA microspheres in the PEO electrospinning solution increased the density
of microspheres in the resulting fibers (Figure 7-2C,D). Microsphere numerical density
within the fibrous scaffold was higher for solutions starting with microspheres at 0.07
and 0.09 g/mL compared to those starting with lower microsphere concentrations
(Figure 7-2C, p<0.05).
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Figure 7-2 Dose-dependent inclusion of PLGA microspheres in nanofibrous mats. (A) SEM
micrograph showing PLGA microspheres fabricated by the double emulsion technique (Scale bar
= 50 µm). (B) Histogram of microsphere diameter. (C) PLGA microsphere density with a field of
view (FOV) of a PEO fiber mat increases with increasing microsphere density in the
electrospinning solution. *indicates significant difference compared with lower values, p<0.05.
(D) Bright-field images of PEO fiber mats formed from solutions of increasing PLGA MS density
(Scale bar = 500 µm).

7.4.2

Fabrication and Electrospinning of Microsphere-Laden Nanofibrous Scaffolds

As described above, and shown schematically in Figure 7-3, a fabrication system was
developed to entrap microspheres within a fibrous scaffold.

In this technique, the

sacrificial PEO fiber population containing microspheres is co-electrospun with PCL
fibers onto a common rotating mandrel. Fluorescent labeling of PCL fibers (green) and
microspheres (blue), while the PEO component remained unlabelled, identifies the blend
of the three components (Figure 7-4A). Upon hydration, the sacrificial PEO fibers
dissolve away, resulting in a structure in which microspheres are entrapped between
aligned PCL fibers. SEM images of composites before (Figure 7-4B) and after (Figure
7-4C,D) PEO removal shows that microspheres remain entrapped between the aligned
fibers throughout the fabrication process. Notably, this dispersion is seen through the
thickness of the composite when cross sections are viewed end on (Figure 7-4D).
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Figure 7-3 An approach for decoupling drug delivery from scaffold mechanics. Composite
scaffolds are formed from microspheres delivered through a sacrificial PEO fiber fraction coupled
with a stable PCL fiber fraction (Pre-Wash). With dissolution of the PEO (After-Wash), MS
remain entrapped within the slow degrading and surrounding fibrous PCL fibrous network.

Figure 7-4 Realization of composite MS-laden scaffolds with sacrificial content. Bright-field with
overlaid fluorescent image (A, 4X, Scale bar = 50 µm) and SEM (B, Scale bar = 20 µm) of
PEO/PCL/MS composite. In (A), blue shows MS, green shows PCL fibers, and black shows
sacrificial PEO fibers within the composite structure. After PEO removal, microspheres remain
entrapped and distributed between the remaining PCL fibers (C and D, arrows, Scale bar = 10
µm).
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7.4.3

Mechanical Properties of Composite Scaffolds as a Function of Microsphere
Inclusion

To better understand the mechanical consequences of microsphere inclusion, networks
were formed in which a graded concentration of polystyrene microspheres was
entrapped either within or between the nanofibers of the scaffold. PS microspheres (15.7
µm diameter) were used here because PLGA microspheres would dissolve when mixed
into the solvents employed for electrospinning PCL.

Scaffolds were fabricated as

depicted in Figure 7-5A and 7-5D, with one jet used to produce a PCL fiber
population, and a second jet used to produce a microsphere-containing fiber population
of either PCL or PEO. Tensile testing showed that when microspheres were included
within the PCL fiber population, both the stiffness and modulus decreased with each step
of increasing microsphere density (Figure 7-5B and C). Conversely, in composites
where the microspheres were entrapped between fibers after sacrificial fiber removal, no
change in stiffness was observed at any microsphere density (Figure 7-5E). Likewise,
modulus in these composites did not differ from control values at Low microsphere
densities.
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Figure 7-5 Construction and mechanical analysis of composite MS-laden scaffolds. (A) Schematic
of electrospinning PCL/PCL-MS scaffold. (B) Stiffness of scaffold decreases with increasing MS
density (Control = 0, Low = 0.05, Med = 0.1, High = 0.2 g MS/mL electrospinning solution). (C)
Modulus decreases with increasing MS density. (D) Schematic of electrospinning PCL/PEO-MS
scaffold. (E) Stiffness does not change with increasing MS density. (F) Modulus decreases at
medium and high density MS inclusion, but not at low inclusion density. *indicates p < 0.05 from
control.

7.4.4

Controlled Release from Microsphere-Laden Nanofibrous Composites

To determine if molecules could be released from the composite in a controlled fashion,
BSA- and CS-containing PLGA microspheres were fabricated and release rates
determined for both free microspheres and microspheres entrapped within the
composite structures. The encapsulation rate for each molecule was 13% and 11%,
respectively, with a burst release occurring over the first day for free microspheres,
followed by a sustained release over 27 days (Figure 7-6B). The initial burst release was
larger from the CS-containing microspheres compared to BSA-containing microspheres.
By day 27, free microspheres had degraded to the point where clumping of the polymer
was apparent (data not shown). When either BSA- or CS-containing microspheres were
electrospun into the composite, a slightly-more gradual release profile was observed over
the first 5 days, with sustained released occurring thereafter (Figure 7-6C) perhaps due
to washing steps that occurred during PEO removal. Contrary to free microspheres,
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microspheres entrapped in nanofibrous scaffolds remained distinct, most likely due to
physical protection and isolation when media was changed (data not shown). When the
microsphere populations were mixed 1:1 and electrospun into a single nanofibrous
composite (Figure 7-6D, black = CS, red = BSA), a similar graded release profile for
each molecule was observed over 35 days.

Figure 7-6 Controlled release from composite MS-laden scaffolds. (A) Overlay of light and
fluorescent micrographs showing mixed MS population (BSA MS = red, CS MS = black, scale bar
= 250 µm). (B) Sustained release of bovine serum albumin (BSA) or chondroitin sulfate (CS) from
PLGA microspheres with time in physiologic conditions. (C) Sustained release of BSA and CS
from composite PCL/PEO-MS scaffold containing either BSA or CS microspheres. (D) Sustained
release of both BSA and CS from a single composite system containing both BSA and CS
microspheres at a 1:1 ratio.
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7.5

Discussion

Electrospun nanofibrous scaffolds are a promising tool for fibrous tissue engineering as
they provide excellent structural cues and can foster development of anisotropic
mechanical properties similar to native tissues [50]. Indeed, we have grown constructs in
vitro, under chemically defined conditions and with the addition of matrix-promoting
growth factors that reach 50-100% of the tensile properties of native meniscus and
annulus fibrosus [53, 129]. Simply providing a guided micropattern for tissue formation
may not be enough, however, as both tissue development and regeneration occur in the
context of a host of biologic factors whose timing and doses vary considerably. Moreover,
upon implantation of a scaffold, our ability to control the chemical environment (i.e., the
provision of pro-matrix forming growth factors in culture medium) is lost. Further
functionalization of these scaffolds to enable delivery of drugs, growth factors or other
chemicals would further our ability to both guide construct maturation and dictate cell
behavior in vivo and in vitro.

Several recent reports have shown that micro-and nano-particles can be incorporated
into electrospun nanofibers. In one report, Lim and colleagues demonstrated that silica
particles ranging in size from 100-1000 nanometers could be electrospun from a solution
of polyacrylimide to create a ‘bead on a string’ fiber morphology [238]. Also, Dong et al.
incorporated two distinct populations of nanospheres into electrospun polyurethane
fibers, suggesting the ability to multiplex delivered factors, but did not evaluate release
[200]. Towards drug delivery, Melaiye et al. incorporated silver(I)-imidazole cyclophane
gem-diol complexes into tecophilic polymer electrospun fibers, and demonstrated that
release of this molecule from particles within the fibers could prevent microbial growth
[239]. Finally, Qi et al. fabricated BSA-loaded Ca-alginate microspheres and emulsion
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electrospun the spheres within PLLA fibers. In this context, BSA released at a slower
rate and with a lower initial burst than from free Ca-alginate microspheres [202]. While
these previous studies represent early efforts to protect a molecule during fabrication
and release it from a particle in a fiber, they did not address the mechanical
characteristics of the system or how to decouple the fiber function, degradation, and
microsphere release kinetics.

Given the mechanical roles these scaffolds must play upon in vivo placement (where the
tensile moduli of fiber reinforced tissues are on the order of 100 MPa [240]), we
endeavored to create a system where microspheres could be delivered without
significantly disrupting the overall scaffold mechanics. The inclusion of particles within
fibers disrupts individual fiber architecture (Figure 7-1B) and creates local stress
concentrations, thereby modifying the overall mechanical properties of the scaffold.
When the microspheres were included within the load-bearing PCL fibers, scaffold
stiffness decreased even at low microsphere concentrations (Figure 7-5B). Conversely,
in our composite system that contains particles between the fibrous network but not the
fibers themselves, stiffness remained unchanged (Figure 7-5E) at all microsphere
densities explored. Of note, while stiffness did not change in our composite, the modulus
did decrease at the medium and high microsphere concentrations. This result was due to
a slight increase in scaffold cross sectional area with microsphere inclusion caused by
decreased fiber packing, and may be considered a limitation of our design.

Spatial and temporal control of growth factor presentation is an important consideration
in directing cell behavior during development and repair. Delivery of particles within a
fiber may complicate release by coupling molecular diffusion within a fiber and/or fiber
degradation with the release kinetics of the factor from the particle itself. Our approach
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delivers particles via a sacrificial fiber population that is removed immediately upon
hydration. When particles are of sufficient size (20 microns, in this case), they remain
entrapped within the fibrous network but are exposed directly to the aqueous
environment. This approach decouples the release kinetics of the microspheres from the
degradation kinetics of the fibers themselves. Furthermore, using PEO allows for a
compatible solvent system (water) for sacrificial fiber production, such that the PLGA
microsphere structure is not disrupted with exposure to organic solvents (i.e., the
DMF/THF solution used to dissolve PCL). When two model agents, BSA and CS, were
included in microspheres in the composite, release kinetics were independent from one
another and comparable to free microspheres, suggesting that release is indeed
independent of the surrounding fiber population (Figure 7-6).

The potential applications of a composite nanofibrous system that can deliver multiple
factors in a controlled fashion while maintaining mechanical functionality are
enumerable. For example, a cascade of growth factors (i.e., PDGF followed by VEGF)
might be delivered to promote vascularization of the implanted construct [123]. This
would be particularly suited for the knee meniscus, whose dense structure and limited
vascularity does not allow for endogenous repair. Alternatively, one might engineer the
system to provide for instantaneous release of mitogenic (i.e., FGF) or migratory factors,
followed by a delayed release of a pro-matrix forming compound (i.e., TGF-β). This
construction would promote cell infiltration from surrounding tissue and division during
an initial period of repair, followed by transition towards a matrix deposition phase of
development. Delivered factors also need not be solely anabolic/growth promoting. For
example, microparticles might be designed to deliver proteases locally to engender local
matrix disruption to enhance bridging of new matrix between the host tissue and the
implanted material. Similarly, the distribution of particles need not be homogenous,
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with gradients of local release established both through the depth and along the fiber
plane.

While the results of this study are promising, and the system meets our stated design
criteria, some issues remain to be optimized. First, it is not clear how microsphere size
influences mechanical properties; in this work, microspheres were on the order of 20-30
microns. Larger microsphere sizes might further disrupt mechanical properties, while
smaller particles could be lost from the scaffold through the porous structure. Additional
studies are required to examine this variable. Another point of optimization involves the
steric and biologic influence of the particles themselves.

We have previously

demonstrated that both meniscus fibrochondrocytes and mesenchymal stem cells attach
to and infiltrate electrospun PCL scaffolds [50, 107, 129, 218]. While the microspheres in
this formulation are composed of a biocompatible material (PLGA), local pH changes
with PLGA degradation might influence cellular activity. Further, sacrificial fibers were
used here to deliver microspheres. We previously utilized these sacrificial fibers (at a
level of ~40-60% of the composite) to increase scaffold porosity and enhance cell
infiltration into the depth of the aligned nanofibrous structure [107]. For microsphere
inclusion, our highest PEO content was on the order of 15%. It remains to be determined
how this low level of sacrificial fibers (and the potential decrease in fiber packing due to
the microspheres themselves) influences cell infiltration. Future iterations may utilize a
multiple spinneret system comprised of one source jet delivering PCL or another slowdegrading structural fiber population, one source jet delivering PEO fibers, and the final
jet delivering microspheres through additional sacrificial PEO fibers. Such a multi-jet
system would also allow for the provision of additional mechanical functionality via
variation in the mechanical properties of the PCL or slow eroding component [241]. A
final point of optimization is the microspheres themselves.
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We used a traditional

fabrication technique (water/oil/water emulsions) to entrap model compounds in order
to demonstrate multi-factor release.

While sufficient for proof of principle, we did

observe the commonly seen burst release with each compound. Others have shown that
microsphere fabrication methods can be tuned to enable release with a multitude of
profiles, including constant, early burst, and late burst [242]; such methods would be
useful in further tuning towards the intended biologic applications described above.

7.6

Conclusions

Overall, this study describes an approach for the creation of drug-delivering anisotropic
nanofibrous scaffolds for fibrous tissue engineering. In this fabrication method the
inclusion of microspheres does not significantly modify the mechanical properties of the
scaffold or the release properties of the microspheres entrapped within the composite.
Importantly, multiple populations of microspheres releasing unique factors can be
incorporated, allowing for the complex control of cellular behavior through spatially and
temporally-tuned release. Vascular recruitment, cellular phenotype and matrix
elaboration may all be dictated via the proper release of single or multiple factors from
these composites. Rather than creating a simple template for new ECM deposition, this
advanced composite provides higher order functionality for mechanical and biologic
guidance of tissue regeneration.
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8:

Vascularization of VEGF-Loaded Electrospun Scaffolds
for Fibrous Tissue Repair Using Sacrificial Fibers and
Entrapped Microspheres

8.1

Abstract

Aligned electrospun scaffolds provide an instructive environment for fibrous tissue
engineering. Additional functionalization, such as the ability to deliver growth factors
from these materials, would further guide cell behavior and expand the clinical
applications of such materials. Because biofactor inclusion can alter the mechanics of the
scaffold fibers, our goal was to identify alternative delivery techniques for applications in
orthopedic tissues, where scaffold mechanics are important. In this work, composite,
aligned fibrous scaffolds composed of both slow-degrading poly(ε-caprolactone) (PCL)
fibers and sacrificial poly(ethylene oxide) (PEO) fibers were formed via multi-jet
electrospinning. PEO fibers within the composite scaffold were used to directly deliver
biologic factors (burst release) or to entrap poly(lactide-co-glycolide) (PLGA)
microspheres containing these same factors (controlled release). Composites delivering
basic fibroblast growth factor (bFGF) stimulated the proliferation of meniscus
fibrochondrocytes (MFCs) in vitro. When evaluated in vivo, delivery of vascular
endothelial growth factor (VEGF) from these composites enhanced blood vessel density
in the peri-implant space in a dose-dependent manner. This system has the potential to
deliver different combinations of growth factors, inflammatory regulators, antibiotics
and other chemical cues to create a regenerative environment at the site of injury,
restoring tissue function in situations where endogenous repair capacity is limited.
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8.2

Introduction

Tissue engineering of dense fibrous structures of the musculoskeletal system, such as the
knee meniscus and annulus fibrous, presents a particularly difficult challenge. Not only
must the temporary scaffold architecture provide a defined anisotropic mechanical
environment, but the scaffold must also drive the ordered behavior of cell populations
that typically have low density and metabolic activity [52]. Many orthopedic structures,
such as the knee meniscus, exist in challenging environments typified by little vascular
support, high mechanical loads, and consequently, minimal repair potential [119].
Successful repair in this context requires that natural and synthetic scaffolds recruit
and/or maintain a highly active cell population to infiltrate the material and to deposit
organized matrix that regenerates the original tissue structure. In situ cell recruitment is
simpler and more cost effective than implanting scaffolds already loaded with expanded
cells. Significant progress has been made towards matching the mechanical environment
of such fibrous tissues with engineered materials; however, the ability to direct cells,
activate differentiation and promote cell recruitment in these settings is also of
paramount importance [14].

Electrospinning is a simple method to generate polymeric nano- to micron-sized fibers
via electrostatic forces [53]. Various synthetic and biological polymers can be employed
that create a permanent structure or degrade over defined timescales [52, 53, 211, 243].
Fibers can be collected on a variety of surfaces to control organization and alignment,
and multiple fibers can be spun into a single composite scaffold from multiple polymer
sources [52, 107, 213-215]. Electrospinning has been used in many tissue engineering
applications, including blood vessels, tendons, meniscus, annulus fibrosus, and cartilage
[50, 129, 218-222].
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Previously, we have developed a number of different electrospun scaffolds with unique
benefits for orthopedic tissues. We have created scaffolds composed of 100% poly(εcaprolactone) (PCL) fibers that possess relevant anisotropic mechanical properties and
long-term degradation profiles (Figure 8-1A). When seeded with meniscus
fibrochondrocytes (MFCs) or mesenchymal stem cells and cultured in vitro under
defined conditions, the tensile modulus of the neotissue formed was close to that of
native meniscus tissue, with robust matrix deposition and cell distribution throughout
the structure [50, 51]. To further improve the properties of this structure, a multi-jet
apparatus was developed, where multiple fiber populations were collected onto a single
rotating mandrel to generate an aligned, composite scaffold (Figure 8-1B) [107, 147]. In
one illustration, scaffolds containing a blend of PCL fibers and poly(ethylene oxide)
(PEO) fibers resulted in a more porous structure upon hydration, as PEO fibers instantly
dissolved away. Dissolution of the PEO fibers created voids between the PCL fibers, and
with this additional porosity, composite scaffolds were better infiltrated and had
increased matrix deposition with time in vitro compared to scaffolds containing PCL
fibers alone [107]. While extensive in vitro work has been performed, it is not yet clear
how these scaffolds will perform in vivo. In this work, we hypothesized that electrospun
scaffolds containing PCL and PEO would be well tolerated in vivo and would be
populated by cells from the subcutaneous space. Also, we posited that composite
scaffolds containing both PCL and PEO fibers would be better infiltrated than those
containing only PCL fibers, due to the increase in porosity [148].

In addition to fostering cell infiltration, scaffolds should promote cell recruitment and
activation at the repair site. Interestingly, many of the polymers used in electrospinning
have also been used in drug delivery applications as well, suggesting that such scaffolds
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could provide biologic as well as structural cues. Unfortunately, electrospinning utilizes
harsh organic solvents that can denature large molecules such as growth factors [244].
Direct addition of growth factors to the polymer solution prior to electrospinning does
not consistently produce bioactive scaffolds, with several groups demonstrating a
marked loss of activity after spinning [183-185]. In order to overcome this limitation,
alterations to the fabrication process can be implemented, for example through an initial
water/oil emulsion step prior to electrospinning [187, 188], or through post-fabrication
chemical modification of the fibers [130, 171]. Alternatively, specialized coaxial
electrospinning devices can be employed that protect growth factors within a central
channel in the fiber, although the equipment needed can be complex to build and use
[132, 195, 196].

As another option to the approaches mentioned above, we developed two distinct
methods to deliver active biologic factors from aligned nanofibrous scaffolds. The first,
most direct method involved modifying to our sacrificial fibers to enable electrospinning
of PEO in water, without the use of organic solvents or alcohol. We hypothesized that
this all-aqueous formulation would uniquely harbor and release functional growth
factors without any additional fabrication steps (Figure 8-1C). This method represents
a simple technique to release growth factors with an immediate ‘burst’ from sacrificial
fibers.

An alternative approach for delivering bioactive growth factors from fibers is to
incorporate secondary structures in or between the fibers that protect these delicate
molecules during the fabrication process. Approaches include the use of bubbles,
microparticles and microspheres [114, 200-202]. Previously, we developed a technique
to entrap degradable poly(lactide-co-glycolide) (PLGA) microspheres (MS) between
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electrospun PCL fibers by loading the MS into the sacrificial PEO fiber population. The
result is a MS-composite scaffold containing distinct PCL fibers and PLGA microspheres
after PEO removal through hydration (Figure 8-1D) [114]. This technique limits the
mechanical perturbations to the scaffold as the microspheres reside outside the
structural elements, while also creating drug delivery capabilities that are materially
distinct from the structural fibers. PLGA microspheres are FDA approved for use in
humans, and can deliver a broad range of chemicals with diverse release profiles,
including growth factors [245-250]. Multiple microsphere populations can be mixed into
the scaffold, a useful property when delivering time- and dose-sensitive molecules that
work best in concert [123, 251, 252]. Previously, we simultaneously delivered the small
molecules bovine serum albumin (BSA) and chondroitin sulfate (CS) over a month from
a single MS-composite scaffold with distinct release profiles [114].

Figure 8-1 Schematics of the fiber populations, pre- and post-wash scaffold structures, and
hypothetical drug release profiles for scaffolds capable of delivery. (A) PCL scaffold. (B)
Composite scaffold. (C) Composite scaffold with drug delivery. (D) MS-composite scaffold with
drug delivery.
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Having established this delivery framework, the current study sought to deliver growth
factors from the novel MS-composite scaffolds in order to elicit biologic responses both
in vitro and in vivo. Because shear forces and phase separation during microsphere
fabrication, and electrostatic forces during electrospinning, can all result in growth factor
degradation [253], we first assayed for bioactivity in vitro. To do so, basic fibroblast
growth factor (bFGF) was delivered from MS alone and MS-composite scaffolds. bFGF
has a strong mitogenic effect on MFCs and is relatively inexpensive for optimization
studies [10, 111]. Upon confirmation of bioactivity and a favorable response in vivo for
composite scaffolds and MS-composite scaffolds, we next focused on the delivery of
vascular endothelial growth factor (VEGF) from both sacrificial fibers and microspheres
in composite scaffolds, hypothesizing that this growth factor would improve
vascularization of scaffolds in vivo. VEGF is an important factor in the molecular cascade
that controls angiogenesis [254-256], and could play a vital role in healing and
integration after scaffold or neotissue implantation [117, 118]. Previously, VEGF has been
shown to improve vascularity in engineered materials [123, 257-259], with an optimal
release profile similar to that of our MS-composite scaffolds [260]. We hypothesized that
the two techniques (delivery from sacrificial fibers and from entrapped MS) would result
in distinct delivery profiles; while sacrificial PEO fibers dissolve instantly, PLGA
microspheres degrade over weeks or months. Further, the effect of dosage was explored
by including different fiber fractions of PEO-VEGF fibers within the composite scaffolds,
and we hypothesized that vascularization would occur in a dose-dependent manner. The
effects of VEGF were assessed via semi-quantitative histological analysis inside
macropores that transit the scaffolds and serve as vascular conduits. Results from this
work validate this technology as a multifunctional scaffold capable of both mechanical
and biologic instruction for fibrous tissue engineering.
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8.3

Materials and Methods

8.3.1

Fabrication and Characterization of Microspheres

Microspheres (MS) were fabricated using a double emulsion technique [114]. Briefly,
0.5g 75:25 DL-lactide/glycolide copolymer (Purasorb PDLG 7502, generously provided
by Purac Biomaterials, Gorinchem, Netherlands) was dissolved in 1 mL dichloromethane
(DCM, Sigma-Aldrich, Allentown, PA). Next, this solution was combined with 0.5 mL
10% bovine serum albumin containing 0 or 20 µg basic fibroblast growth factor (bFGF,
Peprotech, Rocky Hill, NJ) and sonicated for 5 seconds at speed 10 to form a primary
emulsion. Polyvinyl alcohol (1 mL 1%, PVA, Sigma-Adrich, St. Louis, MO) was added,
and the mixture sonicated again, and subsequently poured into 100 mL 0.1% PVA to stir
gently for 3 hours while hardening. Afterwards, microspheres were filtered to below 70
µm in diameter, centrifuged, lyophilized and frozen until ready for use. The
microspheres were visualized using a scanning electron microscope (SEM, Philips XL20
by FEI, Hillsboro, Oregon) to confirm round, smooth spheres. The average microsphere
diameter was 20 µm [114]. To characterize release from microspheres, 1.5 mL tubes
containing 50 µg microspheres and 1 mL phosphate-buffered saline (PBS) were
incubated at 37°C on a rocker for 7 days. At set timepoints, the tubes were centrifuged,
and the supernatant was removed, stored, and replaced. bFGF concentration in the
supernatant was measured with an ELISA kit (Quantikine, R&D Systems, Minneapolis,
MN). The assay work was performed in triplicate over several distinct fabrications to
ensure consistency of release profile (n=3).

To

determine

if

bFGF

remained

bioactive

after

encapsulation,

a

meniscus

fibrochondrocyte (MFC) proliferation assay was employed. Briefly, 0-3 month old bovine
meniscus tissue was dissected in a sterile fashion, with care taken to remove all
surrounding synovial tissue. The meniscus was minced and plated on tissue-culture
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plastic (Corning, Sigma-Aldrich, St. Louis, MO) in basal media (Dulbecco’s modified
Eagle’s

medium

containing

10%

fetal

bovine

serum

and

1%

penicillin/streptomysin/fungizone). MFCs emerged onto the plate and proliferated over
the course of 2 weeks. For the proliferation assay, 40,000 MFCs were cultured in basal
media (control), plus 50 ng/mL of aqueous FGF, plus 50 mg control microspheres, or
plus 50 mg bFGF microspheres. The microspheres were suspended above the cells with a
hanging cell culture insert (Millicell, Millipore, Billerica, MA). After 3 days, the relative
cell density was determined using the colorimetric MTT assay ((3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide), Invitrogen, Carlsbad, CA) by normalizing to the
control condition (n=3/group, 3 replicates, one representative data set shown).

8.3.2

Fabrication and Characterization of Scaffolds, Composite Scaffolds and MSComposite Scaffolds containing bFGF

To fabricate composite scaffolds, three electrospinning solutions were prepared and
mixed overnight prior to fabrication: 14.3% w/v poly(ε-caprolactone) (PCL, 80 kDa,
Sigma-Aldrich, St. Louis MO) in a 1:1 mixture of tetrahydrofuran (THF, Fisher Chemical,
Fairlawn NJ) and N,N-dimethylformamide (DMF, Fisher Chemical), 10% poly(ethylene
oxide) (PEO, 200 kDa, Polysciences, Warrington PA) in 90% ethanol (EtOH), and 10%
PEO in ddH2O. A custom-built trijet electrospinning device was used that forms an
interpenetrating mesh of distinct polymer fibers [147]. A total of 20 mL of
electrospinning solution was added to syringes that were fixed with 18G needles and
loaded into syringe pumps (2 mL/hr). The needles were charged (+15kV) and
reciprocated using custom fanners to better disperse the fiber jets. A vertical, centrallylocated rotating mandrel (10 m/s) was placed between 3 vertical metallic shields (+5kV),
which helped to guide fibers onto the mandrel. Composite scaffolds with different fiber
fractions were produced with the following configurations: three jets of PCL to form a

129

‘PCL Scaffold’, 1 jet of PCL and 2 jets of PEO in EtOH to form a ‘Composite Scaffold’, 1 jet
of PCL and 2 jets of PEO with 0.05g MS/mL PEO solution in ddH2O to form a ‘MSComposite Scaffold’. The PEO fibers constituted 50% of the composite scaffold and 25%
of the MS-composite scaffold weight immediately after electrospinning, as measured by
mass loss following incubation in an aqueous environment. The difference in PEO
content was attributed to the mass of microspheres remaining in the MS-composite
scaffold after PEO removal, as well as differences in the width of the fiber cloud extruded
from the needles due to the inclusion of microspheres. Both control and bFGF
microspheres were formed into composite scaffolds. After fabrication, all scaffolds were
stored at -20°C. SEM images were captured (Philips XL20 by FEI, Hillsboro, Oregon)
after incubation in 90% alcohol for 2 hours to remove the soluble PEO. Bioactivity was
assessed as described above, using the following conditions: basal media (control), plus
50 ng/mL of aqueous bFGF, plus 80 mg PCL of scaffold, plus 80 mg of blank composite
scaffold, or plus 80 mg of bFGF MS-composite scaffold (n=3/group, 2 replicates, one
representative data set shown).

8.3.3

In Vivo Implantation of Composite Scaffolds and MS-Composite Scaffolds
containing bFGF

PCL scaffolds, composite scaffolds, blank MS-composite scaffolds and bFGF MScomposite scaffolds were implanted subcutaneously in the dorsum of Sprague-Dawley
rats, with approval from the VA Animal Use Committee. All scaffolds underwent 15
minutes of UV sterilization prior to implantation. Each scaffold was placed within a
distinct pouch, and the anatomic location was randomized. After 2 weeks, rats were
sacrificed and the samples dissected with care to maintain the surrounding tissue
capsule (n=3/scaffold type/time point, 2 replicates). Samples were frozen in OCT media,
sectioned onto glass slides and stained for DAPI (Prolong Gold, Invitrogen, Carlsbad,
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CA) to identify cell nuclei. Blood vessels and proliferating cells were identified via
immunohistochemical detection of alpha smooth muscle actin (aSMA, 1:200 dilution,
Abcam, Cambridge, MA) and anti-phospho-histone H3 (PHH3, 1:500 dilution, SigmaAldrich, Saint Louis, MO), respectively, using the rabbit SuperPicture kit (Invitrogen,
Carlsbad, CA). The PHH3 samples were counterstained with hematoxylin.

8.3.4

In Vivo Implantation of Composite Scaffolds and MS-Composite Scaffolds
containing VEGF

The previously described MS-composite scaffolds were fabricated to contain
recombinant rat VEGF 165 (R&D Systems), at either 0 or 16 µg VEGF added per 0.5g
PLGA. Composite scaffolds with PEO fibers containing VEGF were also fabricated to
assess the effect of immediate VEGF release (at differing dosages). The following
configurations were employed with the multijet electrospinner: 2 jets of PEO in 90%
EtOH and 1 jet of PCL to form a ‘Control Composite Scaffold’, 1 jet of PEO in 90% EtOH
and 1 jet of PEO containing 2.2 µg VEGF/mL PEO in ddH2O and 1 jet of PCL to form a
‘Low VEGF Composite Scaffold’, and 2 jets of PEO containing 2.2 µg VEGF/mL PEO in
ddH2O and 1 jet of PCL to form a ‘High VEGF Composite Scaffold’ (see Figure 8-4A).
To determine release profiles, 10-20 mg of composite scaffold (control, low VEGF and
high VEGF), microspheres alone, and MS-composite scaffold (control and VEGF) were
maintained in 1 mL of PBS at 37°C for 1 week. At set timepoints, the tubes were
centrifuged, supernatant removed and fresh PBS was added back. Growth factor release
was determined with a rat VEGF ELISA Quantikine Kit (R&D Systems, Minneapolis,
MN), and normalized to starting biomaterial weight (n=3/group, performed in duplicate,
one representative data set shown).
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After fabrication, rectangles (1mm x 10mm x 15mm) of scaffold were prepared for
implantation. Blood vessel pores were created by cutting 8 equally-spaced 1 mm holes
using a biopsy punch as shown in Figure 8-5B [261]. Constructs were implanted
subcutaneously into rats for 2 weeks as previously described. Upon sacrifice, samples
were excised, embedded in OCT and sectioned en face. Samples were stained for
Picrosirius red for collagens and DAPI for cell nuclei, as described above, as well as with
von Willebrand factor (vWF, 1:1000 dilution, Abcam, Cambridge, MA) using the
SuperPicture Kit to identify blood vessels, as previously described.

In order to semi-quantitatively assess vessel formation in the constructs, samples were
stained with aSMA (n=4-7 pores/construct, 3 constructs/scaffold type; or 12-21
pores/scaffold type total). Using GIMP image software (GNU Image Manipulate
Program, www.gimp.org), the scaffold and background color was removed using the
‘Color Threshold’ function, leaving only the aSMA stain as shown in Figure 8-6A.
‘Positive’ staining was defined as greater than 0.05% color in a given field of view, which
included 1 pore per image. Also, the number of lumens per pore were counted manually
in triplicate (per pore) and averaged across samples.

8.3.5

Statistical Analysis

Significance was determined via 1-way ANOVA for the MTT proliferation assay and
lumen quantification with p < 0.05, followed by Tukey’s post-hoc test. When analyzing
the percent of pores staining positively for aSMA, Fisher’s exact test was used with p <
0.005 to account for 10 direct comparisons possible in the data set. All calculations were
performed SYSTAT software (Chicago, IL).
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8.4

Results

8.4.1

Fabrication and Characterization of Microspheres, Composite Scaffolds and
MS-Composite Scaffolds containing bFGF

PLGA microspheres encapsulating bFGF were fabricated using the double-emulsion
technique. Microspheres were smooth and round in shape (Figure 8-2A), with a similar
size profile to prior studies (~20 µm diameter) [114]. bFGF was released in a sustained
manner over 7 days (Figure 8-2B). When cocultured with MFCs for three days, bFGF
MS stimulated cell proliferation, with a 40% increase in cell density that was comparable
to the addition of 50 ng/mL aqueous bFGF (p < 0.001) (Figure 8-2C). Next, the
microspheres were mixed with PEO electrospinning solution and simultaneously
electrospun with PCL to form a MS-composite scaffold. Also, PCL scaffolds and
composite scaffolds were fabricated to serve as controls. SEM images revealed increased
porosity in composites after PEO removal, consistent with previous findings [107], and
microspheres were entrapped between the PCL fibers in the MS-composite scaffolds
(Figure 8-2D) [114]. The proliferation rate of MFCs did not change with 3 days of
exposure to PCL or composite scaffolds (Figure 8-2E). In contrast, MS-composites
scaffolds containing bFGF increased MFC density by 50%, to levels comparable to the
direct addition of aqueous bFGF (p < 0.001) (Figure 8-2E). This study demonstrated
that bFGF encapsulated in microspheres and MS-composite scaffolds remained
bioactive, despite the fabrication procedures used to create the biomaterials.
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Figure 8-2 Characterization and in vitro bioactivity of microspheres and MS-composite scaffolds.
(A) SEM image of PLGA microspheres (scale bar = 50 µm). (B) Cumulative release of bFGF from
microspheres over 7 days, as measured by ELISA. (C) Exposure to aqueous bFGF and bFGF MS
result in higher cell density after 3 days, as measured by normalized MTT. (D) Schematic and
SEM images of PCL scaffolds, composite scaffolds and MS-composite scaffolds containing
microspheres (circle) (scale bar = 20 µm). (E) Cell density increased after 3 days in conditions
containing bFGF, demonstrating the maintenance of growth factor bioactivity through the
fabrication process. * indicates significant difference from control, p < 0.001.

8.4.2 In Vivo Implantation of Composite Scaffolds and MS-Composite Scaffolds
containing bFGF
PCL scaffolds, composite scaffolds, blank MS-composite scaffolds and bFGF MScomposite scaffolds were implanted subcutaneously in rats for 2 weeks. Upon sacrifice,
all samples were well integrated with the adjacent tissue and surrounded by a thin
vascularized capsule (Figure 8-3A). DAPI staining showed sparse infiltration of the
PCL scaffolds by cells from the subcutaneous space after 2 weeks. Increased scaffold
infiltration was seen for composite scaffolds and MS-composite scaffolds, both of which
contain sacrificial PEO fibers that increased porosity (Figure 8-3C). This finding was
consistent with our past observation that increased porosity improves infiltration in
vitro [107]. Of note, the composite scaffold and MS-composite scaffold appeared to be
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slightly compressed compared to PCL scaffolds (double arrows, Figure 8-3C), despite
all groups starting with the same thickness at implantation. Also, sacrificial PEO was not
removed from the scaffold prior to implantation. In order to assess the effects of bFGF
delivery from MS-composite scaffolds, the proliferation marker PHH3 was used.
Histology revealed an increased number of proliferating cells within the bFGF MScomposite scaffolds compared to other groups, demonstrating the bioactivity of the
encapsulated growth factor in vivo (Figure 8-3D). Also, vascularity was confirmed in
the capsule via aSMA staining (Figure 8-3E, arrows). Notably, vessels did not penetrate
the scaffold under any condition.

Figure 8-3 In vivo response to MS-composite scaffolds containing bFGF. (A) All scaffolds were
well integrated with the adjacent tissue and surrounded by a thin, vascularized capsule. (B)
Schematic of histological sections from the materials. (C) Cells were better distributed through
composite scaffolds (which contain sacrificial PEO) than PCL scaffolds after 2 weeks (scale = 100
µm). (D) More cells stained for the proliferation marker PHH3 in the bFGF composite scaffold
compared to blank composite scaffolds (PHH3 - brown, hematoxylin counterstain - purple, scale
= 50 µm). (E) Blood vessels were identified in the capsules of all samples (aSMA staining, scale =
500 µm).
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8.4.3

In Vivo Implantation of Composite Scaffolds and MS-Composite Scaffolds
containing VEGF

We next investigated the effect of incorporating VEGF in composite scaffolds and MScomposite scaffolds on vascularization. For this, we utilized delivery from both the
sacrificial PEO fibers (using 2 distinct doses) and from entrapped MS (Figure 8-4A).
When electrospun into PEO fibers, the majority (85-93%) of VEGF was released on the
first day (Low = 50 and High = 175 pg VEGF/mg scaffold). In contrast, the release
profiles from the MS-composite scaffolds (as well as the microspheres alone) exhibited a
slower, more sustained release over 7 days to a total of 400 pg/mg (for MS alone) and 5
pg/mg (for MS-composite scaffolds) (Figure 8-4B), with attenuation of release in the
MS-composite scaffold compared to the microspheres alone, as previously observed
[114].

Figure 8-4 Delivery of VEGF from composite scaffolds and MS-composite scaffolds. (A)
Schematic depicting contents for each jet in the electrospinner that collect on a rotating mandrel
to form an intermingled mesh for each type of scaffold fabricated. (B) Cumulative VEGF release
over 7 days as measured by ELISA from composite scaffolds (left), and both microspheres alone
and MS-composite scaffolds (note differences in scale for y-axes) (right).
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Four types of composites containing VEGF were implanted subcutaneously (Figure 85A). After 2 weeks, cells colonized the macropores created as vascular conduits and
deposited collagen (Figure 8-5C,D). Cells and collagen decreased in density with
increasing depth into the scaffold, from both the outer edge of the scaffold and from the
pore perimeter (solid and dashed arrows, respectively, Figure 8-5D). A greater amount
of vWF staining was observed in VEGF-containing scaffolds compared to control
scaffolds, demonstrating the stimulation of blood vessel formation with VEGF delivery
(Figure 8-5F,G). Within the pore, cell organization changed with increased VEGF
delivery, with circular structures reminiscent of lumens identified at high VEGF doses
(arrows, Figure 8-5H). aSMA staining confirmed the presence of blood vessels, with
more lumens present in VEGF composite scaffolds compared to control composite
scaffolds (Figure 8-5I). Similar staining patterns were observed in VEGF MScomposite scaffolds (Figure 8-5J), where VEGF scaffolds exhibited significantly more
staining for aSMA than control scaffolds.
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Figure 8-5 In vivo response to MS-composite scaffolds containing VEGF. (A, B) Schematics of
different electropun materials, and the areas that were analyzed histologically in C-D, F-G. (C)
DAPI staining and (D) Picrosirius red staining of a pore in the scaffold, showing cells and
collagen, respectively (scale = 500 µm). (E) Schematic of the area analyzed histologically in H-J.
(F, G) vWF staining of pores show improved vascularity in the composite scaffolds containing
VEGF. (H) DAPI staining shows progressively more organization of cells into lumen-like
structures (arrows) with increased VEGF delivery (scale = 100 µm). (I, J) aSMA staining of pores
show significantly more vessels in VEGF-containing scaffolds (scale = 100 µm).

Image analysis was used to quantify the aSMA staining prevalence and the number of
lumens per pore (Figure 8-6A). While there was variability in the magnitude of
vascularization between animals, the trends were similar (Figure 8-6B). ‘Positive
staining’ was defined as >0.05% color per image, which included a single pore. For
control composite scaffolds, only 30% of pores stained positively for aSMA. Conversely,
60% of pores for low VEGF composite scaffolds and 100% of pores from high VEGF
composite scaffolds stained positively for aSMA, demonstrating a dose-dependent
response in vessel recruitment after 2 weeks in vivo. Similarly, VEGF MS-composite
scaffolds resulted in 95% of pores staining positively for aSMA, compared to only 54%
for control MS-composite scaffolds (Figure 8-6C). The aSMA stain identified both early
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capillary formation, seen as non-distinct shapes within the pore, as well as organized
circular lumens, representing competent blood vessels. Significantly more lumens were
found in the presence of both high VEGF composite scaffolds and VEGF MS-composite
scaffolds, demonstrating the efficacy of VEGF delivery from both fibers and
microspheres (Figure 8-6D).

Figure 8-6 Quantification of enhanced vascularization through VEGF delivery. (A) Representative
image demonstrating the image processing used to clarify the aSMA staining. (B) The amount of
aSMA staining in composite scaffolds varied in magnitude between animals, but followed a
similar pattern (2 representative animals shown). (C) High VEGF composite scaffolds and VEGF
MS-composite scaffolds stimulated vascularity compared to other groups (positive stain threshold
> 0.05% color, * indicates difference from respective control, p < 0.005). (D) Similarly, high
VEGF composite scaffolds and VEGF MS-composite scaffolds had more lumens per pore
compared to control conditions (line indicates difference, p < 0.05).
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8.5

Discussion

The ability to control cell behavior in engineered tissues may be critical to successful
tissue regeneration. This is particularly true in fibrous tissues, where extreme
mechanical forces, reduced metabolic activity, and little access to blood supply pose
significant challenges. Further, mechanical cues alone from the surrounding
environment may not be sufficient to control cell fate. For example, mesenchymal stem
cells, which are easily accessible and possess a number of appealing properties, may need
significant chemical guidance to develop a stable and appropriate phenotype [262]. With
this work, we present a range of techniques for delivery of bioactive growth factors from
electrospin fibrous scaffolds (Figure 8-1) that do not affect the overall mechanical
properties of the scaffold, and that can be tuned to deliver different types of factors with
time-varying release profiles.

Because only small molecules were previously delivered from electrospun MS-composite
scaffolds [114], we first demonstrated that active growth factors could be encapsulated
and released from the materials, eliciting a biological response both in vitro and in vivo.
Exposure to microspheres and MS-composite scaffolds containing bFGF stimulated MFC
proliferation to similar levels as the addition of 50 ng/mL aqueous bFGF, despite
differences in dosage (Figure 8-2). Further, while previous work washed out the PEO
fibers prior to cell seeding, we did not remove PEO prior to use, further simplifying the
scaffold preparation process. Allowing the PEO to dissolve in situ did not adversely affect
cell proliferation or morphology, or affect in vivo behavior (data not shown). In contrast,
while control PLGA microspheres did not affect cell behavior in vitro, PLGA
microspheres caused a heightened immune response in vivo, stimulating in a slight
increase in vascularity for all MS-containing scaffolds, perhaps due to the acidic byproducts of PLGA degradation. An increased number of immune cells were identified
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using H&E in MS-composite scaffolds compared to composite scaffolds without MS
(data not shown). Finally, we demonstrated that similar to prior in vitro work, scaffolds
containing sacrificial PEO fibers resulted in better cell infiltration in vivo due to an
increase in the porosity of the scaffold.

Interestingly, the doses of VEGF that stimulated vessel formation were significantly
lower than previous reports [123, 263, 264]. While we attempted to encapsulate
comparable levels of VEGF to prior work, a significant proportion of the growth factor
dosage was either excluded during fabrication or denatured, according to ELISA
measurements. Despite the low quantity of VEGF delivered from both sacrificial fibers
and entrapped microspheres, the angiogenic response in vivo was robust for all
conditions, suggesting that either the ELISA results were misleading or that significantly
lower doses of VEGF are needed to stimulate a vascular response than previously
reported. Indeed, many reports only describe the theoretical VEGF loading prior to
biomaterial fabrication, and they may also experience similar decreases in growth factor
dosage after material fabrication.

Two distinct release profiles elicited similar responses in vivo. A relatively large initial
burst of VEGF from composite scaffolds resulted in similar vascularization as a much
smaller, sustained release of VEGF from MS-composite scaffolds (a 40-fold difference in
dosage). Aside from minimizing growth factor expense, the materials used here present
unique opportunities for designing delivery schemes that closely resemble natural
biological cascades in vivo. For example, a burst of VEGF could be followed by a
sustained release of platelet-derived growth factor, which demonstrated improved vessel
maturation compared to VEGF alone [123, 265]. Or, an initial burst of antibiotic could
help prevent infections associated with surgery [266].
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While this work presents a number of interesting new techniques to deliver growth
factors from electrospun fibers with distinct release profiles, some limitations do exist.
First of all, it is unclear whether the vessels present at 2 weeks would continue to mature
or recede with time in vivo. Using our system, we could deliver additional growth factors
that promote vessel maturation, such as the VEGF/PDGF combination mentioned
earlier. Further, it is unclear if the 1 mm pores would be sufficient to sustain the
metabolic needs of the cells in the scaffold, and more testing must be conducted to
understand the effect of such pores on the mechanical properties of the material.
Another approach to promote vascular invasion would be to include a large-diameter
sacrificial fiber population that creates pores wide enough to harbor capillaries and other
blood vessels. Finally, the subcutaneous space is significantly different from the synovial
environment of the knee, so biomaterial degradation, release profiles and biological
response will also need to be studied in that context. Large animal studies are on-going
to assess the role of both composite scaffolds and growth factor delivery from such
scaffolds.

8.6

Conclusions

Growth factors are a powerful tool to control cell behavior in tissue engineering
materials. Because fibrous tissues are especially challenging to engineer, incorporating
the capability to deliver growth factors from electrospun scaffolds without compromising
mechanical properties will improve the success of such materials. Two novel approaches,
one simple method that allows for a burst release and a more complex method that
allows for sustained release, can be combined in a wide array of ways to generate unique
delivery schemes that mimic natural cascades or promote regenerative behavior in the
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neotissue. With this work, we hope to bring electrospun scaffolds closer to a clinically
successful therapy for fibrous tissue repair.
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9:

Conclusions and Future Work

Meniscus repair remains elusive in medicine today. Since meniscus tears are one of the
most prevalent injuries in orthopedics, a successful meniscus treatment will prove
extremely valuable and lucrative, and will have a significant impact on the orthopedic
field. However, despite major efforts by many researchers around the world, we have not
been able to engineer a structure that mimics the complexity of the native tissue itself or
regenerates the tissue in a functional way. Not only is the meniscus composed of various
specialized cell populations, multiple layers of uniquely-oriented collagen fibers, and
distinct regions of proteoglycan that all blend seamlessly together, but also the overall
shape of the tissue features curves and arches that must precisely match the overlaying
femoral condyles and underlying tibial plateau in order to successfully balance joint
mechanics, creating an architectural challenge on many levels.

Three potential repair schemes exist for a degradable tissue engineering meniscus
therapy. In the simplest case, a tear is filled with a degradable material (Figure 9-1A)
that restores continuity of the tissue across the injury region, either through the material
itself or by delivering chemical cues locally. In cases where complex tears require entire
regions to be resected, a patch of material would be inserted (Figure 9-1B) that can
harbor cells and also match the surrounding physiological characteristics. Finally, in the
most extreme situations, the entire meniscus can be removed and replaced (Figure 91C) by a complete meniscus construct, complete with insertion sites to the bone.
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Figure 9-1 Potential treatments after a meniscus injury. (A) A material is used to promote
integration across a clean meniscus tear. (B) After meniscectomy, the removed tissue is replaced
with new material, capable of recapitulating the function of the resected tissue. (C) In extreme
cases, complete meniscus replacement is required, with insertions into the tibial plateau at the
meniscus horns.

We believe that the most promising approach is to create a meniscus patch (Figure 91B), due to the prevalence of meniscectomy after injury. By maintaining a majority of the
original tissue, joint mechanics are minimally changed, and guide patch insertion and
geometry. Based on the work described in this thesis, as well as other work performed in
the lab, we recommend the repair procedure described in Figure 9-2. Specifically, an
electrospun patch should include sacrificial fibers to increase porosity, which promote
maturation and result in better integration properties with native tissue. Hastening these
properties will decrease the amount of time a patient is non-weight bearing after
implantation. Also, drug-delivering microspheres should be entrapped between the
fibers in the scaffold, and vascular conduits formed to support cell metabolism during
regeneration. The addition of expanded cells to the exterior of the scaffold will further
improve integration, although the cost associated with isolating and expanding
autologous cells may outweigh this benefit. Based on current work, we also recommend
that a cocktail of growth factors are delivered from the electrospun material. These
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chemicals should promote the properties of immature, healing meniscus in the
neotissue, and create a regenerative environment that stimulates optimal tissue
formation. Specifically, we propose a short-term release of bFGF (to increase cell density
around the repair site) and VEGF (to stimulate early vascularization that supports
regeneration) from sacrificial fibers, along with delivery of both TGF-β (to stimulate
matrix production) and PDGF (to mature /sustain existing blood vessels) from
entrapped microspheres. With this approach, vasculature would be continuously present
from early timepoints, and integration/maturation properties would slowly improve over
time. Eventually, as the original tissue is regenerated through matrix deposition, the
scaffold and associated vascularity will recede, leaving a tissue that is functionally similar
to the original tissue.

Figure 9-2 A potential meniscus repair scheme.
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Future work can explore the delivery of other types of molecules from electropun
scaffolds to promote meniscus repair. For example, early work suggests that enzymes
such as hyalurodinase could be used to decrease matrix density at the repair site [267],
allowing for more cell migration and new matrix deposition that spans the injury region.
Further, regulators of the immune response, such as dexamethasone, could be delivered
locally, tempering inflammatory processes that might inhibit regenerative behavior.
Because both short- and long-term delivery schemes are possible, with multiple fibers
and microsphere populations in a single scaffold, this biomaterial provides a significant
amount of flexibility in terms of delivery of different factors that support regeneration.

Despite the progress that has been made to date in creating a meniscus repair patch, a
number of challenges remain. Specifically, our current fabrication technique creates thin,
flat sheets of scaffold, and it is unclear how these can be formed into the 3-sided c-shape
of the meniscus. Once we have identified a way to create the overall architecture, other
surgical realities must be tackled. Current technology allows for measurement of the
exterior rim of a resected region using an arthroscopic measuring tape (used in the
Menaflex procedure), but a new device would be needed to measure the radial thickness.
Further, we need to develop a way to cut the scaffold to the correct dimensions, with
minimal damage to the remaining scaffold. The material currently requires delicate
handling, which is unlikely in an orthopedic OR. It ideally must also be inserted
arthroscopically, as opening the knee is costly and time-consuming, and will significantly
limit the use of such a therapy. Finally, while we have demonstrated that new matrix will
interface the scaffold and native tissue, temporary sutures or a glue may help ensure
scaffold stability prior to maturation and must be thoroughly tested.
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Prior to human studies, a number of large animal studies will be crucial in
understanding the potential for success. The in vitro work performed in this thesis
provides a significant amount of information for designing in vivo studies. However, the
synovial environment is very different from both the in vitro culture conditions and the
subcutaneous space in a rat, so we must test the behavior of cells on these scaffolds in the
knee, as well as the effects on the material properties and degradation rates of the
polymers that are used. Preliminary studies in an ovine model show some cell infiltration
into the scaffolds, but that the scaffolds become dislodged over time [148]. Further, we
will need to test if local growth factor delivery stimulates cell behavior in ways similar to
in vitro and subcutaneous in vivo studies, which is not a liquid environment like the
knee.

Finally, while a patch may restore joint mechanics and minimize pain to the patient, the
ultimate goal is to extend the period of time before a patient must receive a knee
replacement, ideally removing the need for that surgery entirely. While total knee
arthroplasty (TKA) is relatively routine and has a high success rate, it is a major surgery
with large associated costs both in medical expenses as well as in lost wages during
recovery. Also, revision surgeries are tricky and expensive, and with the population
aging, so we must delay the need for such extreme surgeries as much as possible.
Delaying the onset of osteoarthritis, and subsequent TKA surgery, by maintaining joint
mechanics through the use of such a patch will make this therapy a success, and will
likely result in the therapy being embraced by both surgeons who would finally have a
clinical option for their patients beyond resection, and payers who would be happy to
decrease the number of expensive TKAs.
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Overall, I must believe that successful meniscus regeneration will some day exist,
because we have been able to conquer many other challenging conditions. The problem
is lofty: meniscus repair requires a mix of architectural, chemical and biological
optimization and design. It is evident that the solution will not be straightforward, but
the successful design and implementation of such a therapy will certainly revolutionize
the field of orthopedics.
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